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The transmissible spongiform encephalopathies (TSEs) are a group of neurological 
disorders caused by the conversion of the cellular prion protein (PrPc) into a structurally 
distinct isoform (PrPSc). PrPc is a cell surface glycoprotein, which binds copper via a 
sequence of highly conserved repeats within its N-terminus. Data on the genetic regulation 
of PrPc expression is sparse, and its function has been the topic of much unresolved debate. 
This study aimed to determine the normal cellular methods regulating PrPc expression and 
metabolism, and to advance current understanding of its function.
The importance of copper is clearly demonstrated both at the gene level, with transcription 
significantly increased in PrP null cells in response to increased exogenous copper 
concentrations, and at the protein level. Copper has previously been shown to induce PrPc 
internalisation. Here it is shown that concentrations of copper, clearly within physiological 
parameters, showed a significant and rapid internalisation response, and that the octameric 
repeat domain and palindromic region are essential for this reaction. PrPc protects against 
copper toxicity induced both by the copper ion itself and the oxidative stress that Fenton 
reaction of the copper ion can induce. Oxidative stress also stimulates both the prion 
promoter, with up regulation induced by DMSO, and a PrPc mediated cellular protective 
reaction in response to DMSO and xanthine oxidase insults. The octameric repeat domain 
and the hydrophobic region are necessary for protection against both copper and oxidative 
stress insults, suggesting that they are highly important for PrPc function. The results 
support the central role of the octameric repeat region and copper binding in the 
metabolism and function of PrP°, and also provide insight into the importance of other 
regions in both copper and oxidative stress response.
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The Transmissible Spongiform Encephalopathies (TSEs; also known as prion diseases) are 
a group of diseases characterised by spongiform changes in the brain tissue. Disease onset 
manifests as dementia and loss of motor function, leading ultimately to death. The TSEs 
have received much attention in recent years due to publicity surrounding the increase in 
cases of Bovine Spongiform Encephalopathy (BSE) in cattle and the emergence of variant 
Creutzfeldt Jakob disease (vCJD) in humans. A possible link between the two has caused 
much concern.
BSE and vCJD are the most widely known of the TSEs. Other members of the TSE family 
include scrapie in sheep and goats; chronic wasting disease in elk and deer; and 
Gerstmann-Straussler-Scheinker syndrome (GSS), fatal familial insomnia (FFI), and Kuru 
in humans. In humans, hereditary and sporadic CJD onsets in later life, usually over the 
age of 60, with patients displaying the symptoms of dementia and loss of motor function. 
In these cases death is rapid, usually within 3 months of the onset of symptoms. Post 
mortem examination of these patients reveals the spongiform changes in the brain from 
which these diseases derived their name, sometimes accompanied by plaques of insoluble 
amyloid-like protein. vCJD, the form linked to BSE, differs from this in that onset usually 
occurs in much younger patients (of age 15-30 years) and progression is slower with death 
12-15 months after the onset of symptoms (Will & Ward, 2004).
Despite the transmissible nature of the agent the majority of cases (around 85%) in humans 
are sporadic or hereditary, thought to be caused by somatic or autosomal dominant 
inherited mutation in the prion gene (Tabrizi et al., 2003). Following the onset of 
symptoms, disease progression is rapid and the effect of dominant inheritance on affected 
families has made the search for prevention and treatment for those affected vital.
The emergence of these diseases is not a recent event. Cases of scrapie in sheep were 
being reported in the eighteenth century, although the disease may have been present 
before this time (Brown & Bradley, 1998). Even the early reports show appreciation of the 
infectious nature of the disease. The transmissible nature was further corroborated in 
1936, due to accidental inoculation of flocks of sheep with scrapie from a vaccine against
1
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louping-ill virus. A suspension of brain, spinal cord and spleen tissues from sheep with the 
louping ill virus was used to make the vaccine. The tissues had been appropriately treated 
to be used as a killed vaccine (Gordon, 1946). The scrapie agent was in one or more of the 
tissues used for the vaccine, it was resistant to the denaturing conditions used to prepare 
the louping-ill virus inoculum, and had an incubation period of at least two years. At this 
time the agent responsible was thought to be a slow virus. However, it was appreciated 
that the nature of the virus was unusual, it was very small, resistant to inactivation by 
chemicals and heat, and had an indefinite life in storage (Gajdusek, 1967).
Early investigations into the scrapie agent indicated that it was resistant to methods usually 
able to deactivate viruses, such as nucleases, UV irradiation and heat, but unstable in 
protein denaturing agents such as protease K, trypsin and urea (Prusiner, 1982). From this 
information the ‘protein only’ hypothesis of the scrapie agent was proposed. This was the 
first report of a protein able to cause infection independently of a viral or other foreign 
agent, and is now widely accepted as the correct theory of prion diseases. The term prion 
protein (PrP) was first proposed by Stanley Prusiner, who used it to define the agent as an 
infectious protein. The term is short for proteinacious infectious particle. Later it was 
determined that this disease isoform (PrPSc) was a conformationally altered isoform of a 
normal cellular protein (PrPc). Early studies much overlooked this normal isoform in 
favour of the disease isoform. However, more recently an appreciation of the need to 
understand the role of the protein in health to understand how it malfunctions in disease 
has resulted in considerable investigation into PrPc.
Before the start of the BSE epidemic in 1985, the existence of the TSEs was virtually 
unknown. The BSE epidemic brought TSEs into the public consciousness, not only 
because of their detrimental affect on farming and agriculture, but also due to a potential 
link to vCJD. The BSE epidemic was thought to be caused by the feeding of meat and 
bone meal (derived from sheep and cattle) to cattle (Wilesmith et al., 1992; Collee & 
Bradley, 1997a; Pattison, 1998). Some of this meat and bone meal was thought to have 
come from infected animals so the disease may be passed on by ingestion of the infective 
agent. Since this linked the consumption of infected foodstuffs and disease, when the new 
phenotypic variant of CJD (vCJD) emerged for the first time in 1996, this caused a nervous 
public to place the cause firmly with eating infected beef.
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The cost to farming of the BSE epidemic was devastating. Not only did beef sales fall, but 
also new and strict restrictions on the quality of beef for consumption were enforced. The 
Feed Ban prohibited the use of animal protein in animal feed to prevent this route of 
transmission. Only certain parts of the animal could be used for consumption and meat 
had be prepared in such a way that there was no risk of brain or spinal cord contaminating 
it. This was known as the Specified Risk Material Control and banned the use of 
mechanically recovered meat, since mechanical preparation stripped meat from the bone 
by high pressure and there was a high risk of infected material contaminating the final 
product. The Over Thirty Months Rule required that cattle for meat had to be sent to the 
abattoir when still under 30 months in age (Food Standards Agency, 2005). To make 
matters worse for Britain’s farmers, the EU imposed a ban on exports of British beef, 
effectively destroying the overseas market and causing further financial problems for the 
UK agricultural industry. Another cause for concern was that several cases of vCJD had 
been reported in farmers implying an increased risk may arise from working with infected 
animals. However, whilst this is a consideration for farmers, veterinary surgeons, abattoir 
workers, and butchers, the link between working with infected animals and developing 
vCJD is still unproven, and providing precautions are taken workers should not be at 
unacceptable risk (Collee & Bradley, 1997b).
Some of the restrictions imposed are still currently in place (The Feed Ban and the 
Specified Risk Material Control) and are deemed to have made the quality of British beef 
much safer, others have been relaxed (The Over Thirty Months Rule) since the number of 
cases has declined steadily to almost negligible levels (Pattison, 1998). Instead a BSE 
screening programme for cattle over the age of 30 months has been implemented to reduce 
the risk of infected meat entering the food chain (Food Standards Agency, 2005).
The spread of chronic wasting disease (CWD) amongst deer and elk in the wild has also 
become a cause for some concern. It was originally thought that outbreaks of CWD were 
localised and self-limiting. However recently it has become evident that this disease is 
now widespread and still spreading. Since this is happening in wild populations the spread 
cannot be attributed to farming practises. Links have been demonstrated between deer 
grazing on land where CWD infected deer have previously grazed or have decomposed 
and the development of CWD. Also uninfected deer grazing with infected deer are at 
increased risk of developing CWD. This has lead to the hypothesis that the infective agent 
can persist for considerable periods in soil after an infected animal has died and
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decomposed, and can be transmitted from the saliva and faeces of infected animals to those 
grazing around them (Miller & Williams, 2004; Miller et al., 2004). In addition the 
potential for transmission from infected sewage sludge on agricultural land has also been a 
matter of concern. Since it is unknown if CWD or other TSEs such as BSE can transmit to 
humans this way, such potential transmission is of concern. Potentially farm produce 
grown on land where infection has been present previously or where infected animals may 
have grazed could pose a threat to human health. However, although cattle could 
potentially be infected this way, infection rates would not be high enough to sustain the 
epidemic and human contact with soil and vegetable crops is considered acceptably low 
risk (Gale & Stanfield, 2001).
Whilst public perception of the risks associated with eating infectious meat has not 
diminished, the general public are widely influenced by media attention, and since cases of 
BSE and vCJD are in decline, interest has turned to more current threats, such as MRS A 
and bird flu. There are, however, still important issues that need to be resolved, including 
how to deal with infected sheep and cattle, especially since the scrapie agent appears so 
resistant to heat and denaturing agents. As discussed above, the worry that prions may 
remain in the soil for prolonged periods of time after the animal has decayed, or may enter 
the water supply is a matter of some concern. Also the potential for spread from milk from 
contaminated animals has caused worry. However the World Health Organisation (WHO) 
has found no evidence of infectivity from milk of infected animals, and on this basis milk 
is deemed to be safe. Finally, despite the reduction in both the number of BSE and vCJD 
cases, the incubation period of the disease is prolonged, in some reports up to forty years 
(Croes et al., 2002), and there is no way of knowing how many humans could be 
incubating a disease that takes so long to present symptoms.
Diagnosis is a problem for the TSEs in both humans and animals. By the time of 
symptomatic presentation the disease is advanced, and once the brain tissue has been 
destroyed there is currently no way to reverse the damage. Therefore early diagnosis is 
essential to maintain the quality of life of the patient. Much research has focused on this 
problem with many hopeful avenues proving ineffective. Many current diagnostic 
methods require using techniques such as immunohistochemical analysis of tissue sections 
and western immunoblotting for the PrPsc agent in brain tissue post mortem, which 
certainly does not allow for early diagnosis (Kovacs et al., 2004; Gavier-Widen et al., 
2005). Attempts have been made to find PrPsc in blood samples or, alternatively, to screen
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for changes in blood chemistry that occur during the early stages of the disease with little 
success. However recently an amplification reaction of PrPsc has been proposed as a 
possible mechanism for detecting very low levels of PrPsc. The technique is called protein- 
misfolding cyclic amplification (PMCA) and has been shown to be sensitive enough to 
detect PrPsc in blood with 100% specificity (Saborio et al., 2001; Castilla et al., 2005). 
However, despite being a promising early diagnostic test, this is still highly experimental 
and would not yield rapid results. Accordingly, it might not be appropriate for use as an on 
site test for farmyard animals but may have a place in human diagnostics.
In addition to the problem of diagnosis there is currently no cure for prion diseases. 
Treatment focuses on managing the symptoms and making patients comfortable. A great 
deal of research has focused, ineffectually, on finding a cure. Pentosan 
sulphate/polysulphate is known to cure PrPsc infected cells in vitro and so has been 
suggested as a potential treatment. Recently pentosan polysulphate was use to treat a 
eighteen year old (at the start of treatment) male with advanced vCJD (Todd et al., 2005). 
Drug delivery had to be by daily cerebrovascular infusion and some evidence of 
improvement in awareness and sleep cycles was detected in the patient. However, despite 
improvement, brain atrophy continued to progress, and, given the unpleasant 
administration process of the drug, investigations still continue into finding a better agent 
for treatment of these diseases.
The problem of the long incubation period coupled with the difficulties in detecting the 
scrapie agent impacts on other areas of health care. The potential transmission of CJD by 
use of human pituitary derived hormones was recognised even before the start of the BSE 
epidemic (Koch et al., 1985), and by 2006 it was documented that at least 160 cases of 
CJD had been transmitted to patients in this way (Lewis et al., 2006). CJD is also known 
to have been transmitted to patients by cadaveric dural grafts. Patients that developed 
iatrogenic CJD as a result of receiving such grafts presented symptoms anywhere between 
16 months and 23 years (Thadani et al., 1988; Martinez-Lage et al., 1994; Kobayashi et 
al., 2003), therefore the onset of the disease can be prolonged. As a result it is difficult to 
estimate how many patients could have been infected and allow physicians to provide the 
appropriate follow up support.
Blood and blood product transmitted TSE infection has become a cause of concern. Blood 
may be collected from a person incubating the disease and distributed unknowingly to
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many other people. Several cases of CJD transmission this way have been confirmed and, 
due to the strict criteria for diagnosis of transfusion acquired infection, more may have 
occurred but been overlooked (Llewelyn et al., 2004; The vCJD Working Party of the 
Standard Advisory Committee on Transfusion Transmitted Infections, 2005). Blood 
products in Europe must comply with specific guidelines concerning the quantity of white 
blood cells in the final product, since leucocytes are known to express PrP. However, it is 
not possible to remove the leukocyte population altogether without great excessive cost to 
the NHS and additionally, it has not been determined if the scrapie agent can exist free in 
the blood plasma. If it can be transmitted free in plasma the risk cannot be eradicated since 
even packed cells contain plasma. The risks are compounded for neonatal care where 
blood and blood products are split into several smaller bags, and so blood from one 
infected donor may potentially reach several recipients. In light of current knowledge on 
the transmission of the TSEs, new restrictions on blood donors have been introduced. 
These exclude people who have received human pituitary derived hormones, patients who 
have received human dura matter grafts or corneal grafts, people identified as being 
members of a family at risk of inherited prion disease, and people who have received blood 
or blood products since 1980 (UK Blood Transfusion Services, 2005). The potential for 
transmission has been a cause of much distress to patients requiring blood products on a 
regular basis, such as haemophiliac patients who have already lived through the risk of 
HIV and hepatitis B from the blood products they have received only to find out that they 
may now be at risk of vCJD also.
The NHS is further affected by the lack of knowledge on how vCJD can be transmitted. 
Studies have shown that the disease protein can become attached to surgical instruments so 
firmly that normal decontamination procedures are rendered useless. If these instruments 
are then used on further patients, the disease could be passed on through contact. 
Consequently surgical instruments used for procedures where there is contact with high or 
medium risk tissues in patients with a potential risk of incubating CJD should be destroyed 
after use or kept only for research purposes (World Health Organisation, 2003). This has 
been of considerable concern with tonsillectomies, where the tissue removed contains high 
numbers of leucocytes and shows positive immunohistochemistry for PrPsc during disease 
(Frosh et al., 2001). Further disciplines such as endoscopy (Bramble & Ironside, 2002), 
dentistry (Azarpazhooh & Leake, 2006) and opthalmics (Hogen & Cavanagh, 1995) are 




Healthcare professionals are also themselves affected by the potential risks of working 
with infected patients. Although there has been no evidence to date of transmission from 
person to person by contact such as that seen in the care environment, there are risks to 
health workers in terms of contaminated blood and bodily fluids, however as long as 
standard infection control practises are applied (for example gloves, waste bags, and sharps 
bins) the risk to healthcare workers is minimal. Other settings where risk may be 
heightened include post mortem examination of tissue and surgery (ACDP/SEAC Joint 
Working Group, 2003).
The TSEs still have wide reaching effects both on farming and public health. This is area 
of so many unknowns and uncertainties that much still needs to be done to establish exact 
dangers to the public. More needs to be understood about the disease agent to best 
determine how to treat and manage or prevent prion disease. Elucidating the role of the 
normal isoform of the prion protein (PrPc) may provide important information on disease 
pathogenesis and potential pathways of treatment.
PrPc is a cell surface glycoprotein, located on the exterior leaflet of the plasma membrane. 
It is also a metalloprotein with a high affinity for copper (Section 1.3). Its suggested 
functions have included copper transport and metabolism, cellular protection possibly as an 
antioxidant itself, and signal transduction (Section 1.5). However despite much 
investigation the role of PrPc is still unclear.
This study focuses on the cellular isoform of the prion protein, PrPc, and considers both the 
activity of the protein itself and the genetic mechanisms that control protein production. 
The primary aims are to elucidate the normal cellular methods of PrPc regulation and 
metabolism, and to advance current understanding of its function. In addition, further 
emphasis is placed on determining how these factors may become altered in disease, and, 
where appropriate, consideration is given to potential therapeutic intervention.
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1.1 Genetic Control of PrPc Expression
PrPc knockout mice are resistant to infection with scrapie (Weissmann et al., 1994), and 
thus transmission of prion diseases and the resulting neurotoxicity requires the presence of 
PrPc (Brown et al., 1994; Brandner et al., 1996). The level of PrPc expression has been 
shown to influence the incubation period of the disease in mice (Scott et al., 1989; Fischer 
et al., 1996), and polymorphisms within the gene promoter alter PrPc expression levels 
(Hills et al., 2001; Sander et al., 2005). Hence, the role of the promoter and expression 
control elements may be fundamental in both disease pathogenesis and control.
1.1.1 Overview o f Eukaryotic Promoter Control
Regulation of protein expression is an essential function of all cells. A careful balance 
must be maintained for normal cellular homeostasis, and the ability to appropriately up or 
down-regulate specific proteins in response to stimuli is crucial to avoid damage to the 
individual cell or organ. Such is the importance of maintaining correct cellular expression 
levels that regulation occurs by mechanisms throughout the cell, acting on the gene itself, 
and all pathways through creation to destruction of the protein product. These regulatory 
mechanisms include; control of the transcription of mRNA from DNA by elements within 
the promoter sequence or up-stream of it; control of the translation of the mRNA by 
mRNA turnover (in turn influenced by the ability of the mRNA to form secondary 
structures to increase stability, by poly-adenylation, and by alternative splicing) or by 
micro RNAs (miRNAs) binding to sites within the mRNA sequence; and regulation of the 
protein itself by turnover mechanisms within the cell. The control of transcription is 
thought to be the most important factor for regulation of protein levels. A short description 
of eukaryotic promoter control is covered below.
Eukaryotic promoter control is extremely complex. A pre-initiation complex (PIC) must
assemble around the appropriate sequence of DNA, functioning to first uncoil supercoiled
DNA, and second to allow the attachment of DNA polymerase and other proteins forming
the transcription apparatus, which unzips, transcribes and rezips the DNA of the gene. The
PIC is a multi-protein complex, which includes general transcription factors, such as TFIIA
- H, and DNA polymerase II. Many genes have a TATA box motif, which provides a
binding site for transcription factors, located approximately 25 base pairs upstream of the
transcription start site (TSS). For genes lacking a TATA box, prior to the TSS there is an
initiator region and this determines the strength of the promoter. In addition to this
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promoter region, genes may have other regulatory regions, which are usually (but not 
always) located 5’ to the promoter region and may be thousands of base pairs away from 
the TSS. Depending on the transcription factors that bind them, these regions may enhance 
or inhibit protein expression (van Driel et al., 2003; Sipos & Gyurkovics, 2005).
1.1.2 Features o f the PrP Promoter
Early characterisation of the PrP gene (prnp) found that both prion isoforms (PrPc and 
PrPsc) were encoded by the same gene, and that no evidence of gene rearrangement was 
seen when comparing scrapie infected tissues to uninfected tissues (Basler et al., 1986). 
This provided further evidence that the transition from PrPc to PrPsc was the result of post 
translational modification rather than a result of gene rearrangement or alternative splicing. 
The study by Basler et al. described the hamster prnp. The hamster gene was composed of 
two exons, the first was located lOkb upstream of the second, which encoded the entire 
uninterrupted open reading frame (ORF). In addition, several features typical of 
housekeeping genes were identified in the promoter (the region of DNA upstream of the 
putative transcription start site) including a GC rich region lacking a TATA box and three 
repeats of a sequence encoding Spl binding sites. Spl factors bind to these GC rich 
regions and, by direct protein-protein interaction of factors binding adjacent sites, loops 
the DNA to synergistically activate the gene by directly or indirectly recruiting proteins of 
the transcription apparatus (for review see Li et al., 2004).
The structure of the prion gene has now been characterised in several species. In contrast 
to the initial study describing the two exon structure of hamster prnp, in most species it 
was found that the gene includes three exons with the third, final exon encoding the entire 
ORF (Inoue et al., 1996; Saeki et al., 1996; O’Neill et al., 2003). The preceding two exons 
encode an mRNA 5’ untranslated region (Westaway et al., 1994). The human gene, 
however, was shown to have the same structure as the hamster gene, with two exons and 
one intron present, and the second exon encoding the ORF (Puckett et al., 1991).
Following the determination of the three exon structure of mRNA from other mammalian 
species, Li & Bolton (1997) discovered the presence of a further exon in hamster mRNA, 
which showed significant sequence homology with exon 2 from other mammalian species. 
This data did not disprove the original finding that hamster mRNA was composed of two 
exons but instead showed there were two splice variants of the hamster mRNA, one with 
and one without the middle exon 2. In addition this study showed that the two variants
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were expressed at different levels in different parts of the brain, with the two-exon 
structure favoured over the three exon structure, and that expression was altered during 
infection causing an increase in the levels of the three exon structure. This indicated that 
exon 2 may be involved in the regulation of PrP expression. The equivalent exon has also 
been found in humans (Lee et al., 1998). This sequence has not been found in the mRNA 
transcript but sequence analysis of the gene, when compared to that of the mouse and 
sheep genes, shows a conserved region corresponding to the exon 2 sequence, which is 
flanked by splice sites. Since this exon has still not been identified in PrP mRNA 
transcripts it is thought that, like the hamster mRNA three exon transcript, expression 
levels of this mRNA variant may be considerably lower than its two exon counterpart and 
so remain undetected. An alternative theory is that exon 2 is redundant for the regulation 
of PrP expression, and so its loss from the mRNA transcript is of no consequence.
In agreement with the initial study, all characterised prion promoters lack a TATA box, are 
rich in GC sequences, and include Sp-1 binding sites. Other features of the prion promoter 
that have been identified include four highly conserved motifs, AP-1 and AP-2 binding 
sites, and an inverted CCAAT motif (not present in the bovine or ovine promoter), which 
can enhance or inhibit promoter activity dependant on what transcription factors bind to 
them (see Figure 1.1; Westaway et al., 1994; Saeki et al., 1996; Inoue et al., 1997; O’Neill 
et al., 2003). Promoter activity is further regulated by chromatin conformation, as shown 
by Cabral et al. (2002), who demonstrated the use of a histone deacetylase inhibitor could, 
though chromatin disassembly, cause a significant increase in promoter activity and an 
increased response to factors known to modulate the PrP promoter including nerve growth 
factor (NGF) and cAMP.
Exon 1 Intron 1 Exon 2 Exon 3
u




Heat Shock Elements AP-2 & AP-1 Sites Sp-1 Motifs
Inverted CCAAT Element
Figure 1.1 Gene structure of prnp. Shown are the documented regulatory domains of the promoter 
region. The long (over lOkb in most species) intron 2 is represented in a shortened form by two lines.
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1.1.3 Prnp Non-Coding Region and Gene Regulation
In addition to the above promoter domains influencing expression, intron 1 is required for 
full activity of the promoter (Inoue et al., 1997). The study by Inoue et al. using the 
bovine gene found that although intron 1 contributed to promoter activity, it was not an 
enhancer region. The authors suggest that intron 1 may be involved in tissue specific 
expression or synergistic control of the promoter. Intron 1 was not required for the full 
activity of the rat promoter. An area of promoter activity has been identified adjacent and 
5’ to exon 2 of the murine gene, and the intron 1 sequence was shown to contain two areas 
of potential transcription factor binding sites, however an mRNA transcript lacking exon 1 
was not found (Baybutt & Manson, 1997). The implication is that this region may not 
have its own active TSS or that mRNA levels are so much lower than the full length 
mRNA that only this is detected. In addition, this area was shown to contain elements 
capable of suppressing activity of both the promoter and the intron 1 regulatory region.
The role of intron 1 in promoter control is further supported by evidence from Premzl et al. 
(2005). This study identified thirty-three potential regulatory elements within the non­
coding region of human, mouse, bovine, ovine, and tamar wallaby prnp, seven of these 
elements occurred in all five species. Some were located in intron 1 and some in intron 2, 
indicating that the intron 2 sequence may also have regulatory function. Of the motifs 
conserved across all species tested were regions expected to bind myeloid zinc finger-1 
(MZF-1), myocyte enhancer factor-2 (MEF2), Octamer 1 (Oct-1), myelin transcription 
factor 1 (MyTl), and nuclear factor of activated T-cells (NFAT).
1.1.4 Prnp and Cellular Stress
Heat shock has been shown to up-regulate both prnp mRNA and protein expression by 1.5 
to 2.5 fold in human cells, and two heat shock elements have been detected in the rat prion 
promoter (Shyu et al., 2000). Using repressors of transcription it was shown that this up- 
regulation occurs at a transcriptional level and is abolished or reduced when the heat shock 
elements are absent or mutated (Shyu et al., 2002). In addition, heat shock proteins are up- 
regulated in the end stages of prion disease (Kenward et al., 1994), indicating that PrP 
mRNA levels may also be up-regulated causing an increase of protein expression. Since 
disease progression is directly related to PrPc expression this may, in part, account for the 
rapid progression of the disease in the end stage.
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Using hyperbaric oxygen as a model of oxidative stress, it has been shown that oxidative 
stress can up-regulate both PrP mRNA and protein levels in mouse neuroblastoma cells 
(Shyu et al., 2004). In this study up-regulation of heat shock protein 70 (hsp70) was also 
seen, indicating that oxidative insults may up-regulate prnp activity by the modulation of 
heat shock proteins. These would activate the promoter by binding to the previously 
described heat shock elements. Stress caused by hypoglycaemia has also been found to 
up-regulate PrP mRNA and protein through a heat shock mediated response, which may 
involve c-Jun N-terminal kinase (JNK), a signalling kinase that modulates transcription 
factor production and activity (Shyu et al., 2005a).
Nitric oxide (NO) is a highly reactive radical used as a signalling molecule by cells. It has 
been found that PrPc is up-regulated both at the mRNA and protein level in response to 
direct insult with NO or indirectly in response to lypopolysaccharide treatment, which 
caused up regulation of neurone specific nitric oxide synthase (nNOS: Wang et al., 2005). 
Investigation into the mechanism of this up-regulation revealed that it was mediated by a 
signalling pathway utilising guanylyl cyclase, MEK, and p38 MAPK signalling proteins. 
This pathway is involved in cellular survival (Torii et al., 2004; Sumbayev & Ysinska, 
2005), implying PrPc may be up-regulated as a cell survival response.
Copper up-regulates PrP° at the protein level (Brown et al., 1997a). Copper induced up- 
regulation of prnp is thought to involve activation of the promoter by metal response 
elements (MREs) or MRE-like sequences. Within the bovine prnp, an inverted MRE at 
position -2070 and two MRE-like elements at positions -2653 and -2599, differing from 
the MRE sequence by just one nucleotide, have been located by sequence analysis (Varela- 
Nallar et al., 2005). However deletion studies using the bovine promoter find that the 
removal of these elements does not fully inhibit the ability of copper to up-regulate 
expression and activation was not mediated by MRE-binding transcription factor-1 (MTF- 
1), indicating that there may be other motifs and factors involved in regulation of the gene 
in response to copper. This, in turn, may indicate that the ability of the gene to become 
activated in response to copper is so important that several regions of the gene sequence 
are functional for copper induced regulation. A further finding of the study is that copper 
induced up-regulation is not mediated by the induction of a general stress response, which 




The study described above is in contrast to a study by Toni et al. (2005), who find that 
copper down-regulates prnp activity at both the mRNA and protein level. The most likely 
reason for the difference, and a point raised by the Varela-Nallar study, is that response to 
copper is cell line specific. Since PrPc expression is variable in dissimilar tissues it is most 
likely that genetic control mechanisms operate differently within these tissues, and both 
studies agree that copper is able to influence the activity of prnp.
1.1.5 Prnp and All-Trans Retinoic Acid
All-Trans Retinoic Acid (ATRA) is a drug used for the treatment of promyelocytic 
leukaemia. It is an effective treatment, sending the disease into remission by inducing 
terminal differentiation of the malignant clone. ATRA has been found to down regulate 
PrPc expression (Rybner et al., 2002). It is possible that ATRA exerts its effect on the PrP 
promoter by modulation of transcription factors involved in cellular differentiation. Mytl 
is a transcription factor involved in cellular differentiation and, as discussed above (Section 
1.13), a highly conserved Mytl binding element is found in prnp from several species 
(Premzl et al., 2005).
An alternative mode of action of ATRA could be activation of the retinoic acid receptor 
(RAR) allowing it bind to Retinoic Acid Response Elements (RAREs) either as a 
homodimer or as a heterodimer with Retinoic X receptor (RXR). The RAR can act as an 
enhancer or a repressor of transcriptional activity depending on the orientation in which it 
binds to DNA (for review see Bastien & Rochette-Egly, 2004). Once bound, protein 
interactions recruit transcription factors such as AP-1 and AP-2. However, as yet no 
RAREs have been identified in the prnp, indicating that ATRA may be more likely to exert 
a secondary effect through activation of transcription factors rather than direct interaction 
of RAR with prnp.
ATRA was also found to down regulate PrP expression by Cabral et al (2002), who 
propose that down regulation of PrP results through the activity of AP-2 transcription 
factors, their interaction with AP-1 transcription factors and the repression of c-fos, which 
is also involved in modulating gene expression. Similarly ATRA induces expression of 
MKP-1, which inactivates members of the mitogen activated protein (MAP) kinase family, 
including JNK. In turn, this results in reduced activation of c-Jun and c-fos and potent 
inactivation of AP-1 (Kitamura et al., 2002). PrP may be down-regulated by ATRA using 
these pathways in the opposing way to that suggested for up-regulation by copper.
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G iv en  the correlation o f  d isea se  progression  w ith  PrPc lev e ls , factors that dow n-regu late  
exp ression  m ay have a potential role in d isea se  therapy or m anagem ent. It m ight be 
p o ssib le  that A T R A  and other sim ilarly  reacting agents cou ld  be used  to s lo w  the  
p rogression  o f  the d isease .
1.2 PrPc Structure
PrPc is a ce ll surface protein bound to the m em brane by a g ly co p h osp h atid y lin osito l (G PI) 
anchor (Stahl et al., 1987). It is a g lycop rote in  and can assu m e di, m ono or u n g lycosy la ted  
states. N -lin k ed  g ly co sy la tio n  occurs on  tw o  asparagine residues, found at am ino acid  
p o sitio n s 180 and 196 in m ou se PrPc (L ehm ann & Harris, 1997). T he protein  seq u en ce  
a lso  contains an N -term inal signal seq u en ce (resid u es 1-23 in m ice) for d irection  into the 
en d op lasm ic  reticulum  (E R ) during syn th esis , an octam eric repeat reg ion  (5 1 -8 9 )  and a 
hydrophobic dom ain  (1 1 0 -1 4 6 ). The linear structure o f  PrPc is  sh ow n  in figure 1.2.
N-term inal signal O ctam eric repeat Hydrophobic GPI anchor signal
peptide  region dom ain sequence
Figure 1.2 Linear structure of unprocessed murine PrP. Shown are the characterised domains, di­
sulphide bride and N-glycosylation sites.
T he secondary structure o f  PrPc from  several sp ec ies  has been  determ ined by nuclear  
m agnetic  resonance (N M R ) spectroscopy. In m ice  PrPc has three alpha h e lice s  at am ino  
acids 1 1 4 -1 5 4 , 1 79 -193 , and 2 0 0 -2 1 7 , and a short anti-parallel beta sheet w ith  am ino acids 
128-131 com p lem en tin g  161-193  (F igure 1.3; R iek  et al., 1996). A  d isu lfid e  bridge links 
the cy ste in e  residues at p ositio n s 179 and 2 1 4  in m ou se PrPc, and by d oing  so tethers the 
start o f  h e lix  2 to the m idd le o f  h e lix  3. T he N -term in u s is predom inantly unstructured and 
h igh ly  flex ib le  (D on n e et al., 1997; R iek  et al., 1997), but m ay assu m e so m e secondary  





Figure 1.3 Proposed three 
dimensional structure of  
murine PrPc. Shown are the 
structure of the PrPc C- 
terminus as determined by 
NM R spectroscopy (left), and 
the putative full length PrPc 
structure with the flexible N- 
terminus assuming a coiled 
formation on copper binding 
(right). Adapted from Riek et 
al. (1996).
D esp ite  sm all variations in the prim ary seq u en ce, all characterised m am m alian  PrPcs share 
the sam e tertiary structure, and the unstructured N -term inal section  is h igh ly  con served  
(W opfner et a l., 1999). The structure is a lso  m aintained for ch ick en , turtle and frog PrPc 
ev en  though the am ino acid seq u en ces share on ly  30%  h o m o lo g y  w ith  m am m alian PrPc 
(C a lzo la i et a l ., 2 0 0 5 ). The m ost con served  region s across m am m alian, avian, reptilian  
and am phibian PrPc are (w ith  reference to m am m alian  PrPc) the am ino acid  residues  
around p ositio n s 15-20  (w h ich  indicate the p o sitio n  o f  the N -term inal c lea v a g e  site), 100- 
110 at the start o f  the hydrophobic reg ion , 1 1 2 -1 1 9  o f  the hydrophobic dom ain, and the C- 
term inal structural dom ains. Such con servation  ind icates th ese reg ion s are o f  im portance  
to the function  o f  PrPc.
The octarepeat region  has proved o f  m uch interest. In m ost m am m alian  sp ec ies , it contains  
the am ino acid seq u en ce P H G G G W G Q  repeated four tim es w ith  a further in com p lete  
repeat at the start o f  the region. C opper b inds to th is repeat seq u en ce, w ith  each  repeat 
bind ing  on e copper m o lecu le  (S ectio n  1.3). D esp ite  the in v o lv em en t o f  d ifferent am ino  
acid  m otifs , a form  o f  this repeat reg ion  is  h igh ly  con served  across m am m alian , avian and 
reptilian sp ec ies , ind icating it m ay be o f  considerab le im portance for the function  o f  the
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protein (Wopfner et al., 1999; Calzolai et al., 2005). However amphibian PrPc lacks amino 
acid sequence homology of this region (Strumbo et al., 2001).
In prion diseases, the C-terminal structure of PrPc is altered such that the predominantly 
alpha helical structure of PrPc is replaced by a higher beta sheet conformation (Pan et al., 
1993). This structural change is thought to be a post-translational modification of PrPc 
catalysed by the presence of PrPsc. The modification results in a change in solubility of the 
protein and partial resistance to digestion by proteinases (Prusiner, 1982).
1.3 PrPc and Copper Binding
9 +The octameric repeat domain has been proven to bind copper (II)/Cu in vitro and in vivo 
(Homshaw et al., 1995a; Brown et al, 1997b). The amino acid sequence PHGGGWGQ is
repeated four times, with an incomplete repeat found at the start of the region, and is highly
* 2+conserved among mammalian species. Each repeat has been shown to bind one Cu 
molecule and this copper binding is relevant at physiological concentrations, with PrPc 
binding becoming saturated at about 5 pM compared to the blood exchangeable 
concentration of 8 pM (Kramer et al., 2001; Bums et al., 2002). Jackson et al (2001) 
report that the octameric repeat region has a dissociation constant for copper (II) of 10'14M, 
which is highly suggestive of copper binding under physiological conditions. In support of 
this, binding affinities of PrPc for copper have been shown to lie between 108 and 1016 M'1 
depending on the number of copper atoms bound (Thompsett et al., 2005).
2+Cu binding in the octameric repeat domain is five co-ordinated, and it is this co­
ordination that is thought to give the PrP N-terminus its secondary structure when copper 
saturated. Of the repeat sequence, the HGGGW sequence is thought to be most important
9-1- 9-1-for copper binding, with all but the third glycine (G) acting to stabilise Cu binding. Cu 
is four co-ordinated by the residues of the octameric repeat domain, it binds with three 
nitrogen atoms and one oxygen atom. The nitrogens are donated from the histidine (H) 
imidazole and the de-protonated amides from the next two glycines, and the oxygen is 
donated from an additional binding to the second glycine involving the amide carbonyl 
(Figure 1.4; Stockel et al., 1998; Aronoff-Spencer et al., 2000; Bums et al., 2002;
9-4-Chattopadhyay et al., 2005). The four co-ordination of Cu by the octameric repeats is
planar. The five co-ordination arises from a further binding to the oxygen atom of a water
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m o lecu le  that lie s  ax ia lly  ab ove the Cu2+ atom . The o x y g en  from  the w ater m o lecu le  a lso  
form s a polar bond w ith  the am ine o f  the tryptophan (W ) indole. The octam eric  repeats 
m ay asso c ia te  w ith  each  other by interaction o f  the n itrogens from  the h istid in e im id azo le  
and the tryptophan o f  on e octam eric repeat w ith  the backbone carbonyls o f  the h istid ine  
and the first g ly c in e  o f  the adjacent repeat (B urns et a l., 2 0 0 2 ). T his m ay result in a 
stack ing  e ffec t, resu lting in the acquired h e lica l structure o f  the PrPc N -term inus on  copper  
binding.
1st G lyc in e
H istid ine
A xia l W ater 
M o lecu le
2nd G lycin e
H istid ine
Im idazole
Figure 1.4 Proposed co-ordination of copper by amino acids HGG of a single octarepeat. Nitrogen 
atoms are shown in blue, oxygen in red, carbon in grey, and hydrogen in white. Adapted from Ji & 
Zhang (2004).
T w o further copper b inding conform ations have been  described  (A ron off-S p en cer  et al., 
2 0 0 0 ; C hattopadhyay et a l ,  2 0 0 5 ). T h ey  are su ggested  to arise due to in com p lete  
saturation o f  the octam eric repeat region  as a fu n ction  o f  C u2+ concentration , as op p osed  to 
the ab ove descrip tion  that is the conform ation  assum ed  by the octam eric repeats in h igh  
copper concentrations (4  eq u ivalen ts or greater) w here fu ll saturation occurs. A n  
interm ediate conform ation  occurs at 1-2 eq u iva len t copper concentrations, w here h istid in es  
from  tw o  adjacent repeats bind on e C u2+ m o lecu le  v ia  their im id azo le  n itrogens and the 
C u2+ is further bound by tw o  o x y g en s  from  w ater m olecu les . T he third conform ation
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occurs at low copper concentrations, and is thought to involve three or four of the histidine 
imidazoles.
Further evidence supporting the above secondary structure of the PrPc N-terminus when 
saturated with copper was provided by theoretic computation of the binding energies (Ji & 
Zhang, 2004). This found that the structure proposed above has a higher binding energy 
for copper than other potential conformations of the octameric repeat region. This study 
also noted that the binding energy of ceruloplasmin, a serum protein involved in the 
transport of copper, is much lower than that of the octameric repeat region binding copper 
as a five co-ordinate. Therefore, it is likely that copper is incorporated most effectively 
into PrPc when delivered chelated to serum proteins, as this is a more energetically 
favourable reaction than incorporation of free copper. Additionally, Brown (1999) showed 
that PrPc specific uptake of Cu2+ by neurones required chelation, supporting that in a cell 
system incorporation of Cu2+ into PrPc is more favourable when the copper ion is presented 
as a chelate, and Thompsett et al. (2005) show the binding affinity of PrPc for copper is 
higher than that of ceruloplasmin, so PrPc could effectively compete with transport proteins 
for bound copper ions.
In addition to the octameric repeat domain, a fifth binding site located between the 
octarepeat region and the structured C-terminus at amino acid residues 92-96 has been 
demonstrated (Hasnain et al., 2001; Jackson et al., 2001; Bums et al., 2003). The histidine 
residue at amino acid position 96 thought to mediate this binding. Two co-ordination 
modes have been proposed for this site, the first suggests a six co-ordinate structure with 
histidine 96, glutamine 98, methionine 109, histidine 111, and two further bonds that may 
be provided by water (Hasnain et al., 2001). The second theory proposes that only amino 
acids residues 92-96 are involved in Cu2+ co-ordination. In this model, Cu2+ is four co­
ordinated, binding to four nitrogens provided by the histidine side chain and backbone, the 
threonine (95) and the glycine (94; Bums et al., 2003). However co-ordination of this site 
does not occur when only these three amino acids (94-96) are present; the two glycines at 
positions 92 and 93 are required. Hence the authors suggest that one of these glycines may
9-1-co-ordinate axially to the Cu atom in a similar way to that seen for the water molecule 
and tryptophan in the octameric repeat region. Mutation of either histidine, at amino acid 
96 or 111, to alanine results in the loss of one copper binding site from the full length 
protein (Thompsett et al., 2005), indicating that both histidines are involved in copper 
coordination by the fifth site making the first proposed binding mode the most likely.
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Copper binding to the fifth site is pH sensitive, and stability is lost at pH6.5. The 
importance of this fifth site remains to be determined, however Bums et al. (2003) offer 
the theory that it may simply be an extension of the copper binding octameric repeat 
domain. A further weak copper binding site may exist around amino acids 135-155 
(Jackson et al., 2001), but this has not yet been substantiated.
As a result of the association of PrP° with copper molecules, copper binding has been 
implicated as an important factor in the disease process. Quaglio et al. (2001) 
demonstrated that Cu2+ could convert PrP° into a protease resistant form that was not the 
same as the disease form. As such the authors suggest that copper binding may produce an 
intermediate form in the conversion of PrPc to PrPsc. However, more recently the binding 
of copper to full length recombinant PrPc has been shown to prevent PrPc conversion into 
the PrPsc isoform and the formation of amyloid fibrils of PrPsc at pH 7.2, which is the 
approximate pH of the extracellular environment (Bocharova et al., 2005). Furthermore, 
PrP° lacking the octameric repeat region was also found to be protected against conversion 
by the presence of copper, perhaps indicating that binding to the fifth site may play a role
9-t-in this protection also. At pH 6, where binding of Cu to the octameric repeats and the
9-1-fifth site becomes unstable, the protection of Cu against conversion is much less. The
94*authors also showed that Zn has a protective effect, although this is not as efficient as
9 +  •Cu . Bocharova et al. explain the disagreement between the studies by the suggestion 
that Cu2+ binding stabilises a nonamyloidogenic proteinase K resistant form of PrPc 
preventing it from undergoing disease specific structural changes.
With the wealth of data supporting copper binding by PrPc the potential for binding other 
metals has been investigated. Stockel et al (1998) report that binding is highly specific for 
copper, with other metals including Ca2+, Co2+, Mg2+, Mn2+, Ni2+, and Zn2+ apparently 
having no affinity for the octameric repeat binding sites. However, Brown et al (2000)
9  I I
find that manganese (Mn ) can be substituted for copper and that over time Mn loaded 
PrPc develops protease resistance accompanied by alteration to a higher beta sheet 
structure. The affinity of PrPc for other metals has also been demonstrated by Jackson et al
(2001) who find that Ni2+, Zn2+, and Mn2+ bind three or more magnitudes more weakly
2+than Cu to the octameric repeats and six, seven and ten magnitudes more weakly 
(respectively) to the fifth site. Alteration in brain tissue metal ion concentrations is a 
feature of prion diseases and incorporation of metal ions other than copper into PrPc may 
be involved in the disease pathogenesis (Wong et al., 2001a).
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1.4 PrPc Trafficking and Metabolism
PrPc has a wide distribution within the body with expression found in many tissues, 
including heart, lungs, spleen, kidney, skeletal muscle, uterus, and various glands, however 
highest expression is seen in neuronal tissues (Robakis et al., 1986; Horiuchi et al., 1995). 
In most tissues PrPc has a short half-life, just 3-6 hours in neuronal cells and as little as 1.5 
-  2 hours in splenocytes. The longest reported half-life is found in lymphocytes, where 
PrP° persists for over 6 hours (Caughey et al., 1989; Borchelt et al., 1990; Parizek et al., 
2001; Li et al., 2003). PrPc is a cell surface glycoprotein and in neuronal tissues shows 
localisation to the synapses. It has been reported at synaptic terminals (Fournier et al., 
1995; Gohel et al., 1999), and pre-synaptic (Herms et al., 1999) and ubiquitous (Laine et 
al., 2001) localisation have also been described.
1.4.1 Normal PrP° Trafficking and Processing Within the Cell 
To reach its cell surface location, PrPc is directed co-translationally into the endoplasmic 
reticulum (ER) by the N-terminal signal peptide. Here the signal peptide is cleaved, as is 
the C-terminal GPI-anchor signal peptide, which is replaced with the GPI anchor. The 
mannose side chains are added, and converted into complex glycans within 30 minutes of 
addition. The correctly folded protein then exits the ER to the golgi, and from there is 
transported to the cell surface (Figure 1.5: Nunziante et al., 2003; Winklhofer et al., 2003).
PrPc is associated with regions of the cell membrane known as lipid rafts. Protein 
localisation to lipid rafts is defined as partitioning with detergent resistant membranes 
(Sharma et al., 2002). However the composition of these detergent resistant membrane 
domains varies and PrP° shows a preference for regions rich in cholesterol, sphingomyelin 
and palmitolyoleoylphosphatidylglycerol (Mahfoud et al., 2002; Briigger et al., 2004; 
Critchley et al., 2004). Mahfoud et al. found a sphingolipid-binding domain at amino 
acids 179-211 of the protein sequence, which may have a role in directing PrPc into lipid 
rafts and determining its position in the cell membrane.
In addition to PrPc localisation at the cell surface, it has been shown that PrPc, as well as
PrPsc in disease, is secreted or shed from the cell surface. Secreted PrPc lacks its GPI
anchor, and is released by exosomes (Fevrier et al., 2004). However there is still
disagreement about whether the secreted form is actually secreted by the cell or if, instead,
it is cleaved from the cell membrane at the anchor attachment site. There is evidence that
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the am ount o f  PrPc found in ce ll culture m ed ia  is reduced in the ab sen ce o f  serum , 
su g g estin g  that serum  en zy m es such  as p h osp h olip ase  C or D m ay be in v o lv ed  in the 
c lea v a g e  o f  PrPc from  the ce ll surface resu lting in  an apparent secretory form  (P arizek et 
al., 20 0 1 ; Parkin et a l., 2 0 0 4 ).
^  Correctly Processed PrP1 
^  Incorrectly Processed PrPc
Cell Membrane and Raft Domains











Figure 1.5 Cellular trafficking o f PrP. Pathways of correctly folded (blue) and incorrectly folded (red) 
PrP trafficking to and from the cell surface.
C ell surface PrP° is  a lso  m etab olised  by a d ifferent c lea v a g e  p rocess to that w h ich  rem oves  
the GPI anchor. The flex ib le  N -term inus is separated from  the globular C -term inal reg ion  
by c lea v a g e  at am ino acids 1 1 1 -1 1 2 , located  at the start o f  the palindrom ic reg ion  (C h en  et 
al ., 1995). T his c leavage is m ediated  by A  D isin tegrin  A nd M etallop rotease 10 
(A D A M  10), T um our n ecrosis  factor a -C on vertin g  E n zym e (T A C E ), and z in c  m atrix
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metalloproteases (MMPs; Vincent et al., 2001; Parkin et al., 2004). Zinc MMPs may, in 
turn, be activated by increased exogenous copper concentrations (Parkin et al., 2004). 
Since the N-terminus of PrPc binds copper and it is this region that is cleaved, the cleavage 
event may be relevant for the function of PrPc. Cleavage is altered in infected cells, with 
the N-terminus cleaved at amino acids 88-89 by the calpain family of proteases (Chen et 
al., 1995; Yadavalli et al., 2004). Hence the metabolism of PrP may have an important 
impact on the disease progress, although it is not possible to say whether the alteration in 
metabolism causes or is a result of the disease pathology.
Although PrPc is lost into the surrounding extracellular environment by shedding, the 
majority of cell surface PrPc is internalised and directed into endosomes (Borchelt et al., 
1993). Internalisation has been suggested to occur by clathrin, dynamin-1 and caveolae 
mediated pathways (Shyng et al., 1994; Magalhaes et al., 2002; Peters et al., 2003). PrPc 
internalised by both clathrin-coated vesicles and the dynamin-1 pathway is directed into 
early endosomes (Shyng et al., 1994; Magalhaes et al., 2002) and from there may be 
directed back to the golgi (Magalhaes et al., 2002). PrPc internalised by the caveolae- 
mediated pathway is transferred straight from the caveolae-containing endocytic vesicles 
into late endosomes and/or lysosomes so bypassing the classical early endosome 
internalisation pathway (Peters et al., 2003). Caveolae is a type of raft protein involved in 
internalisation, therefore the localisation of PrPc at the cell surface in different raft types 
may determine its mode of internalisation. In addition, internalised PrPc is directed into 
recycling endosomes, from where it can be quickly relocated back to the cell surface if 
required (Magalhaes et al., 2002). Recycling endosomes are rich in lipid raft components 
(Gagescu et al., 2000), therefore it is likely that the destination of PrPc inside the cell is 
determined by the rafts to which it is directed. The internalisation pathways of PrPc are 
shown in Figure 1.5.
The N-terminal region of PrPc has been implicated in the control of PrPc internalisation 
(Shyng et al., 1995; Lee et al., 2001; Nunziante et al., 2003; Sunyach et al., 2003). Shyng 
et al. (1995) proposed that the far N-terminus contains a domain capable of binding to 
other membrane proteins that would the target PrPc to clathrin-coated pits for 
internalisation. This suggests that this form of internalisation could not happen in the 
absence of the N-terminal region. Specifically it has been found that movement out of raft 
domains for internalisation by non-caveolae pathways is dependant on the six N-terminal 
amino acid residues in the mature protein, NH2 -KKRPKP, at position 23-28 of the N-
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terminus (Sunyach et al., 2003). Hachiya et al. (2004) also found that these amino acids 
were important for intracellular trafficking of PrPc by interacting with the microtubule- 
dependent motor proteins kinesin and dynein, allowing movement to and from the synapse. 
The C-terminus, in particular the final 14 residues, has also been implicated in the control 
of PrPc internalisation. However, this region was suggested to direct PrPc into a caveolae 
mediated internalisation pathway (Kaneko et al., 1997).
1.4.2 Copper Induced Internal isation
Copper induces the internalisation of PrPc. This response was shown to be rapid at 500 
pM CuSC>4 and significant at 200 pM (Pauly & Harris, 1998; Lee et al., 2001). The 
minimum concentration of CuSCU that produced a response was 100 pM. In addition, zinc 
(100 pM ZnS0 4 ) also significantly internalised PrPc, but cobalt, manganese and iron at 
concentrations as high as 500 pM did not produce any effect. Miura et al. (2005) suggest 
that PrPc at the cell surface binds Cu2+, reduces it to Cu+ before trafficking into endosomes, 
here the internal pH is low enough (pH 5.5-6.5) that the Cu+ is released. The authors 
suggest that the complete intact octameric repeat region is vital for the reduction reaction 
and, therefore, for internalisation to occur.
N-terminal deletion of PrPc and specifically deletion of the octameric repeat domain 
significantly inhibits copper induced internalisation (Pauly & Harris, 1998; Lee et al.,
2001). As suggested previously, it is likely that the role of the octameric repeat domain is 
to bind copper, thus binding produces the internalisation response. The importance of the 
histidines at amino acid positions 68 and 76 of the octameric repeat domain in copper co­
ordination is seen by the abolition of internalisation in mutant constructs where these 
histidines have been replaced with glycine (Perera & Hooper, 2001). Moreover, disease 
associated mutation of the octameric repeat domain, where nine extra octameric repeats are 
present (PGM; found in patients with familial CJD), abolishes internalisation.
Copper and zinc stimulated internalisation directs PrPc into early endosomes and to the 
golgi (Brown & Harris, 2003). However the preferred pathway for this reaction is still 
under debate. Brown & Harris conclude that copper and zinc induce internalisation via 
clathrin-coated pits. In contrast, Marella et al. (2002) find that copper induced 
internalisation occurs through a caveolin-dependant pathway in neurones and microglia. 
Further, it can be disrupted by the antibiotic filipin, which acts by binding membrane 
sterols and so disrupting lipid rafts where caveolae is found.
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1.4.3 PrP° Quality Control and Disease Associated Mutants 
Cellular quality control mechanisms ensure that incorrectly assembled proteins are targeted 
for destruction so that they cannot exert a detrimental effect on cellular function. 
Incorrectly processed proteins are recognised in the ER, a ubiquitin protein tag is added by 
ubiquitin ligases in the ER membrane and the incorrectly folded proteins are directed by 
this tag to the proteasome via the ER associated destruction (ERAD) pathway (for review 
see Hampton, 2002). The correct folding and processing of PrPc is important for it to reach 
its membrane position. Incorrectly processed PrPc such as CtmPrP (PrPc inserted into the 
cell membrane and spanning the membrane via the hydrophobic region in the centre of the 
protein, with the C-terminus facing out of the cell and the N-terminal signal peptide 
remaining uncleaved) is retained in the ER (Stewart et al., 2001). This suggests that 
incorrectly folded PrPc is directed into ERAD for destruction. Further cellular quality 
control mechanisms operate beyond the ER. The pre-octameric repeat amino acid 
sequence was found to be highly important for recognition of misfolded PrPc in post ER 
compartments and causes the incorrectly folded protein to be directed to lysosomes for 
destruction (Gilch et al., 2004).
Disruption of either complex glycosylation or the addition of the GPI anchor interferes 
with PrPc transport to the cell surface. Helix 1 has been identified as essential for the 
correct folding of PrPc. The absence of this helix prevents the attachment of the GPI 
anchor and the complex glycans, and as a result prevents PrPc from reaching the cell 
surface (Winklhofer et al., 2003). The stabilisation of helix 1 by interaction of amino acids 
140, 145, 148, and 149 with amino acid 204 of helix 3 (with reference to the murine 
primary sequence) is also involved in the correct processing of PrPc. C-terminal 
membrane anchorage was found to be essential for complex glycosylation to occur, 
signifying that correct insertion into the cell membrane is important for the correct 
metabolism of PrPc (Walmsley et al., 2001). Additionally, disruption of the disulphide 
bridge prevents complex glycosylation and localisation to the cell surface (Yanai et al., 
1999).
Partial ER retention has been observed for some pathological mutations associated with the 
development of familial prion diseases including PGM (Ivanova et al., 2001). Two other 
pathological mutations associated with inherited disease are the substitution of glutamic
• F^OOl^acid at amino acid position 200 with lysine (PrP ), found in familial CJD, and 
substitution of aspartic acid at position 178 with asparagine (PrPD178N), associated with
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FFI. Bovine representations of these two mutations, showed a lack of complex 
glycosyation and were retained within the ER (Negro et al., 2001). The retention of the 
p rpE200K mutant was not as severe as that seen for the PrPD178N mutant, with cell surface 
localisation also seen. A mutant associated with GSS, where the glutamine at position 217 
has been substituted for arginine, with also a valine at position 129 rather than methionine 
(prpQ217R-129Y), is atso stained inside the cell (Singh et al., 1997). This mutant is found 
mostly within the ER but also in endosomes and lysosomes. Less than 45% of PrPQ217R' 
129V was found to reach the cell surface. In light of these studies, the role of ER processing 
and quality control is thought to play a significant part in diseases pathogenesis.
Two further pathological mutations associated with hereditary CJD, the substitution of 
threonine at amino acid position 183 with alanine (PrPT183A) and the substitution of
r i  Q O C
phenylalanine at position 198 with serine (PrP ), have been shown to be misfolded, lack 
the GPI anchor and are not complex glycosylated (Kiachopoulos et al., 2004). These 
mutants were not retained in the ER but were found to be secreted from the cell, most 
likely due to the lack of the GPI anchor and so lack of tethering to the cell surface. Since 
PrPsc forms protein plaques in the brains of infected individuals this could be highly 
significant for the disease pathogenesis.
ERAD directed PrPc degradation occurs in the proteasome (Yedidia et al., 2001). It is still 
under debate how mutant PrPc retained in the ER reaches the proteasome. Ma and 
Lindquist (2001) have found that PrPD178N, as well as wild type PrPc, reach the proteasome 
by retrograde transport to the cytoplasm. Jin et al. (2000) found that PrPQ217R was 
associated with the ER chaperone BiP for an abnormally long time before being targeted to 
the proteasome for degradation. The authors suggest that PrP folding is promoted by BiP, 
which recognises misfolded PrPc and mediates retrotranslocation to the proteasome. 
However, Drisaldi et al (2003) find that this is not the case, and that mutant and wild type 
PrPc reach the proteasome via a pathway not as yet characterised that does not involve 
retrotranslocation from the ER. Studies of proteasome inhibition have shown that PrP° 
accumulates in the cytosol. This accumulation of PrPc results in neurotoxicity and 
cytosolic PrPc forms aggregates of PrPsc-like protein (Ma et al., 2002; Ma & Lindquist,
2002). This may have implications for the disease process and further highlights the 
importance of cellular quality control in dealing with misfolded PrPc.
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1.5 The Elusive Function of PrPc
Initial studies on transgenic mice showed that there is little effect on development and 
behaviour when prnp is knocked out (Biieler et al., 1992; Weissmann et al., 1994), 
signifying redundancy of the protein. However subtle effects are seen. Knockout mice 
display alterations in circadian rhythms, sleep disturbance, impaired learning ability, 
weakened exercise capability, and reduced anxiety response (Tobler et al., 1996; Nishida 
et al., 1997; Tobler et al., 1997; Criado et al., 2005; Nico et al., 2005a; Nico et al., 2005b) 
indicating that PrP may be involved in homeostatic systems. In addition, knock-out mice 
suffer increased susceptibility to oxidative stress (Klamt et al., 2001; Brown et al., 2002).
1.5.1 PrP° in Copper Transport and Metabolism
Copper is an extremely toxic metal, present in high enough concentrations at the synapse 
to cause damage. Therefore the cell has an excess of mechanisms for copper metabolism 
(for review see Camakaris et al., 1999; Bertinato & L’Abbe, 2004). As discussed in 
section 1.4.2, copper binding internalises PrPc. This has led to the suggestion that PrPc is 
involved in copper metabolism, possibly by binding and removing toxic copper ions or by 
delivering them to specific targets within the cell. Copper up-take has been shown to 
correlate with the level of PrPc expression in mouse cerebellum (Brown, 1999). Copper 
binding to PrP° is pH sensitive with stability lost as pH declines. Endocytosis into acidic 
organelles such as late endosomes and lysosomes may result in the release of copper 
(Bums et al, 2002). The release of copper at the synapse on depolarisation is related to 
PrP° expression (Brown, 1999), therefore PrPc may have a role in containing synaptic 
copper fluctuations by binding copper ions and delivering them to storage vesicles. 
Copper liberated after internalisation may be utilised by other cellular proteins, or instead, 
PrPc may not release copper on internalisation but deliver copper ions directly to 
intracellular proteins, thus functioning as a copper transport molecule. Alternatively, if 
PrPc were to be directed to neutral cellular compartments, it would retain bound copper, 
and so might function as a sink in which excess copper is collected and stored to protect 
against cellular damage.
The up-regulation of prnp in response to increased exogenous copper supports a role of
PrPc in response to copper insults. PrPc knockout neurones are more susceptible to copper
induced toxicity than wild type (Brown et al., 1998), and the octameric repeat region alone
is able to rescue survival of these knockout neurones to a level equivalent to that of wild
26
Chanter 1: Introduction
type. Therefore the role of PrP° in binding copper to its octameric repeat region might be 
to prevent the copper ions from damaging the cell. This would be of especial importance 
at the synapses, where local concentrations peak at high levels during depolarisation and 
would be likely to damage the cell in the absence of suitable protection mechanisms. This 
copper binding could, in turn, lower levels of hydrogen peroxide formed from copper ions 
undergoing Fenton or Haber-Weiss reactions and so indirectly protect cells from oxidative 
stress (Brown et al., 1998; Nishimura et al., 2004). PrPc expression by astrocytes may also 
function to protect neurones from copper induced toxicity by taking up copper ions 
released from neurones (Brown, 2004).
A role for PrP° as a storage or transport molecule for copper does not explain other 
properties associated with both the cellular and disease isoforms of the protein. For 
example, the increased susceptibility of scrapie infected cells to oxidative stress in the 
presence of redox active iron (Femaeus et al., 2005) is unlikely to be due to PrPc chelating 
iron, as binding studies of the PrPc octameric repeat domain and various metal ions have 
shown low affinity for this metal (Homshaw et al., 1995a; Homshaw et al., 1995b). This 
implies that the role of PrPc extends to other cellular survival mechanisms such as 
oxidative stress response.
1.5.2 PrP° and Cellular Antioxidant Activity
As stated above, PrPc knockout mice show few developmental or biochemical 
irregularities. However, notable deviations from the wild type include an increased 
sensitivity to oxidative stress and reduced Cu/Zn superoxide dismutase (SOD) activity. 
Scrapie infected mice have compromised antioxidant function (Wong et al., 2001b; 
Thackray et al., 2002). This is also seen in scrapie infected neuronal cells, where increased 
levels of lipid peroxidation markers and decreased activity of SOD and glutathione 
dependant antioxidant mechanisms are observed (Milhavet et al., 2000). Oxidative 
damage is a proposed method by which cells die during the progression of prion diseases 
(Guentchev et al., 2002). This may be due to altered copper metabolism as suggested 
above but also might be a loss of function brought about by the change of PrP structure 
characteristic of prion disease.
PrPc has been shown to be up-regulated and to accumulate at the site of damage in 
ischaemic brain injury in human tissue (McLennan et al., 2004). This was also observed in 
mice (McLennan et al., 2004) and rats (Shyu et al., 2005b). In the mouse model, the
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extent of injury in response to an equivalent insult was much greater in PrPc knock out than 
wild type mice. Increases in inflammatory cytokines and reactive oxygen species (ROS) 
are found in ischaemic injury, and both of these may be involved in the up-regulation of 
PrP° around the injury site. This data indicates that PrP° may have a role in the protection 
against oxidative stress and inflammatory effects of ischaemia. The authors suggest that 
this protective effect is determined by the site of injury and is relative to the level of PrPc 
expression.
A further effect of the absence of PrP° is on mitochondria quantity and morphology (Miele 
et al., 2002). Unusual mitochondrial morphology is observed on ablation of PrPc and 
elevated levels of mitochondrial manganese-dependant SOD are found (Brown et al., 
2002; Miele et al., 2002). Mitochondria produce the vast amount of the cell’s energy and 
in doing so produce large quantities of free radicals, therefore it is likely that they would be 
greatly affected by an inability to deal with oxidative stress that may arise from a loss of 
PrPc function. Mitochodria also play a significant role in apoptosis and so, if their physical 
condition is altered as a result of altered PrPc activity in prion diseases, they may 
contribute to cell death and disease pathogenesis.
In knockout mice, alteration in antioxidant activity in tissues that would normally express 
PrPc has been suggested to account for impaired ability to undergo strenuous exercise 
(Nico et al., 2005b). Knockout mice have higher levels of ROS in muscle tissue as well as 
in neuronal tissue (Klamt et al., 2001). The added oxidative insult from aerobic exercise 
may impair the ability of the muscle to function at the normal level. Additionally, Nico et 
al. note that, despite finding that mitochondrial respiration is unaltered in knockout mice, 
mitochondrial numbers are lower (Miele et al., 2002), and so the mice may be unable to 
generate the energy muscles require for strenuous activity.
Early changes in the brains of infected mice include altered metal ion concentrations and 
this is associated with the decreased ability to deal with oxidative stress insults (Wong et 
al., 2001b). A role for PrPc in delivery or incorporation of copper into this enzyme has 
been suggested (Brown & Besinger, 1998). In cells selected for resistance to copper or 
oxidative stress insults, PrPc is expressed at higher levels to those found in their unstressed 
counterparts (Brown et al., 1997a). Loss of PrPc mediated delivery of copper into Cu/Zn 
superoxide dismutase may account for the increased susceptibility of knock out mice to 
oxidative stress.
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PrPc has been suggested to have activity like that of SOD itself and this has been 
demonstrated using recombinant PrPc in vitro (Brown et al, 1999). The activity was 
dependent on copper binding to the octameric repeat domain and was directly proportional 
to the amount of copper bound. PrPc has been shown to contribute to total SOD activity of 
mouse brain homogenates (Wong et al., 2000). PrPc immunoprecipitation from brain 
homogenates reduced total SOD activity of the remaining tissue proportionally to the 
quantity of PrPc precipitated. Complementary to this data, PrPc has been shown to have 
SOD-like activity in vivo. PrP° isolated from mouse brain demonstrated SOD-like activity 
that was dependent on copper binding to the octarepeats (Brown et al., 2001). At least two 
copper molecules must be bound for this activity to be significant. Although the octameric 
repeat domain is required for the reported SOD-like activity, a residual activity is observed 
using copper refolded recombinant protein lacking the octameric repeat region (Brown et 
al., 1999). This may indicate that copper binding to the fifth site is also able to initiate 
some degree of antioxidant activity from recombinant PrPc.
It should be noted that two studies show contrasting results with both PrPc in vivo and 
recombinant PrPc in vitro shown to have no antioxidant activity at all (Hutter et al., 2003; 
Jones et al., 2005). The disagreement most likely arises from differing experimental 
conditions. These experiments were carried out under conditions where copper was 
rendered biologically unavailable to PrP°. Since the suggested PrPc SOD-like activity is 
dependant on copper binding to the octameric repeat domain, it is doubtful that activity 
would be seen under these conditions. However, as a result of the disagreement, the SOD- 
like function of PrPc remains highly controversial and further study is required to clarify if 
PrPc is a genuine antioxidant.
The importance of the N-terminus in the response of PrPc to oxidative stress is further 
emphasized by Zeng et al. (2003), who show that tethering the N-terminus to the cell 
membrane results in a neuronal phenotype which, despite displaying similar PrP levels to 
wild type, shows a decreased ability to deal with an oxidative stress insult. Sakudo et al 
(2003) also report that the octameric repeat domain is essential in regulating total cellular 
SOD activity and apoptosis. The authors found that cells expressing N-terminally 
truncated PrPc, which lacks the octameric repeat region, show significantly higher levels of 
oxidative stress and apoptosis in response to serum deprivation than wild type cells. As 
well as the octameric repeat domain, the hydrophobic domain at the core of the structured 
C-terminus is also thought to be essential for PrP° antioxidant activity (Cui et al., 2003;
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Sakudo et al., 2005). Whereas the role of the octameric repeat domain is likely to involve 
copper binding, the role of the hydrophobic domain remains to be determined. This 
domain could be part of the enzyme active site or a structurally stabilising region of PrPc.
The putative role of PrPc as an antioxidant enzyme is supported by current knowledge of 
its gene structure and regulation. Prnp is up-regulated in response to cellular stress and 
shares a number of features with several mouse SOD genes (Premzl et al, 2005) including 
the gene structure of two to three exons with the ORF entirely encoded by the final exon, 
and the lack of TATA box. In addition, MZF-1, for which binding sites have been found 
conserved in prnp across several species, is a negative regulator of some mouse SODs 
(Zelko & Folz, 2003).
A role for PrPc as an antioxidant or a modulator of cellular stress is consistent with 
findings that it is involved in mouse embryogenesis (Manson et al., 1992; Miele et al.,
2003). PrPc is expressed in most adult tissues, although to varying extents depending on 
the tissue type. However during embryogenesis expression is more tightly regulated. The 
induction of PrPc mRNA appears to coincide with the period of development where the 
embryo switches from anaerobic to aerobic metabolism and so is exposed to much higher 
levels of ROS. PrPc may be induced to protect the developing embryo from oxidative 
stress insults during development.
1.5.3 Signal Transduction
PrPc has been thought to have a role in lymphocyte signal transduction for some time 
(Cashman et al., 1990). A PrPc mediated signal cascade in lymphocytes is suggested to be 
involved in activation, as memory T lymphoctes express more PrPc than immature cells, or 
in initiating response to proliferation signals (Li et al., 2001; Bainbridge & Walker, 2005). 
In lymphocytes, the accumulation of crosslinked proteins in patches within the cell 
membrane (capping) involves lipid raft proteins. PrP° is targeted to lipid rafts within the 
cell membrane and may become incorporated in these caps. The cross-linking of PrPc that 
is potentially triggered by this close interaction has been suggested to cause activation of 
signal transduction pathways involving calcium signalling and MAP kinase activation 
(Stuermer et al., 2004).
A role for PrPc in signal transduction was strengthened by the finding that in mouse 
neuronal cells PrPc could interact with signalling proteins including Fyn tyrosine kinase,
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synapsin lb and growth factor receptor-bound protein 2 (Grb2; Mouillet-Richard, 2000; 
Spielhaupter & Schatzl, 2001). Fyn is implicated in the control of cell growth. Synapsin 
lb is part of a highly conserved family of synapsins, which are involved in synapse 
formation and neurotransmitter release. Grb2 is involved in transduction of signals from 
receptors at the cell membrane to intracellular signalling molecules. PrP° binding to any of 
these molecules could, therefore, trigger signal transduction cascades. In addition a PrPc- 
binding peptide has been found to activate cAMP and protein kinase A (PKA), and 
extracellular regulated protein kinase (ERK) pathways of neuroprotection (Chiarini et al.,
2002). This is also supported by data from Schneider et al. (2003), who propose a 
transduction cascade by which PrPc stimulation activates ERK1 and ERK2. Overall this 
data suggests that PrPc activation starts a cascade of cellular protective signals, which may 
explain the protective function of PrP° in response to ROS. However it does not account 
for the role of copper in such a reaction. Activation of PrPc in response to exogenous 
signalling molecules may require copper binding or the alteration in N-terminal secondary 
structure imparted by copper binding.
1.5.4 Other Suggested Functions
Other roles for PrPc have been suggested but have received much less attention than those 
discussed above. PrPc binds to neural cellular adhesion molecules (N-CAMs; Schmitt- 
Ulms et al., 2001), and Mange et al. (2002) found that PrP° overexpressing cells showed a 
greater tendency to aggregate than cells expressing normal levels of PrPc, indicating a 
potential role for PrPc as an adhesion molecule. Cleavage of cell surface PrPc at the GPI 
anchor abolished this effect in cells overexpressing PrPc but not in the wild type cells, 
signifying that under normal circumstances PrP° would not be a dominant adhesion 
molecule. The authors also note that the PrPc specific adhesion reaction occurs 
independently of Cu saturation but requires the N-terminus. The specific protein on the 
adjacent cell surface with which PrPc may react is unknown, although it could potentially 
react with itself. There has been little further investigation into PrPc as a cell adhesion 
molecule as it is plausible that the PrPc specific adhesion was an artefact of overexpression.
Disrupted sleep patterns found in patients suffering from FFI along with the findings of 
altered sleep regulation in knockout mice compared to wild type, have advocated a 
potential role for PrPc in promoting sleep continuity (Tobler et al., 1996; Tobler et al., 
1997). The suggestion of a peptidase role for PrPc has arisen because the structured C- 
terminus of murine PrPc shares homology with the active site of rat signal peptidase
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(Glockshuber et al., 1998). Also, a role for PrPc has also been proposed in serotonin 
homeostasis by regulating specific receptor couplings and cross-talk (Mouillet-Richard et 
al., 2005).
1.6 Aims and Objectives
Despite the wealth of information generated by recent studies into many aspects of PrPc, 
little is known about its genetic regulation and as yet there is no overall consensus on the 
function of the protein. The many properties of PrPc provide confusing and sometimes 
misleading clues as to its role within the cell, and no single hypothesis is able to account 
for all the established characteristics of this protein. Overall, the aim of this work is to 
provide further understanding of the regulation, metabolism and function of the cellular 
isoform of the prion protein. The specific aims of this work are listed below.
The aims of studying the structure of the gene and control elements were;
• To investigate the regions of the gene important for driving the production of PrP 
mRNA.
• To determine the importance of the gene in tissue specific expression and how the 
underling tissue affects the expression of PrPc at the genetic level.
• To determine the regions of the gene important for tissue specific expression
• To identify substances that alter prnp activity. Both for the purpose of determining 
the function of PrPc as indicated by the factors that induce it, and for identifying 
substances that may be useful agents for disease management.
• To identify the regions of the gene important for responding to factors that are 
found to modulate expression.
PrPc metabolism and function was investigated at the protein level with the following aims;
• To examine copper induced internalisation of PrPc. Specifically to find the 
conditions under which internalisation occurs optimally and to determine the 
minimum concentration of copper that will induce internalisation.
• To determine if other metals can produce the same internalisation reaction as 
copper.
• To determine the regions of PrPc important for the copper internalisation reaction.
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• To investigate the protection PrPc affords against copper toxicity, including if this 
protection is directed directly against the copper ion itself or if protection is by 
preventing oxidative stress that free copper can cause, and additionally, to identify 
the regions of PrPc important for this protection.
• To investigate if PrPc can protect against cell death induced by oxidative stress 
insults, and the regions of the protein important for protection against free radicals.
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2 Materials and Methods
Reagents were purchased from Sigma (Poole, UK) unless otherwise stated.
2.1 Creation of Plasmid Constructs
2.1.1 Materials
Plasmids -  Vector maps are shown in appendix A 
pcDNA-3.1(+) -  Invitrogen (Paisley, UK) 
pEGFP-Cl -  Clontech (Oxford, UK) 
pd2-EGFP-l -  Clontech 
pd2-EGFP-N 1 -  Clontech 
DsRED-ER -  Clontech
pProHGPrP(m)Sal -  Kind donation from Dr Charles Weissmann (Fisher et al.,
1996)
PCR
Pwo Polymerase -  Roche (East Sussex, UK) 
dNTPs -  New England Biolabs (NEB)
Dpnl -  Invitrogen
Nuclease Free Water -  Promega (Southampton, UK)
Transformation
XL-2 Blue Ultra Competent Cells -  Stratagene (Amsterdam, Netherlands)
LB Broth - Merck (Hertshire, UK)
Agar -  Merck
Kanamycin Sulphate -  Melford Laboratories (Ipswich, UK)
Carbenicillin
Mini-Prep
Qiagen Qia-Quick Spin Mini-Prep Kit -  Qiagen (Crawley, UK)
Glycerol -  Fisher (Loughborough, UK)
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LB Broth -  M erck  
N u c lea se  Free W ater -  Prom ega
Prim ers -  Purchased from  either H elena  (Sunderland, U K ) or M W G  (L ondon , U K )
Prim ers for the introduction  o f  m utations into PrP(m ) through PC R  m u tagen esis are 









5’GGA CTG ATG TCG GCC TCT GCC CCG GGC AGG GAA GCC CTG G 3’ 




5’CTA TGT GGA CAG ATG TCG GCC TCT GCT CAC CGG TCG CCA CCA TGG TGA GC 3’ 




5’ GGC AAC CGT TAC CCA GGA GGG GGT ACC CAT 3’ 




5’ GGT GGC TGG GGA CAA GGA GGG GGT ACC CAT’3 




5’ CCA AAA ACC AAC CTC AAG CAT GTG GTA GTG GGG GGC CTT GGT GGC 3’ 




5’ CCA AAA ACC AAC CTC AAG CAT GTG ATG ATC CAT TTT GGC AAC GAC TGG G 3’ 




5’ GCA GCT GGG GCA GTA GTG CGC TAC TAC CGT GAA AAC ATG TAC 3’ 




5’ GGG AGC GCC GTG AGC GAA AAC ATG TAC CGC 3’ 
3’ CCC TCG CGG CAC TCG CTT TTG TAC ATG GCG 5’
Table 2.1 Primers used for the introduction of deletions into mouse PrPc by site directed PCR 
mutagenesis. The sequences shown are for introduction of the mutation into pEG FP-Cl-PrP(m ) 
unless otherwise indicated.
Primer Name Sequence
EGFP-N 5’ CGT CGC CGT CCA GCT CGA CCA G 3’
EGFP-C 5’ CAT GGT CCT GCT GGA GTT CGT G 3’
PrPF 5’ AAA AAG CGG CCA AAG CCT GG 3’
PrPR 5’ GGA TCT TCT CCC GTC GTA ATA G 3’
pEGFP-Cl base 527-547 5’ GCG GTA GGC GTG TAC GGT GG 3’
T7 5’ TAA TAC GAC TCA CTA TAG GG 3’
Table 2.2 Sequencing Primers.
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A garose G el E lectrophoresis  
A garose  -  M elford  
T B E  or T A E  B uffer  
E thidium  B rom ide
lOx B lu eju ice  load ing  d ye -  Invitrogen  
X - H ind III fragm ents -  Invitrogen
2.1.2 Creation o f Plasmids fo r PrP1 and PrPc Mutant Studies 
For the co -lo ca lisa tio n , trafficking, and survival assays, sev en  G FP fu sion  constructs have  
been  m ade u sin g  m ou se PrPc (a ccessio n  num ber =  M l 3 6 8 5 ). T he p E G F P -C l-P rP (m ) 
plasm id  w as k ind ly  donated from  M arco Prado (B razil). M utations w ere introduced into  
th is p lasm id  using  PC R  m u tagen esis to g iv e  p E G F P -C l-P rP (m ) A 23-38 , p E G F P -C l-  
PrP(m ) A 51 -9 0 , p E G F P -C l-P rP (m ) A 61-90 , p E G F P -C l-P rP (m ) A 1 1 2 -1 1 9 , p E G F P -C l-  
PrP(m ) A 1 1 2 -136 , p E G F P -C l-P rP (m ) A 1 2 2 -1 4 6  and p E G F P -C l-P rP (m ) A 13 5 -1 5 0  (see  
figure 2 .1 ). A 51-90 , A 67-90 , and A 1 3 5 -1 50  m utations w ere created p rev iou sly  by K ate
Edw ards (U n iversity  o f  C am bridge). A  p E G F P -C l-G P I control, the sam e construct as 
p E G F P -C l-P rP (m ) but lack ing  all o f  PrP ex cep t the N -term inal signal peptide and GPI 
anchor, and p cD N A -3 .1 -P rP (m ), a PrP exp ressin g  vector lack ing the G FP tag, w ere created  
by M aki D a n ie ls  (U n iversity  o f  C am bridge).
N-terminal signal GFP Octameric repeat Hydrophobic GPI signal
sequence 27kDa domain region sequence
______ _ _
-----------
Figure 2.1 Diagrammatic representation o f the construction o f GFP-PrPc showing the location of each 
of the deletion mutants.
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To introduce the remaining mutations the following reaction was prepared, and carried out 
in a Thermo Hybaid PCR Sprint thermal cycler. 200 ng template DNA, 20 pM of each 
primer (see table 2.1), 0.5 pM dNTPs, and 10 pi 1 Ox buffer (100 mM Tris-HCl [pH8.85 @ 
20°C], 250 mM KC1, 50 mM [NH^SCL, with or without 20 mM MgS0 4 ) were added into 
each reaction. When using the buffer without MgSCL reactions were set up with 10, 12, 14 
and 16 pi 25 mM MgSCU (provided) added. Reactions were made up to 99 pi with 
nuclease free water. After a 10 minute hot start at 95°C, 5 units (1 pi) of Pwo polymerase 
were added to the reaction mixture, making a final volume of 100 pi reaction mix. Sixteen 
cycles of 97°C for 1 minute, 55°C for 1 minute, and 72°C for 3 minutes were performed. 
This was followed by one cycle of 95°C for one minute, 55°C for one minute, and 72°C for 
10 minutes. The hold temperature was 4°C. Following PCR, samples were digested in 
Dpnl to remove remaining parental DNA.
2.1.3 Creation o f Plasmids for Promoter Studies
Plasmids for the promoter studies have been made using the bovine promoter sequence and 
include a promoter plus exons 1 and 2 construct (A), a promoter only construct(B), an exon 
1 and exon 2 construct (C), a promoter plus exon 1 only construct (D), and an intron 1 and 
exon 2 only construct (E; see figure 2.2). Constructs D and E were made by Kate Edwards 
(University of Cambridge), and construct A was made by Andrea Holme (University of 
Bath). Constructs B and C were made by Lark Technologies Inc. (Essex -  UK). All 
promoter constructs have been made in pd2-EGFP-l, a promoter-less vector containing 
destabilised GFP with a two hour half-life. The destabilised GFP reporter is a modified 
version of an enhanced variant of GFP (EGFP) made by fusing the C-terminal end of the 
EGFP with amino acids 422-461 of the degradation domain of mouse ornithine 
decarboxlyase, one of the shortest lived proteins in mammalian cells with a half life of just 
30 minutes and no requirement of ubiquitination for destruction (Li et al., 1998). The 
CMV promoter driven, and therefore constitutively expressed, pd2-EGFP-Nl vector was 
used as a control non-specific changes in fluorescence.
Constructs equivalent to A, and E were created using the mouse long incubation prion gene 
(accession number = U29187), by Lark Technologies Inc.
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Exon 2
Exon 1 Intron 1 d2EGFP
Figure 2.2 Bovine prnp  constructs. A, promoter plus non-coding region; B, promoter only; C, non­
coding region only; D, promoter plus exon 1; E, Intron one plus exon 2; F, CM V promoter control; 
and V, vector/background expression control.
2.1.4 Transformation
Transform ations w ere done using  X L -2  B lu e U ltra C om petent C ells . X L -2  B lu e ce lls  w ere  
thaw ed on  ice . 35 pi o f  ce lls  w ere transferred into pre-ch illed  15 m l F alcon  tubes and 0 .7  
pi o f  p-m ercaptoethanol (provided) w as added to th is to g iv e  a final concentration o f  25  
m M . The c e lls  w ere incubated on ice  for 10 m inutes w ith  gen tle  m ix in g  every  2 m inutes. 
5 p i PC R  m u tagen esis D N A  or 10 pi ligation  D N A  w as added to the ce lls  and the ce lls  
w ere then incubated on ice  for a further 30  m inutes. A fter the 30  m inute incubation, ce lls  
w ere heat sh ock ed  at 42°C  for 30 secon d s, then returned to the ice  for 2 m inutes. 965  pi 
LB broth, pre-heated to 4 2 °C , w as added to the c e lls , and then they w ere incubated at 37°C  
for 1 hour w ith  shaking at 2 0 0  rpm. C ells  w ere plated on LB agar p lates contain ing 50  
p g/m l k anam ycin  sulphate or carben icillin  as appropriate, and incubated at 37°C  overnight.
2.1.5 Mini-preps
A ll reagents used  w ere provided  w ith in  the Q IA -sp in  m ini-prep kit to the recipes described  
in the product protocol. Several co lo n ie s  from  a transform ation plate w ere p icked  and 
added to a 50  m l fa lcon  tube contain ing 5 m l o f  LB broth w ith  50  p g /m l o f  relevant 
antib iotic. T h ese  w ere incubated overn ight at 3 7°C  w ith  shaking at 2 0 0  rpm. G lycerol 
stocks w ere m ade o f  each  n ew  c lo n e  by adding 6 0 0  pi o f  ce ll su sp en sion  to 4 0 0  p i o f  
g lycero l d ilu ted  1:1 in L B  broth. C ultures w ere centrifuged  for 10 m inutes at 3 2 2 0  x g  in  
an E ppendorf 581 OR centrifuge to co llec t the ce lls . The Q iagen  Q ia-Q u ick  spin m ini-prep  
kit w as used  to extract the p lasm id  as fo llo w s. The ce ll p ellet obtained  w as resuspended  in 
25 0  pi o f  buffer PI w ith  R N ase A  (provided), and transferred to a m icro-cen trifuge tube.
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250 jul of buffer P2 (lysis buffer) was added to this and mixed by inversion. The lysis 
reaction was stopped by the addition of 350 pi of buffer N3 and mixing as before. Tubes 
were centrifuged at >10 000 xg in a benchtop microfuge for 10 minutes. After 
centrifugation the supernatant was transferred to a mini-prep column and centrifuged at 
>10 000 xg for 1 minute, the flow through was discarded. The column was then washed 
by adding 750 pi of wash buffer with ethanol, centrifuging as before for one minute, 
discarding the flow through, and then centrifuging again for one minute. Plasmid DNA 
was eluted from the column by the addition of 30 or 50 pi of nuclease free water to the 
membrane (depending on the expected yield and desired concentration of the DNA), 
standing for one minute, transferring the column into a microfuge tube and then 
centrifuging as before.
2.1.6 Agarose Gel Electrophoresis
2-5 pi of mini-prep sample was mixed with lOx Bluejuice loading dye and loaded onto a 
1% agarose gel (with 0.5 pg/ml ethidium bromide). The gel was electrophoresed using a 
BioRad mini-sub®cell GT gel tank and BioRad power pac 300, at 75 volts, for 1 hour. 
Gels were photographed under a long wave UV light box. Quantification was made by 
measurement of UV absorption at 260 and 280 nm or comparison of band intensity with 
A,HindIII fragments of known concentration.
2.1.7 Sequencing
300-500 pg of mini-prep DNA was transferred into a micro-centrifuge tube with 5 pM of 
appropriate primer (see Table 2.2) and endonuclease free water to a final volume of 6 pi. 
Sequencing was performed by Paul Jones (University of Bath) using a PE Biosystems ABI 
377 DNA Sequencer or by Gene Service Ltd (Cambridge, UK).
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Nuclease free water 
RLM-RACE
FirstChoice® RLM-RACE Kit -  Ambion (Huntingdon, UK)
Mouse total RNA -  Ambion 
Acid phenol:chloroform -  Ambion 
High fidelity PCR master -  Roche 
Isopropanol 
Ethanol
Gene specific (GS) primers -  MWG (see table 2.3)
Agarose
TAE buffer
100 bp ladder -  NEB
200 pi thin wall PCR tubes -  Fisher
Primer Name Sequence
PrP(m) ex2 F 5’ CTT TGA TGA AAG ACT CCT GAG 3’
PrP(m) GS outer 5’ AAG CAG GAA GGC CTC CCT CA 3’
PrP(m) GS inner 5’ AAG CAC GGT GCT GCT GGA TCT T 3’
PrP(b) ex2 F 5’ CTT TGA TGA AAG ACT TCT GAA TAT AT 3’
PrP(b) GS outer 5’ TCA CAG GAG GGG AAG AGA AGA 3’
PrP(b) GS inner 5’ TGC TCC ACC ACT CGC TTC AT 3’
Table 2.3 Gene specific primers for RLM-RACE nested PCR reactions.
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Cloning of RLM-RACE products
QIA-Quick Gel Extraction Kit -  Qiagen 
pGEM®-T-Easy Vector System I -  Promega 
XL-2 Blue Ultracompetent Cells -  Stratagene 
Agar -  Merck 




All equipment and work surfaces were treated to remove RNases, and RNase free 
plasticware and aerosol resistant tips were used throughout. 1ml of Tri reagent was added 
to approximately 1 cm section of bovine brain and homogenised in a hand-held 
homogeniser. The resulting suspension was transferred to a 1.5 ml microcentrifuge tube 
and centrifuged at 15 300 xg for 10 minutes at 4°C. The supernatant was transferred to a 
new microcentrifuge tube and 200 pi chloroform added. This was agitated vigorously for 
15 seconds then incubated at room temperature for 3 minutes before centrifuging at 15 300 
xg for 10 minutes at 4°C. The upper aqueous phase was transferred to a new 
microcentrifuge tube and 500 pi isopropanol added. Tubes were mixed at room 
temperature for 10-15 minutes before centrifuging at 15 300 xg for 10 minutes at 4°C. The 
pellet was washed in 500 pi 100% ethanol, centrifuged at 15 300 xg for 2 minutes at 4°C, 
and then the ethanol was removed. The pellet was washed twice more in 70% ethanol as 
above. The ethanol was carefully removed and the pellet was allowed to air dry on ice for 
10 minutes before resuspending in 100 pi nuclease free water. RNA was stored at -20°C 
until use. Just prior to use, RNA was quantified by reading a 1 in 50 dilution of the RNA 
in nuclease free water at 260nm in a Cary 50 UV-Visual spectrophotometer.
2.2.2 RLM-RACE
All reactions were carried out using nuclease free equipment as above. The FirstChoice® 
RLM-RACE kit was used for these reactions as described in the product instruction 
manual, all reagents except those listed in the materials above were supplied with the kit. 
To begin, the total RNA was incubated with calf intestine alkaline phosphatase (CIP) to 
remove free phosphate groups from the 5’ ends of degraded mRNA, rRNA, tRNA and 
contaminating genomic DNA. 10 pg total RNA was incubated with 2 pi CIP, 2 pi 1 Ox CIP
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buffer, and nuclease free water to 20 j l i I  total reaction. This was tapped to mix, spun 
briefly, then incubated at 37°C for 1 hour. To stop the reaction 15 pi ammonium acetate 
solution, 115 pi nuclease free water and 150 pi acid phenol chloroform were added to each 
tube. Samples were vortexed thoroughly, centrifuged at 17 950 xg in a benchtop 
microcentrifuge at room temperature, and the aqueous layer was transferred to a new tube. 
To this 150 pi of chloroform was added, samples were vortexed, centrifuged at 17 950 xg 
for 5 minutes, and the aqueous layer was transferred to a new microcentrifuge tube. 150 pi 
of isopropanol was added, tubes were vortexed and chilled on ice for 10 minutes. Samples 
were then centrifuged at 20 800 xg for 20 minutes at 4°C. The resulting pellets were 
washed with 500 pi cold 70% ethanol, centrifuged for a further 5 minutes at 20 800 xg and 
4°C, then the ethanol was removed and discarded, and the pellets allowed to air dry. The 
pellets were resuspended in 11 pi of nuclease free water and stored on ice whilst the next 
reaction was prepared.
RNA from the CIP reaction was treated with tobacco acid pyrophosphatase (TAP) to 
remove the 5’ cap from full length mRNA, leaving only a 5’-monophosphate to which the 
5’RACE adapter was ligated. 5 pi of the CIP treated RNA was incubated with 2 pi TAP, 1 
pi lOx TAP buffer, and 2 pi nuclease free water. The reactions were mixed by tapping, 
pulse centrifuged, and incubated at 37°C for 1 hour. To ligate the 5’RACE adapter 2 pi of 
the TAP reaction was incubated with 1 pi 5’RACE adapter, 1 pi lOx RNA ligase buffer, 
2pi T4 RNA ligase, and 4 pi nuclease free water. Tubes were tapped to mix, pulse 
centrifuged, and incubated at 37°C for 1 hour.
After the addition of the 5’RACE adapter, cDNA was reverse transcribed from the RNA 
sample in the following reaction. 2 pi of the 5’RACE adapter ligated DNA or 2 pi of 
minus TAP control DNA were added to a new microcentrifuge tube with 4 pi of dNTP 
mix, 2 pi random decamer primers, 1 pi M-MLV Reverse Transcriptase (RT), 2 pi 1 Ox RT 
buffer, 1 pi of RNase inhibitor, and 8 pi of nuclease free water. The reaction was tapped to 
mix, pulse centrifuged, and incubated at 42°C for 1 hour. Samples were stored at -20°C 
until use.
The cDNA from the RT reaction was used to set up the first, outer reaction for the nested
PCR. The following reactions were set up in 200 pi thin wall PCR tubes; 1 pi RT reaction,
2 pi 5’ RACE gene specific (GS) outer primer (10 pM), 2 pi 5’ RACE outer primer, 25 pi
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high fidelity PCR master mix, and 20 pi nuclease free water. Tubes were tapped to mix, 
spun briefly, and cycled in a PCR-sprint thermocycler, after a hot start of 3 minutes at 
94°C. The PCR consisted of 35 cycles of 94°C for 30 seconds, 56°C for 30 seconds, and 
72°C for 30 seconds. This was followed by 72°C for 7 minutes. The second, inner nested 
PCR was set up as follows; 2 pi of outer PCR product, 2 pi 5’RACE GS inner primer (10 
pM), 2 pi 5’RACE inner primer, 25 pi high fidelity PCR master mix, and 19 pi of nuclease 
free water. This was cycled as for the outer PCR reaction. The products of the second 
PCR reaction, and control reactions, were run on a 2% agarose gel alongside a 100 bp 
ladder.
2.2.4 Cloning o f RLM-RA CE PCR Products
To characterise the products of the RLM-RACE reaction, the bands obtained from the 
second nested PCR were cut out of the gel and gel purified using the Qiagen QiaQuick gel 
extraction kit as described in the product protocol. Briefly, gel slices in 1.5 ml 
microcentrifuge tubes were incubated with 3 gel volumes buffer QG for 10 minutes (or 
until the gel was completely dissolved) at 50°C with vortexing every couple of minutes. 
One gel volume of isopropanol was added to this solution and mixed, the solution was then 
poured into a QiaQuick column and centrifuged in a benchtop microcentrifuge at 17 950 
xg for 1 minute and the flow through discarded. The column was washed with 750 pi of 
wash buffer, centrifuged at 17 950 xg for 1 minute, the flow through was discarded and the 
column centrifuged again as before. To elute the DNA, 30 pi of nuclease free water was 
added to the membrane of the column, which was placed in a 1.5 ml microcentrifuge tube 
and centrifuged at 17 950 xg for one minute. DNA was stored at -20°C until use.
The Taq polymerase in the PCR master mix leaves A overhangs at the end of amplified 
products so a TA cloning vector, pGEM®-T Easy, was used to clone the PCR products. 
This vector and ligation reagents are provided as a kit and ligations were carried out as 
described in the product protocol. PCR products were ligated into the pGEM®-T Easy 
vector in the following reaction; 5 pi 2x rapid ligation buffer for T4 DNA ligase, 1 pi T4 
DNA ligase, 1 pi pGEM®-T Easy vector, and 3 pi purified PCR product. Ligations were 
incubated at room temperature for 1 hour before transformation into XL-2 Blue 
ultracompetent cells as described in section 2.1.4.
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The pGEM®-T Easy vector contains an ampicillin resistance selection marker and the 
LacZ operon allowing blue-white screening to be used to distinguish successfully ligated 
clones from vector religation due to loss of the T overhangs. The transformed cells were 
plated on agar plates containing 50 pg/ml carbenicillin and spread 30 minutes before use 
with 100 pi lOmM IPTG and 20 pi 50 mg/ml Xgal. White colonies were selected for 
overnight cultures and DNA purified by mini-prep as described in section 2.1.5. Plasmid 




F14 and F21 cells (laboratory derived cell lines)
Cos-7 cells (Kind donation from Professors Harrison and Eisenthal, formerly of the 
University of Bath)
SH-SY5Y cells (Kind donation from Professor Wonnacott, University of Bath) 
C8-D1A cells -  ATCC (Middlesex, UK)
G8 cells-A TCC
Dulbecco’s Modified Eagles Media -  Calbiochem (Nottingham, UK)
Foetal Bovine Serum 
Penicillin/Streptomycin Solution 
Glutamine -  Gibco (Paisley, UK)
Trypsin-EDTA
Cell dissociation buffer -  Gibco
Transfections
FuGene 6 -  Roche 
Geneticin -  Gibco
Chambered Coverslips -  Labtek (Fisher, Loughborough - UK)
2.3.2 Routine Cell Culture
All cell lines were maintained at 37°C and 5% CO2 in a humidified incubator.
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2.3.2.1 F14 and F21 cells
F14 (PrPc knockout mouse cerebellar-neuroblastoma fusion cells) and F21 (PrPc wild type 
mouse cerebellar-neuroblastoma fusion cells). These cells lines were created in this 
laboratory by fusion of cerebellar suspension from PrP null mice with N18TG2 mouse 
neuroblastoma cells (Holme et al, 2003). Cells were cultured in Dulbecco’s Modified 
Eagles Media (DMEM) of composition 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, and 
without sodium pyruvate and glutamine. This was supplemented with 10% foetal bovine 
serum (FBS), and final concentrations of 1 U/ml penicillin and 0.5 mg/ml streptomycin 
(pen/strep). At approximately 95% confluency cells were detached from the culture flask 
by gentle tapping and passaged 1 in 3 or 1 in 4.
2.3.2.2 Cos-7 and SH-SY5Y cells
Cos-7 (African green monkey kidney cell line) and SH-SY5Y (human neuroblastoma) 
cells were cultured in DMEM of composition as described for the F14/F21 cells. Media 
was supplemented with 10% FBS, 2 mM glutamine, and pen/strep. At approximately 95% 
confluency, Cos-7 cells were passaged 1 in 20, and SH-SY5Y 1 in 10, by incubation in 
trypsin-EDTA until the cells detached from the base of the flask.
2.3.2.3 C8-D1A cells
C8-D1A (mouse type 1 astrocyte) cells were cultured in DMEM of composition 4.5 g/L 
glucose, 1.5 g/L sodium bicarbonate, and 4 mM L-glutamine. Media was supplemented 
with 10% FBS and pen/strep. Cells were passaged 1 in 5 at 90-95% confluency, by 
incubation with trypsin-EDTA until the cells detached.
2.3.2.4 G8 cells
G8 (mouse myoblast) cells were cultured in DMEM of composition as described for C8- 
D1A cells, supplemented with 10% FBS, 10% horse serum, and pen/strep. Cells were 
passaged 1 in 5 at approximately 90% confluency, by incubation with trypsin-EDTA until 
the cells detached, and were not allowed to reach confluency to avoid fusion into 
myotubules.
2.3.3 Transfection
All transfections were carried out using FuGene 6 transfection reagent.
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2.3.3.1 Stable Transfection
Cells were plated at 50% confluency in 6-well plates the day before the transfection. To 
perform the transfection 100 pi of serum free media was pipetted into a micro-centrifuge 
tube. 3 pi of the FuGene 6 reagent was then added directly to this and mixed by gentle 
tapping. For each cell line to be created 1 pg of DNA was added to the mixture, mixed as 
before, and incubated at room temperature for 15 minutes. After this time the transfection 
mixture was added drop wise to the cells. The dish was swirled and returned to the 
incubator overnight. Cells were selected with 1 mg/ml geneticin 24 hours after 
transfection, then maintained in 0.5 mg/ml for routine culture.
2.3.3.2 Transient Transfection
Cells were plated in chambered coverslips at 35-50% confluency the day before 
transfection. To 20 pi of serum free media, 0.6 pi of FuGene 6 reagent was added and 
tubes were tapped to mix, then 0.2 pg of DNA was added to this and mixed again. The 
mixture was incubated for 15 minutes at room temperature before addition to the cells. To 
allow full expression and normal turnover of the plasmid product before the start of the 
experiment, cells were incubated under normal conditions for at least 24 hours after 
transfection.
2.4 Live Cell Imaging Studies
2.4.1 Materials
General Microscopy
Chambered Coverslips -  Labtek (Fisher)
OptiMEM serum free, phenol red free media -  Gibco 
CuS04
Glycine -  Fisher
Lyso-Tracker
Lyso-Tracker® Red -  Molecular Probes (Invitrogen)
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Mito-Tracker
Mito-Tracker® Red -  Molecular Probes 
DMSO
Golgi Probe




Defatted Bovine Serum Albumin (BSA)
Hanks
Endoplasmic Reticulum (ER) Probe 
pDsRed-ER -  Clontech
2.4.2 Co-localisation
Viable cells were required for the experiments, therefore cells were plated in chambered 
coverslips at 50% confluency and allowed to adhere before the start of the experiment. 
Images were captured using the Zeiss LS 550 confocal microscope.
2.4.2.1 Lyso-Tracker
Lysosomes were visualised using Lyso-Tracker® Red. Cells were incubated for half an 
hour at 37°C in normal media containing 50 nM probe, then rinsed in Hanks and 
transferred into pre-warmed OptiMEM.
2.4.2.2 Mito-Tracker
The Mito-Tracker® Red probe was dissolved in high quality anhydrous DMSO to a final 
concentration of 1 mM. For cell staining, 100 nM of Mito-Tracker in normal media was 
applied to the cells for 30 minutes. This was replaced with fresh pre-warmed OptiMEM 
and kept incubated under normal conditions until observation of the cells.
2.4.2.3 Golgi Probe
The sphingolipid golgi probe was prepared as a BSA complexed solution, as described in
the product protocol. Briefly, the 250 pg of the probe provided was dissolved in 354 pi of
19:1 chloroform to ethanol solution to produce a 1 mM stock solution of probe. 50 pi of
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stock solution was aliquoted into a small glass test tube and dried under a stream of 
nitrogen and then under vacuum for 1 hour. Dry probe was redisolved in 200 pi of 
absolute ethanol. 10 ml of Hanks with 10 mM HEPES (pH 7.4) was prepared in a 50 ml 
falcon tube. 3.4 mg of defatted BSA was added to this. The probe was added to the tube 
whilst agitating on a vortex mixer. The resulting solution is 5 pM sphingolipid -  5 pM 
defatted BSA solution. For staining, cells were washed in Hanks and then incubated in the 
probe solution at 4°C for 30 minutes. After this the cells were washed again then 
incubated in fresh culture media at 37°C for a further 30 minutes before being transferred 
into pre-warmed OptiMEM.
2.4.2.4 ER Probe
ER was visualised with the plasmid pDsRed-ER using transient transfections as described 
previously. Cells were transferred into pre-warmed OptiMEM before the start of the assay.
2.4.3 Trafficking Assays
For the copper internalisation assays, cells were plated in 4-well chambered coverslips at 
approximately 50% confluency. At time 0, test reagent was added and observations made 
at time zero, ten minutes and two hours. Images were captured as above.






Ethanol -  Fisher 
6-well plates -  Nunc, Fisher 
Hanks Buffered Salt Solution 
Phosphate buffered saline (PBS)
Paraformaldehyde 
Glycine -  Fisher 
Triton-X-100 -  Fisher
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Bovine serum albumin (BSA)
Foetal bovine serum (FBS)
DR1 anti-PrP antibody -  Brown (2000)
FITC conjugated goat anti-rabbit antibody -  Molecular Probes 
Vectorshield hardset mounting media -  Vector Laboratories (Peterborough UK)
2.5.2 IIF
Coverslips were sterilised in ethanol and placed in the wells of a 6-well plate. FI4 cells 
stably transfected with the pcDNA-PrP(m) construct were then plated at 50% confluency 
and returned to the incubator overnight. At the start of the assay, test reagent was added to 
one well of a set of three (2 hour exposure), reagent was added to the second well 10 
minutes from the end of the assay (10 minute exposure) and the third well was left 
untreated (time 0 control). 2 hours after the start of the assay, media was removed from 
the cells, and they were washed once in Hanks. Cells were fixed using 4% 
paraformaldehyde in PBS, and incubated for 30 minutes at room temperature. Following 
fixing, coverslips were transferred into a new 6-well plate and washed three times for 5 
minutes in PBS. Fixed cells were permeablised in 0.1% Triton-X-100 in PBS for 10 
minutes, washed again three times for 5 minutes in PBS, and then incubated for 10 minutes 
in 1% glycine in PBS. Cells were washed three times for 1 minute in PBS before blocking 
in 10% FBS and 0.5% BSA in PBS for 30 minutes. Coverslips were washed briefly in 
PBS, before incubating cells with the primary anti-PrP antibody (DR1, directed against 
amino acids 89-103) at a 1 in 500 dilution in 1% FBS and 0.5% BSA in PBS for a 
minimum of 2 hours at room temperature or overnight at 4°C. Cells were washed three 
times for 5 minutes in PBS to remove excess primary antibody, before addition of the 
secondary goat anti-rabbit FITC conjugated antibody in 1% FBS and 0.5% BSA in PBS. 
Incubation was for a minimum of 2 hours at room temperature or overnight at 4°C in the 
dark. Cells were washed again three times for 5 minutes before mounting in Vectorshield 
hardset mounting medium. Slides were stored at 4°C in the dark until viewing. 
Fluorescence was observed as described for live cell imaging. The final result was derived 
from studying a minimum of 18 cells over four separate experiments.
49
Chapter 2: Materials and Methods
2.6 Survival Assays
The assay of cell viability used here is the MTT assay. Live cells metabolise tetrazolium 
salts into formazan by the succinate-tetrazolium reductase system producing a coloured 




24 Well Plates -  Coming (Fisher)
MTT Reagent
Hanks Buffered Salt Solution 
Di-Methyl Sulphoxide (DMSO)
Copper Sulphate (CUSO4)






Bovine Superoxide Dismutase (SOD)
N-acetyl Cysteine -  Acros (Fisher)
2.6.2 MTT Assays
Cells were plated at approximately 40% confluency for metal assays and 80% confluency 
for oxidative stress assays, and incubated overnight before addition of the test reagent. The 
cells were then returned to the incubator until the time of the assay (4 days for metal 
assays, 24 hours for oxidative stress assays). At the time of the assay the media was 
removed from the cells and replaced by 200 pi of 200 pg/ml MTT reagent in Hanks. 
Plates were incubated for 30 minutes before the reagent was removed and 750 pi of DMSO 
was added to solublise the precipitate. Samples were read at 570 nm in a Cary 50 UV- 
visual spectrophotometer.
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2.7 Cellular Stress Studies
Cellular stress was determined by measurement of either markers of lipid peroxidation or 
direct detection of free radicals.
2.7.1 Materials 
Lipid Peroxidation Assays




Hanks Buffered Salt Solution 
20 mM Phosphate Buffer (pH 7.4)
Reactive Oxygen Species Indicator Experiments
OptiMEM serum free, phenol red free media
Redox Red® Indicator -  Molecular Probes
CM-H2DCFDA
96-well plates -  Nunc, Fisher
PBS
2.7.2 Lipid Peroxidation Assays
Lipid peroxidation is a mechanism of cellular injury caused by, and therefore a useful 
indicator of, oxidative stress. Lipid peroxides break down to form aldehydes, which may 
themselves be reactive and cause further oxidative stress insults. Break down products 
include malondialdehyde (MDA) and 4-hydroxyalkenals (HAE). The measurement of 
these is used to demonstrate oxidative stress injury of cells (Esterbauer et al., 1991, Oxis 
product guide). Reaction of MDA or HAE with N-methyl-2-phenylindole results in a 
coloured product with an absorption maxima of 585nm. The intensity of the colour is 
directly related to the extent of the lipid peroxidation.
n
A homogenate of 5 x 10 cells was required per assay condition. This was achieved by 
using 4-6 T75 cell culture flasks of cells per condition. Cells were grown to be confluent 
at the time of extraction. Test reagent was added 2 days prior to this time. Cells were
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collected by centrifugation at 1200 rpm for 10 mins, washed in Hanks, and then 
centrifuged again as before. The pellet was resuspended in 1.5 ml of 20 mM phosphate 
buffer (pH 7.4) and this was sonicated for 15 seconds to produce the homogenate. 
Immediately after sonication, 15 pi of 0.5 M BHT in acetonitile, to a final concentration of 
0.5 mM, was added to the homogenate to prevent further lipid peroxidation occurring.
Samples were then stored at -80°C until use.
The lipid peroxidation assay was carried out using the Bioxytech ® LPO-586™ kit, as 
described in the product handbook. The provided MDA standard was diluted to create 
standards of final concentration 0, 0.5, 1, 2, 3, and 4 pM concentration in 200 pi. Samples 
were spun to remove cell debris and 200 pi of each sample was transferred into six 1.5 ml 
microcentrifuge tubes so that triplicates could be run for both the MDA and the MDA + 
HAE assays. Immediately prior to use, reagent R1 was diluted 3:1 in the provided diluent 
(18 ml R l: 6 ml diluent).
To start both the MDA and the MDA + HAE assays, 650 pi of diluted Rl was added to 
each tube (standards and samples) and mixed gently by vortexing. For the MDA assay, 
150 pi of 37% HC1 was added to each of the triplicates, and for the MDA + HAE assay, 
150 pi of R2 reagent was added to each of the triplicates. The tubes were mixed well by 
vortexing. Tubes were then incubated at 45°C for one hour. Following incubation turbid 
tubes were centrifuged at 15 000 x g for 10 mins to obtain a clear supernatant. This was 
transferred into a plastic 1 ml cuvette and read using a Cary 50 UV-visual spectrophometer 
at 586 nm. The Cary software was used to plot the calibration curve and calculate sample 
concentrations. Following this a BCA assay (see section 2.8) was carried out on each 
sample to account for differences in protein concentration.
2.7.3 Direct measurement o f  free radicals — Microplate Assay 
Direct measurement of reactive oxygen species (ROS) within cells was made using a
microplate assay utilising CM-H2 DCFDA, which is a chemically reduced, acetmethoxy 
ester of 2’,7’-dichlorofluorescein (DCF). This compound is colourless until the acetate 
groups are removed by intracellular esterases and oxidation occurs within the cell. CM- 
H2 DCFDA is cell permeable until it is oxidised to its fluorescent product inside the cell. 
Oxidation may be induced by hydrogen peroxide (with the assistance of endogenous metal 
ions), organic hydroperoxides, nitric oxide and peroxynitrite (Martin et al., 1998)
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F14 and F21 cells were plated in 96-well plates at 90-95% confluency and returned to the 
incubator overnight. Media was removed from test wells, and replaced by 50 pi of 5 pM 
probe in PBS, and incubated in the dark at 37°C for 20 minutes. Probe was removed from 
the cells and replaced by 100 pi of pre-warmed OptiMEM. Test reagent was added to 4 
wells per experiment, and fluorescence intensity was measured using a microplate reader 
with excitation and emission wavelengths of 488 and 534 nm respectively, at time 0, 30 
minutes, and 2 hours.
2.7.4 Direct Measurement o f Free Radicals -  RedoxSensor™ Red 
RedoxSensor™ Red is a probe that passively enters live cells. Once inside the cell the 
non-fluorescent probe is oxidised to a red fluorescent product, which then accumulates in 
the mitochondria. Alternatively the non-fluorescent probe may be transported to 
lysozymes where it is oxidised to the fluorescent product. The intensity of the fluorescent 
signal is determined by the redox potential of the cytosol, with increased free radicals in 
the cytosol increasing the degree of oxidation of the probe (Chen & Gee, 2000).
Cells transfected with the GFP-PrP constructs were plated in chambered coverslips and 
allowed to adhere. Prior to the start of the assay, cells were incubated with 5 pM probe in 
normal media for 10 minutes, this was removed and cells washed once in Hanks, before 
addition of OptiMEM. Cells were observed by confocal microscopy at the start of the 
assay and 5, 10 and 15 minutes after the addition of test reagent.




Bovine serum albumin (BSA)
2.8.2 BCA assay
Using 1.5 ml micro-centrifuge tubes, protein standards of concentration 0, 200, 400, 600, 
800, and 1000 pg/ml were made up using BSA to a final volume of 50 pi. A volume of 
sample buffer equal to that of the diluted sample was included in this preparation to
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account for any interference of the buffer on the assay. Samples were diluted appropriately 
to a final volume of 50 pi in deionised H2 O, in triplicate. The BCA reagent and 4% (w/v) 
CuSC>4 were mixed in a 50:1 ratio respectively. 1 ml of this reaction mix was added to 
each tube and mixed by vortexing. Samples and standards were incubated at 37°C for 30 
minutes. The standards and samples were transferred to 1 ml plastic cuvettes and read at 
562 nm in a Cary UV-visual spectrophotometer. The Cary software was used to plot the 
calibration curve and calculate the concentration of the samples.
2.9 Native Polyacrylamide Gel Electrophoresis (PAGE)
2.9.1 Materials 
Native PAGE
30% acrylamide -  Protogel (Fisher)
1.5M Tris pH 8.8 
Ammonium Persulphate (APS)
N,N,N’ ,N’ -Tetramethylethylene-diamine (TEMED)
4x Loading Dye (2.35 ml dH20, 1.25 ml 0.5M Tris-HCl pH6.8, 6.0 ml glycerol, 
0.4 ml 0.5% w/v bromophenol blue)
Running Buffer (188 g glycine, 30.2 g Tris base, dH20 to 1L)
Transfer
Methanol
Marvel Dry Semi-Skimmed Milk
PVDF membrane -  Millipore (Watford, UK)
Blotting paper -  Fisher
2.9.2 Native PAGE
To preserve the protein in its native form, non-denaturing conditions were used throughout. 
Cells were extracted by first washing in Hanks, then incubated in extraction buffer 
consisting of 20 mM tris acetate, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 10 mM 
sodium-B-glycerophosphate (pH 7.4), and 1% triton-X-100, with protease inhibitors 1 mM 
sodium orthovandate, 2 mM phenylmethylsulphonylfluoride (PMSF), and 1 mM 
benzamidine, for 20 minutes at 37°C. Cell lysates were collected and briefly spun to
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separate the cell debris from the soluble protein. BCA assays (section 2.8) were used to 
quantify protein so equal amounts could be loaded onto the gel. Lysates were mixed 3:1 
with 4x native loading buffer.
Gels were prepared and run using an ATTO (US) gel tank system. 12% native gels were 
mixed using 3.39 ml H2 O, 4 ml 30 % acrylamide, 2.5 ml 1.5 M Tris (pH 8.8), 100 pi 10% 
(w/v) ammonium persulphate, and 10 pi TEMED per gel, added in the order the reagents 
are listed. 50 pg of protein was loaded in each well and gels were run at 30 mA per gel for 
approximately one hour until the loading dye reached the bottom of the gel. Gels were 
removed from the chamber and read under a Fujifilm FLA-5000 phosphoimager using 
excitation and emission wavelengths of 488 and 530 respectively (optimum wavelengths 
for GFP). Protein was transferred onto a PVDF membrane as described below.
2.9.3 Transfer
Protein from the gel was transferred to a PVDF membrane by a semi-dry transfer protocol. 
Blotting paper was soaked in transfer buffer (500 ml lx running buffer, 200 ml methanol, 
and 300 ml deionised H2 O). On top of this was placed PVDF membrane pre-wetted in 
methanol. This was positioned with care to ensure there were no bubbles between the 
paper and the membrane. The gel was placed on top of this with equal care, and a final 
piece of blotting paper was positioned on the top of the sandwich, which was wetted with 
transfer buffer. The transfer was run for 1 hour 30 minutes using 50 mA per gel in a 
Biorad semi-dry blotter. Following transfer, membranes were placed in 5% (w/v) milk 
powder in TBS with 0.1% (v/v) tween (TBS-t) for 1 hour at room temperature with 
shaking or overnight at 4°C to block the membrane.
2.10Western Blot
2.10.1 Materials
Marvel non-fat milk powder 
Tris Buffer Saline 
Tween 20
Primary Antibodies (see Table 2.4)
Goat anti-mouse HRP secondary antibody -  Dako (Ely, UK)
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Goat anti-rabbit HRP secondary antibody -  Dako 
ECL-plus developing kit -  Amersham (Buckinghamshire, UK) 
Hyperfilm XL -  Amersham









Anti a-tubulin Clone 
B-5-1-2
1 in 10 000 C-terminus Sigma
Table 2.4 Primary antibodies used for western blot.
2.10.2 Western Blotting
Membranes were blotted for PrP using a C-terminal antibody directed against amino acids 
149-165 of the protein (kind gift from Professor Man-Sun Sy). As a loading control 
alpha-tubulin was also blotted. Following transfer membranes were blocked in 5% non-fat 
milk -  tris buffered saline with 0.1% tween (TBS-t) for 1 hour at room temperature or 
overnight at 4°C. Membranes were rinsed in TBS-t before incubation with the primary 
antibody in 1% milk -  TBS-t, for a minimum of 1 hour at room temperature. Two 2 
minute, one 15 minute and three 5 minute washes removed excess primary antibody. 
Membranes were incubated in secondary goat anti-mouse HRP conjugated antibodies, in 
1% milk TBS-t for a minimum of 1 hour. Membranes were developed using the ECL-plus 
kit and film exposure times were between 30 seconds and 5 minutes. A Compact X-ray 
processor was used to develop the films.
2.11 Computer Modelling of Promoter Regions
Gene sequences of the bovine and mouse PrP genes were entered into BIMAS Proscan 
database, the Eukaryotic Promoter Database, SignalScan, TFsearch, and the Transcription 
Element Signal Search (TESS) in Fasta format. The results are accurate as of August 
2005.
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2.12Data Analysis
Data for microscopy experiments was collected over a minimum of four different 
experiments, each of which aimed to collect ten different fields of cells per experimental 
condition. Intensity measurements of live cell experiments were made using the Zeiss 
LSM software. Band intensity measurements for native page and western blots were made 
using Scion imaging software. For all intensity measurements background signal was 
subtracted from the reading to eliminate interference. Statistical analyses were performed 
with Minitab 12 statistical software. General linear model, using dose as a covariate, or 
one-way ANOVA were used for determining significant data trends or point differences, 
respectively, of normally distributed multivariate data, and Tukey’s secondary test was 
used to determine the significant responses. T-tests were used where only two conditions, 
with samples of small size fitting a normal distribution, were to be analysed. Data not 
fitting a normal distribution was analysed using the non-parametric Mann Whitney test for 
comparison of two data sets, or the Kruskal-Wallis test for multiple comparisons.
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3 Genetic Modulation of PrP
The PrPc gene (prnp) has now been sequenced and analysed in several species including 
humans, cattle, sheep, mice, hamsters and rats (Basler et al., 1986; Puckett et al., 1991; 
Saeki et al., 1996; Inoue et al., 1997; O’Neill et al., 2003). Despite regulatory regions 
such as heat shock elements being identified, little is known about the regulation of PrP at 
the genetic level. Since PrPc is necessary for disease progression and appears to be up- 
regulated in disease, the regulation of prnp is an area that may prove invaluable for 
understanding and potentially managing the disease.
Prnp has a three exon structure in all characterised species. However, in hamsters and 
humans the second exon may not be spliced into the final mRNA sequence (Li & Bolton, 
1997; Lee et al., 1998). The third and final exon encodes the entire open reading frame 
(ORF) of the protein. Various motifs involved in promoter control have been identified 
within the promoter region (Section 1.1.2, Figure 1.1), and intron 1 has been identified as 
essential for full promoter activity (Inoue et al., 1997).
The presence of heat shock elements allows the prnp promoter to become activated in 
response to forms of cellular stress (Shyu et al., 2000; Shyu et al., 2002), indicating that 
total levels of PrPc within the cell would be up-regulated as the cell attempted to combat 
the stress insult. The observed up-regulation of the prnp promoter as a result of stress 
induced by nitric oxide (NO) radicals (Wang et al., 2005), oxidative stress induced by 
hyperbaric oxygen (Shyu et al., 2004), and hypoglycaemia (Shyu et al., 2005a) also 
provides evidence of a role for PrPc in dealing with stress insults. In addition to this up- 
regulation, down-regulation of the prnp promoter has also been observed in response to 
ATRA (Rybner et al., 2002), an effect that may be due to direct interaction with the 
promoter or be an indirect response to ATRA modulation of transcription factors.
Eukaryotic gene regulation is highly complex with even the most basic promoter sequences 
requiring numerous transcription factors to recruit and form the transcription apparatus.
58
__________________________________ Chanter 3: Genetic Modulation of PrP Expression
Protein expression in eukaryotic cells is regulated at several levels, including the DNA 
sequence itself, control elements within the mRNA, and by protein turnover. All of these 
factors can be influenced by many other control mechanisms within the cell. Given that so 
many factors can influence the levels of protein within a cell, measurement of total protein 
does not accurately indicate the activity of the promoter. By replacing the ORF of prnp 
with a GFP variant of known half-life it has been possible to look at the genetic control of 
expression. In this way changes in the level of GFP signal indicate changes in gene 
activity not changes in protein turnover.
A recurring problem with previous studies into the factors affecting prnp activity is the 
variability of responses between different cell culture systems. This has lead one group to 
conclude that copper down regulates the prnp promoter (Toni et al., 2005), but other 
researchers to conclude the exact opposite; that copper up-regulates promoter activity 
(Armendariz et al., 2004; Varela-Nallar et al., 2005). This study attempts to address this 
problem by considering several cell lines derived from different lineages with different 
phenotypes. As PrPc is expressed to various extents in separate tissues of the body, the 
underlying cell type was expected to influence the activity of the promoter both at the basal 
expression level and in response to stimuli that regulate activity.
The aims of this work were to elucidate regions of the prnp promoter that were important 
for genetic regulation and to determine the influence of the underlying cell line on 
expression. In addition, copper, DMSO and ATRA were tested on the promoter sequences 
to determine how they may affect gene regulation. This was both for the purpose of 
determining potential functions of PrPc and determining potential compounds that might be 
used in the management of disease progression. The results presented highlight the 
importance of intron 1 in the control of promoter activity and show that this region may 
have its own promoter activity. Copper, DMSO and ATRA were found to alter promoter 
activity in a cell line specific manner, and the regions of the gene sequence that mediate 
these reactions were demonstrated.
3.1 Prnp region activity
Prnp has three exons, of which only the final exon encodes the open reading frame (ORF), 
indicating that the other exons may have another role. In addition intron 1 has previously
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been reported to be essential for the full function of the promoter region (Inoue et al., 
1997). On the basis of this several bovine prnp constructs were made to investigate the 
ability of the gene regions to drive mRNA (and the resulting protein) production. The 
constructs include the whole promoter and non-coding region (construct A), the promoter 
on its own (B), the non-coding region without the promoter (C), the promoter and exon 1 
(D), intron 1 and exon 2 on their own (E), and the CMV promoter as an expressing control 
(F, figure 3.1 A). Each construct was cloned into pd2EGFP-l, a promoterless vector, where 
insertion of a sequence with promoter activity into the multiple cloning site drives the 
production of a destabilised EGFP with a half-life of two hours. Changes in gene activity 
can be measured quickly by looking for changes the level of GFP production. These 
constructs were transfected into several different cell types including F14 (mouse fusion -  
PrP null), F21 (mouse fusion -  wild type PrP), SH-SY5Y (human neuroblastoma), C8- 
D1A (mouse astrocyte), G8 (mouse myoblast), and Cos-7 (African green monkey kidney). 
Stable cell lines were selected. In this way the activity of the constructs could be 
determined and compared across the cell lines.
3.1.1 Comparison o f Promoter Constructs Expression Levels 
To assess the basal level of expression of each construct, cells were observed under the 
LSM 550 confocal microscope with images captured using wavelengths for GFP 
(excitation 488nm, emission 530nm). GFP intensity was quantified using Scion imaging 
software.
The different promoter constructs transfected into different cell lines showed different 
expression levels. Considering first the F14 (PrPc null) cells, the greatest activity, as 
measured by the intensity of GFP compared to the CMV driven control, was seen for 
construct A indicating that the promoter and the non-coding region are important for the 
full activity of the gene (Figure 3.1). However construct B showed significant activity 
demonstrating that this the promoter is active in isolation but enhanced in the presence of 
the non-coding region. Of interest is that construct D showed reduced activity. The level 
of expression of this construct is significantly lower than the construct containing the 
promoter region alone (B; W = 2100, p < 0.001) and not significantly different to that of 
the vector control (W = 64, p = 0.112), indicating that the promoter is effectively switched 
off when followed by just exon 1 of the non-coding region. The exon may, therefore, have 
a yet undiscovered negative regulatory role. Since there are two splice variants of this 
exon, but it is not part of the coding region, a role in regulating protein expression is likely.
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Intron 1 d2EGFP
Figure 3.1 Relative intensity o f PrP prom oter-G FP fusion construct protein products in F14 (PrP null 
mouse neuroblastoma-fusion) cells. (A) PrP Promoter and non-coding region constructs cloned into 
pd2EG FP-l, as described in section 2.1.3, were transfected into F14 cells and stable cell lines 
established. (B) GFP expression levels driven by each of the promoter constructs as detected by 
fluorescence microscopy. Cells were grown on chambered coverslips and observed live. Images shown 
are representative of the fluorescence levels observed over four experiments. Scale bar = 10 pm. (C) 
Quantification o f GFP intensity by measurement o f fluorescence intensity when expression is driven by 
each of the promoter constructs expressed relative to the maximal expression o f the CM V promoter 
driven control. Analysis o f the raw data intensities found that the test constructs indicated by * 
showed significant ability to drive GFP production above the level observed for the vector/background  
control. H = 109.81, p < 0.001, n = 206 cells.
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A  further in teresting observation  is that the constructs C and E exh ib it sign ifican t GFP  
ex p ression , ind icative o f  prom oter activ ity  o f  this region. T his e ffec t appears to be  
independent o f  ex o n  1, s in ce  construct E lacks th is ex o n  but still drives G FP production, 
and is m ost lik ely  m ediated  by intron 1, w h ich  has been  p rev iou sly  reported to be 
im portant for prom oter activ ity  (Inoue et a l., 1997).
3.1.2 Comparison o f Promoter Construct Expression by Cell Line 
T he pattern o f  ex p ression  described  for the F 14 ce lls  is a lso  observed  for the C os-7  ce ll 
lin e  (F igure 3 .2 ). H o w ev er  a d ifferent pattern o f  exp ression  o f  the constructs is seen  for 
the F21 (F igure 3 .3 ), C 8 -D 1 A  (F igure 3 .4 ), and S H -S Y 5 Y  (F igure 3 .5 ). The full length  
construct A  in these ce lls  d oes not exp ress as h igh ly  as in the F I 4 and C o s-7  ce lls , and the 
prom oter a lon e (B ) and ex o n s  (C ) constructs are (w ith  the excep tion  o f  construct C in  the 
F21 ce lls )  exp ressed  higher than the full length  construct. E xp ression  o f  construct D  is  
con sisten t across all o f  the ce ll lines. It sh o w s the lo w est exp ression  and by com parison  








Figure 3.2 Expression of promoter constructs in Cos-7 cells. PrP Promoter and non-coding region 
constructs cloned into pd2E G FP-l, as described in section 2.1.3, were transfected into Cos-7 monkey 
kidney cells and stable cell lines established. (A) GFP expression levels driven by each o f the promoter
62
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Chapter 3: G enetic M odulation  o f  PrP E xpression
constructs as detected by fluorescence microscopy. Cells were grown on chambered coverslips and 
observed live. Images shown are representative of the fluorescence levels observed over four 
experiments. Scale bar = 20 pm. (B) Quantification o f GFP intensity by measurement of fluorescence 
intensity when expression is driven by each of the prom oter constructs expressed relative to the 
maximal expression o f the CMV promoter driven control. Lowest expression is seen for constructs D 
and V, and sim ilar expression is seen for constructs A, B, and C. Analysis o f the raw data intensities 
found that the test constructs indicated by * showed significant ability to drive GFP production above 




Figure 3.3 Expression of promoter constructs in F21 cells. PrP Promoter and non-coding region 
constructs cloned into pd2EG FP-l, as described in section 2.1.3, were transfected into F21 (PrPc wild 
type mouse neuroblastoma fusion) cells and stable cell lines established. (A) GFP expression levels 
driven by each o f the prom oter constructs as detected by fluorescence microscopy. Cells were grown 
on chambered coverslips and observed live. Images shown are representative o f the fluorescence levels 
observed over four experiments. Scale bar = 5 pm. (B) Quantification of GFP intensity by 
measurement of fluorescence intensity when expression is driven by each of the promoter constructs 
expressed relative to the maximal expression of the CM V prom oter driven control. Lowest expression 
is seen for constructs D, V, and E, with sim ilar expression levels seen for constructs A, B, and C. 
Analysis o f the raw data intensities found that the test constructs indicated by * showed significant 
ability to drive GFP production above the level observed for the vector/background control. H = 
112.75, p <  0.001, n = 189 cells.
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Figure 3.4 Expression o f promoter constructs in C8-D1A cells. PrP Promoter and non-coding region 
constructs cloned into pd2EG FP-l, as described in section 2.1.3, were transfected into C8-D1A type 1 
astrocyte cells and stable cell lines established. (A) GFP expression levels driven by each of the 
promoter constructs as detected by fluorescence microscopy. Cells were grown on chambered  
coverslips and observed live. Images shown are representative of the fluorescence levels observed over 
four experiments. Scale bar = 10 pm. (B) Quantification of GFP intensity by measurement of 
fluorescence intensity when expression is driven by each o f the promoter constructs expressed relative 
to the maximal expression of the CM V promoter driven control. Lowest expression is seen for 
constructs A, D, E, and V. Constructs B and C have significantly higher expression levels than all but 
the CM V control (construct F) . Analysis o f the raw data intensities found that the test constructs 
indicated by * showed significant ability to drive GFP production above the level observed for the 
vector/background control. H = 104.42, p < 0.001, n = 173 cells.
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Figure 3.5 Expression of promoter constructs in SH-SY5Y cells. PrP Promoter and non-coding region 
constructs cloned into pd2EG FP-l, as described in section 2.1.3, were transfected into SH-SY5Y  
human neuroblastoma cells and stable cell lines established. (A) GFP expression levels driven by each 
o f the prom oter constructs as detected by fluorescence microscopy. Cells were grown on chambered 
coverslips and observed live. Images shown are representative of the fluorescence levels observed over 
four experiments. Scale bar = 10 pm. (B) Quantification of GFP intensity by measurement of 
fluorescence intensity when expression is driven by each o f the promoter constructs expressed relative 
to the maximal expression o f the CM V promoter driven control. Lowest expression levels are seen for 
constructs D and V. Highest expression levels are observed for constructs B and C. Analysis o f the 
raw data intensities found that the test constructs indicated by * showed significant ability to drive 
GFP production above the level observed for the vector/background control. H = 100.13, p < 0.001, n 
= 116 cells.
A  further d ifferent pattern o f  exp ression  w as ob served  for the G 8 m yob lastom a ce ll line. 
T his ce ll line sh ow ed  the h igh est exp ression  for the full length  construct, m uch low er  
exp ression  lev e ls  for constructs B and C, and ex p ressio n  is  again  seen  for construct E 
(F igure 3 .6 ). C onsisten t w ith  all the other ce ll lin es , the construct conta in ing  ju st the 
prom oter and exon  1 (construct D ) sh ow ed  no sign ifican t exp ression  o f  G FP com pared to
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the vector o n ly  ce lls  (W  =  7 5 .0 , p =  0 .2 2 4 ), ind icating the th is construct is  lik ely  to be 



















Figure 3.6 Expression o f promoter constructs in G8 cells. PrP Promoter and non-coding region 
constructs cloned into pd2EG FP-l, as described in section 2.1.3, were transfected into G8 mouse 
myoblast cells and stable cell lines established. (A) GFP expression levels driven by each o f the 
promoter constructs as detected by fluorescence microscopy. Cells were grown on chambered  
coverslips and observed live. Images shown are representative of the fluorescence levels observed over 
four experiments. Scale bar = 10 pm. (B) Quantification of GFP intensity by measurement o f  
fluorescence intensity when expression is driven by each o f the promoter constructs expressed relative 
to the maximal expression of the CMV promoter driven control. Highest expression is observed for 
construct A and all other constructs show significantly lower expression, however construct E is 
significantly higher than the vector control (V). Analysis o f the raw data intensities found that the test 
constructs indicated by * showed significant ability to drive GFP production above the level observed 
for the vector/background control. H = 73.88, p < 0.001, n = 97 cells.
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3.1.3 Murine Promoter Express ion
Since the constructs studied above are bovine and they have been expressed in several 
murine cell lines, they may suffer from different expression patterns due to the differences 
between the cellular control mechanisms from different species. Therefore, two murine 
promoter constructs have been created, the whole promoter and non-coding sequence 
(construct A) and the intron 1 and exon 2 sequence (construct E). These have been used to 
determine if the bovine sequence is expressed differently to the murine sequence in murine 
cells (Figure 3.7). No detectable expression was seen for either of the murine constructs in 
the human derived SH-SY5Y cells, most likely due to species difference.
Expression levels of the murine constructs in F14 cells are very similar to the levels seen 
for the bovine constructs (Figure 3.1 and 3.7). Expression of the murine construct A is 
lower in the F21 cells than the bovine construct, and higher in the C8-D1A cell line than 
seen for the bovine. This may reflect species-specific transcription control mechanisms 
within these cells, which recognise different genetic signals (or respond differently to the 
same genetic signals) and so influence basal expression levels of the constructs. Again 
construct E is able to drive expression of GFP, indicating that intron 1 of the mouse gene 
sequence also contains control elements. However this is only significant in the F14 cells, 
perhaps indicating that this region is less important for control of expression of murine 
prnp than for bovine. Alternatively, the genetic control mechanisms of the underlying cell 
type may act differently on the bovine control elements within this region compared to the 
mouse, thus affecting expression.
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Figure 3.7 GFP Intensity o f the mouse prom oter constructs in each o f the cell lines where expression 
can be detected. (A) Individual cell pictures. Scale bar = 10 pm. (B) Quantification with respect to 
the CMV promoter driven control. Analysis o f the raw data intensities found that the test constructs 
indicated by * showed significant ability to drive GFP production above the level observed for the 
vector/background control. H = 228.14, p < 0.001, n = 334 cells.
68
Chanter 3: Genetic Modulation of PrP Expression
3.2 Modelling of the Promoter Region Within Intron 1
Various databases have been developed for evaluating eukaryotic signal sequences within 
regions of genes that may have high regulatory function. Such databases use defined 
signal sequences to identify regions of coding sequence recognised by RNA polymerise II 
and include programmes such as PROSCAN, the Eukaryotic Promoter Database (EPD; 
Perier et al., 2000), and Promoter 2.0 prediction server of the Centre for Biological 
Sequence Analysis. In addition, databases can recognise sequences of DNA that encode 
binding sequences of transcription factors and enhancer or repressor sequences. The 
Transcription Element Search System (TESS; Schug & Overton, 1997) uses TRANSFAC 
(Wingender et al., 2000), IMD, and CBIL-GibbsMat databases to predict the position of 
transcription factor binding sites. Signal Scan is a further database that carries out this 
function (Prestridge, 1991).
3.2.1 P rom oter P redictions
Analysis of mRNA has previously shown two splice variants of PrP mRNA and defined 
the position of the PrP promoter by mapping the exon sequences. However as shown 
previously (for constructs C and E), the non-coding region is able to drive GFP production 
on its own, indicating that the transcription apparatus can be activated by signal sequences 
within this region. To investigate potential signal sequences the bovine and murine prnp 
sequences were entered into the PROSCAN, EPD, and Promoter 2.0 databases. The 
results obtained are accurate as of the end of August 2005.
The results consistently show a region of promoter activity in intron 1 (see Table 3.1, and 
diagrammatical representation in Figure 3.8). Using PROSCANvl.7, the presence of a 
TATA box at position 1610 of the bovine post origin sequence inside intron 1 was 
predicted. This is highly significant, in so much as PrP has often been classified as a 
house-keeping gene due to its lack of TATA box. When the long incubation mouse 
sequence is analysed by the same methods a TATA box is not found but strong promoter 
activity is predicted within the same region. Interestingly, however, even if this TATA 
box is active, previous studies that have determined the position of the promoter based on 
the mRNA species would indicate that it is secondary to the promoter region preceding 
exon 1. This may indicate that the function of the gene product is so important that several 
mechanisms are required to ensure that protein production can be initiated when required.
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A n alternative explanation  con sid erin g  the experim ental data described  in this chapter is 
that d ifferent in itiation  m ethods m ay be used  by d ifferent ce ll types.
Bovine Mouse
Transcription T ype L ocation T ype L ocation
C om p lex TFIID 1372 JC V  repeated 1919
B in d in g TFII-I 1403 Seq u en ce
sites. O ct-Factors 1541 M LTF 2131
IgH C .2 1548 C PI 2151
TFIID 1581 O ct-Factors 2155
T A T A 1610 IgH C .2 2 1 5 7
O ct-Factors 21 5 7
2 1 6 4
O T F -2A 2165
Prom oter 1 3 5 9 -1 6 0 9 1921-
R eg ion 2171
E stim ated 1610 U nknow n
T S S
Table 3.1 Identification o f putative promoter sites inside intron 1 by consideration of binding sites for 
the transcription apparatus. Bovine (accession number AF163764) and long incubation murine 
(accession number U29187) gene sequences were entered into the PROSCAN v l.7  database and 
regions of probable prom oter activity calculated by this database. For both gene sequences a 
promoter region inside o f intron 1 is found in addition to the known promoter site preceding exon 1. 
The binding sites for the transcription apparatus are listed with their locations are expressed relative 
to the previously determined transcription start site (TSS) o f each sequence.
Exon 1 Intron 1 Exon 2 Exon 3
-4329
TFIID TFIID Estimated TSS
TFII-I Oct Factors TATA
~ * n  ~ i
IGHC.2
Figure 3.8 Diagrammatic representation o f the putative promoter region within intron 1 of bovine 
prnp. The data obtained by entering the bovine (accession number AF163764) and murine (accession  
number U29187) gene sequences into the PROSCAN v l.7  database are shown relative to their position 
within the prnp  gene sequence.
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3.2.2 Transcription Factor Predictions
To look at the transcription factor binding sites found within the bovine and mouse 
sequences, the sequences were entered into the TESS and Signal Scan databases and are 
accurate to the end of August 2005.
Transcription factor analysis of the bovine sequence shows four regions of high intensity 
transcription factor binding sites, indicating that these regions are of considerable 
importance to the genetic control of expression (figure 3.9A). The first two are located in 
the promoter sequence, with one just before exon 1 and the other slightly further up-stream 
around the area where the heat shock factors are found in the rat gene. The second two 
sites are inside intron 1 , one of which corresponds with the site that may have promoter 
activity within this region and the other occurs immediately before the start of exon 2 .
Binding sites in the mouse sequence are not as localised as the bovine sequence (figure 
3.9B). The promoter sequence appears of greater importance for mouse gene regulation 
with several high intensity sites, two of which correlate with equivalent sites in the bovine 
promoter region. In addition the intron 1 sequence appears less active for gene regulation. 
Although it does have several areas of high frequency of binding sites, these are not as 
intense as for the bovine intron 1 region.
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Figure 3.9 Frequency of transcription factor (TF) binding sites throughout the bovine and murine 
genes from the start o f the published gene sequence to the end of exon 2. The bovine (A; accession 
number AF163764) and murine (B; accession number U29187) gene sequences were entered into 
TFSearch with a minimum acceptable homology value o f 0.85. The plots show the frequency of  
binding sites per 100 bases. Shown above each plot is the gene to indicate the position of the exons and 
intron 1.
For both seq u en ces it is found that there are no transcription factor b ind ing  sites w ith in  
ex o n  1. S in ce  construct D , com p osed  o f  the prom oter and ex o n  1 on ly , sh ow ed  no ab ility  
to drive G FP production  in  any o f  the ce ll lin es th is is lik e ly  to be sign ificant. It m ay  
su ggest that the in flu en ce o f  th is reg ion  on  gen e activ ity  is not a repressor e ffec t but rather 
a result o f  the lack o f  transcription factor b ind ing  sites.
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3.3 mRNA variants
S in ce  the G FP constructs and the database p red ictions both sh o w  a potential area o f  
prom oter activ ity  in intron 1, the ex isten ce  o f  an m R N A  sp ec ies  that w as lack ing  ex o n  1 
w as investigated . For th is, an R T -P C R  based  m ethod, R N A -lig a se  m ediated  rapid 
am p lifica tion  o f  cD N A  ends (R L M -R A C E ) w as used . T his m ethod sp ec ifica lly  targets full 
length capped m R N A  and adds an adaptor onto the 5 ’ end. T his ensures that the sp ec ies  
that are found are the result o f  full length  m R N A , not degradation products. A  nested  PC R  
using  adapter and gen e sp ec ific  prim ers is then u sed  to identify  variations in the 5 ’ ends o f  
m R N A  (sectio n  2 .2 ). S in ce  a sp ec ies  lack ing ex o n  1 m ay be rare, an additional primer 
overlapp ing  the end o f  the adapter w ith  a short gen e  sp ec ific  seq u en ce w as a lso  used  to 
avoid  such a sp ec ies  b ein g  m issed . m R N A  from  b ov in e  (n =  3) and m urine (n =  1) total 
brain tissu e  w ere tested  (F igure 3 .1 0 ).
Bovine Mouse
A B C D E F G  A B C D E F G
1,000 b p ------
500 bp------
100 bp------
Figure 3.10 RLM -RACE identification o f bovine and murine 5 ’ mRNA splice variants. Total RNA 
was extracted from bovine and murine brain samples. The total RNA was treated to add an adapter 
RNA sequence to the 5 ’ end o f only mature capped mRNA. A reverse transcription reaction was used 
to create cDNA from the RNA sample and the mRNA o f interest was amplified using a nested PCR 
reaction, with primers directed against the adaptor sequence (or part o f the adaptor sequence) and 
against the PrP mRNA to ensure only full length species o f PrP mRNA were detected. To visualise the 
PCR reaction products 10 pi o f each reaction mixture was electrophoresed on a 2% agarose gel 
containing ethidium bromide, and the DNA-ethidium bromide detected by viewing under a long range 
UV light box. A) 100 base pair DNA ladder. B) Adapter primer nested PCR reaction. C) Adapter- 
Exon 2 Specific primer nested PCR. D) GAPDH positive control reaction. E) PCR mix negative 
control. F) Minus adapter negative control. G) First nested PCR result.
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The results showed that the PCRs had worked correctly with the positive control lane (D) 
showing a band corresponding to GAPDH, and the negative control lanes (E & F) clear of 
contamination. Several bands are seen in lane B, where the 5’ adapter primer was used, 
these are likely to correspond to different splice variants of PrP mRNA. From this lane it 
is unclear if an exon 2 only splice variant is present. However, a band is observed in lane 
C, where the adapter-gene specific primer was used. This band is of the correct size to 
correspond to a variant lacking exon 1 for both the bovine and murine tissues. To confirm 
that this band was a mRNA splice variant lacking exon 1, the PCR products were 
sequenced. Example results of the bovine and murine sequencing are shown in Figures 
3.11 and 3.12 respectively.
The sequencing results obtained from the PCR products of the RLM-RACE reactions show 
that a splice variant lacking exon 1 can be found in both bovine and murine brain tissue. 
The bovine full length clones aligned with exon lb (subject base pair number 4330-4382) 
and exon 2 (subject base pair number 6826-6923), and murine clones aligned with exon 1 
(subject base pair number 6205-6251) and exon 2 (subject base pair number 8442-8539). 
Splice variants lacking exon 1 aligned with the exon 2 sequence only.
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A. Bovine exons 1+ 2
Q uery =  B o v in e  c lon e , 842  bases
Subject =  B o s  taurus prion protein PrP (PrnP) g en e, a lternatively  sp liced , prom oter, ex o n s  
la , lb , and 2 , partial sequence. A c c e ss io n  num ber =  A F 163764
Exon 2 alignment
Q u e r y :  6 4 5  a t c t g c t g t g a t t c a g c t c a a g t t g g a t t t g t g t c t c t g g g a a g a c a g a t g c t t c g g c t t  7 0 4  
I  I  I  I  I  I  I  I I I  I  I  I I  I  I !  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  . 1 I I  I  I  I  I  I I  I  I  I  I  I  i  I  I  I  I  I  I  I  I I
Sbjct: 6 9 2 3  atctgctgtgattcagctcaagttggatttgtgtctctgggaagacagatgcttcggggc 6 8 6 4
Q u e r y :  7 0 5  g g t t g a a a c t g t t c a g t t t t c a a a t a t a t t c a g a a g t c c t  7 4 4  
I I I I I I I 1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 8 6 3  ggttgaaactgttcagtttgcaaatatattcagaagtcct 6 8 2 4
Exon 1 alignment
Q u e r y :  7 4 2  c c t g c t t c t g c g a g a g a g a a g a c g c t c t c a g c t c t g c g g c t g t c a g c g a c t g  7 9 3  
I I I I I ! I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III I I I I II I I I I
S b j c t :  4 3 8 3  cctgcttctgcgagagagaagacgctctcagctctgcggctgtcagcgactg 4 3 3 2
B. Bovine exon 2 only
Q uery = B o v in e  c lon e , 84 0  bases
Subject =  B o s taurus prion protein PrP (P m P ) g en e , a lternatively  sp liced , prom oter, ex o n s  
la , lb , and 2, partial sequence. A c c e ss io n  num ber =  A F  163764
Exon 2 alignment
Q u e r y :  6 5 6  a t c t g c t g t g a t t c a g c t c a a g t t g g a t t t g t g t c t c t g g g a a g a c a g a t g c t t c g g c t t  7 1 5  
I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 9 2 3  a t c t g c t g t g a t t c a g c t c a a g t t g g a t t t g t g t c t c t g g g a a g a c a g a t g c t t c g g g g c  6 8 6 4
Q u e r y :  7 1 6  g g t t g a a a c t g t n c a g t t t t c a a a t a t a t t c a g a a g t c  7 5 3  
I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 8 6 3  ggttgaaactgttcagtttgcaaatatattcagaagtc 6 8 2 6
Figure 3.11 Bovine RLM-RACE sequencing results. Clones from the RLM -RACE reactions were 
sequenced using a PE Biosystems ABI 377 DNA sequencer (Gene Service Ltd, Cambridge). Examples 
of clones obtained from the bovine RLM -RACE reactions were aligned with bovine prnp  using NCBI 
BLAST. A) Variant containing exon lb . B) Variant lacking exon 1. Exon sequences are indicated in 
red. Slight variations may be seen between the published and obtained sequences due to the accuracy 
of the sequencing reaction, mutations introduced by the PCR Tac polymerase, or polymorphisms in 
the gene sequences, which are more common in untranscribed sequences such as introns where the 
mutation is likely to be silent and so not affect the gene function.
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A) Murine exons 1+ 2
Q uery =  M urine c lon e, 8 30  bases
Subject =  M urine lon g  incubation prion protein. A ccess io n  num ber =  U 2 9 1 8 7  
Exon 2 alignment
Q u e r y :  6 8 6  a g t c t g c t t g g c t c t c c t a a a t t g g a c t g g t a c c a c t a g g a a g g c a g a a t g c t t c a g c t c  7 4 5  
I  I I I I  I I  I I I I I I I I  I I  I  I I  I  I  I  I  I  I  I  I I  I I  I  I  I  I I  I  I I I  I I  I  I  I I  I I  I  I I  I I  I  I  I I  I  I I 
S b j c t :  8 5 3 9  a g t c t g c t t g g c t c t c c t a a a t t g g a c t g g t a c c a c t a g g a a g g c a g a a t g c t t c a g c t c  8 4 8 0
Q u e r y :  7 4 6  g g t t g a a a t g g t t c a g t t c t g a a a t a t a c t c a g g a g t c c t  7 8 5  
I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  
S b j c t :  8 4 7 9  ggttgaaatggttcagttctgaaatatactcaggagtcct 8 4 4 0
Exon 1 alignment
Q u e r y :  7 8 3  c c t g c c a c c g a t g c g a c g c a g c g c c c a g a a t c n g t c  8 1 8  
I I  I  I I I  I I  I I I I I  I I  I  I I  I  I I I I  I  I  I  I  I  I  I  I  I  I I I
S b j c t :  6 2 5 2  cctgccaccgatgcgacgcagcgcccagaatcggtc 6 2 1 7
B) Murine exon 2 only
Q uery =  M urine c lon e , 80 0  bases
Subject =  M urine lon g  incubation prion protein. A c c e ss io n  num ber =  U 2 9 1 87
Exon 2 alignment
Q u e r y :  6 8 8  a g t c t g c t t g g c t c t c c t a a a t t g g a c t g g t a c c a c t a g g a a g g c a g a a t g c t t c n n c t c  7 4 7  
I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III 
S b j c t :  8 5 3 9  agtctgcttggctctcctaaattggactggtaccactaggaaggcagaatgcttcagctc 8 4 8 0
Q u e r y :  7 4 8  n g g t t g a a a a t g g t t c a n t t c t g a a a t a t a c t c n g g  7 8 3  
1 1 1 1 1  1 1 1 1 1  ii 11 1 1 1 1 1 1 1 1  i 11 ii 1 1 1  ii 
S b j c t :  8 4 7 9  -ggttg-aaatggttcagttctgaaatatactcagg 8 4 4 6
Figure 3.12 Murine RLM-RACE sequencing results. Clones from the RLM -RACE reactions were 
sequenced using a PE Biosystems ABI 377 DMA sequencer (Gene Service Ltd, Cam bridge). Examples 
of clones obtained from the murine RLM -RACE reactions were aligned with murine prnp  using NCBI 
BLAST. A) Variant containing exon 1. B) Variant lacking exon 1. Exon sequences are indicated in 
red. Exon sequences are indicated in red. Slight variations may be seen between the published and 
obtained sequences due to the accuracy o f the sequencing reaction, mutations introduced by the PCR 
Tac polymerase, or polymorphisms in the gene sequences, which are more common in untranscribed  
sequences such as introns where the mutation is likely to be silent and so not affect the gene function.
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3.4 Exogenous Factors Affecting Promoter Activation
The genetic control of PrPc expression is very likely to be affected by factors related to 
protein function and, in turn, factors that regulate promoter activity might be valuable clues 
to the function of the protein. PrPc has previously been linked to cellular stress response 
and earlier studies have shown that the rat promoter is up-regulated in response to heat 
shock (Shyu et al., 2000; Shyu et al., 2002). Given that PrP° binds copper and has been 
implicated in oxidative stress response, copper, DMSO (to induce oxidative stress) and 
ATRA, were chosen to be investigated for the effect on gene activity in the different cell 
lines.
The GFP variant used to monitor expression driven by the promoter constructs is 
destabilised, it has a half-life of just 2 hours as opposed to the 24 hour half-life of normal 
enhanced GFP reporters. Therefore any changes in gene expression should quickly 
become evident by monitoring changes in the GFP signal. Due to the instability of the 
GFP variant, transient changes should be detected as well as persistent alterations in 
activity. All of the following experiments have been run at least in triplicate and up to 
twelve times for confirmation of positive results.
3.4.1 P rom oter R esponse to Cu
Stably transfected cell lines were plated in six well plates and allowed to adhere before the 
start of the experiment. Cells were treated with 100 pM Q1SO4 for 2, 4, 8 , 24, 48 hours or 
left untreated. Following treatment, cells were washed in Hanks and extracted in native 
extraction buffer (see Methods, section 2.9). For this the 100 pi extraction buffer was 
distributed over the cell monolayer, incubated for 20 minutes at 37 °C and the lysates 
collected. Equal amounts of protein were run on a native gel and observed under a 
phosphorimager at optimum wavelengths for GFP detection (excitation 488, emission 
530), before being transferred onto a PVDF membrane and blotted for tubulin as a loading 
control.
Examples of the levels of GFP detected for the full-length construct A are shown in figure 
3.13 and the quantification of this data shown in figure 3.14. The only cell line to show a 
significant response to copper when compared to the CMV promoter driven control was 
the PrPc null F I4 cell line. In the F14 cells GFP intensity driven by construct A starts to
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increase after 4 hours exp osu re, b eg in s to plateau after 8 hours exp osu re and is sign ifican t  
after 24  hours w ith  activ ity  about 1.5 tim es that o f  the untreated c e lls  (F =  4 .8 8 , p =  0 .0 3 7 ). 
Sm all fluctuations are seen  for som e o f  the other ce ll lin es but th ese are not sign ifican t  
w h en  com pared  to fluctuations o f  the C M V  control (F =  0 .2 4 , p =  0 .9 9 4 ). T he vector  
control w as a lso  tested  by th is m ethod to rule out a background response. N o  exp ression  
o f  the vector  w as found in  any o f  the ce ll lin es in resp on se  to copper at any tim e point (data  
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Figure 3.13 Direct detection o f GFP signal driven by the whole prom oter and non-coding region 
construct A in each of the cell lines in response to copper treatment. Cell lines stably transfected with 
the destabilised GFP reporter vector driven by whole bovine prnp  gene construct (A; containing the 
promoter and non coding sequence up to the end of exon 2), were treated with 100 plM C u S 0 4 for 2, 4, 
8, 24, or 48 hours, or left untreated for the time 0 control. Equal quantities o f the extracted protein 
were separated by electrophoresis on a 12% native acylam ide gel and detected by excitation o f the 
GFP and recording the intensity o f the emitted light. Samples were then transferred onto a PVDF 
membrane and blotted for tubulin as a loading control. The GFP detection is shown compared to the 
respective tubulin loading control.
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Figure 3.14 Quantification o f prnp  copper response. Cell extracts were electrophoresed on 12% native 
acrylam ide gels, GFP was excited at light wavelength 488 nm and the intensity o f emission at 530 nm 
measured. Protein was then transferred onto a PVDF membrane and blotted for tubulin as a loading 
control. The tubulin blots were quantified by densitometry. The GFP signal driven by the whole gene 
(promoter and non coding region up to the end o f exon2) construct A is shown in comparison to that 
driven by the CM V promoter control in A) F14, B) F21, C) C8-D1 A, D) G8, E) SH-SY5Y, and F) Cos-7 
cell lines in response to treatment with 100 pM C u S 0 4 for 2, 4, 8, 24 and 48 hours. Expression is 
shown relative to the time 0 GFP intensity and quantified with respect to tubulin as a loading control. 
Shown are the mean and SEM. The F I4 cells showed a significant change in construct A activity 
compared to the CM V control (F = 4.88, p = 0.037), the remaining cell lines showed no significant 
response (F = 0.24, p = 0.994). n = min 3, max 12 individual time series.
T o in vestigate  the reg ion s o f  prnp  that w ere resp on sib le  for the reaction  to copper all o f  the
gen e part constructs w ere tested  in the sam e w ay  as construct A  and the C M V  control.
D esp ite  the lack o f  reaction o f  construct A  in m ost o f  the ce ll lin es, copper w as tested  in all
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o f  the ce ll lin es to avo id  a sign ifican t response b ein g  m issed . E xam p les o f  o n ly  the cell 
lin es and constructs sh o w in g  sign ifican t alterations in activ ity  are sh ow n  in figure 3 .15  and 
the quantification  o f  all o f  the constructs that cou ld  be d etected  by this m ethod  are sh ow n  
in  figure 3 .1 6 . T he constructs that did not exp ress h igh ly  en ou gh  to be quantified  have not 
b een  included  s in ce  it w ou ld  have been  inaccurate to attem pt to quantify b eyon d  the 
lim ita tion s o f  the softw are.
M o st o f  the constructs sh ow ed  a low er signal to background ratio than w as seen  for 
construct A . T his e ffect is  m ost lik e ly  to be due to the low er basal lev e l o f  activ ity  o f  these  












Figure 3.15 Direct detection o f GFP signal driven by the constructs that showed a significant response 
to copper (F = 2.73, p < 0.001). Cell lines stably transfected with the destabilised GFP reporter vector 
driven by each o f the bovine prnp  gene constructs (B, containing the prom oter only; C, containing the 
non-coding sequence from the start o f exon 1 to the end o f exon 2; D, the promoter plus exon 1; E, 
intron 1 and exon 2), were treated with 100 pM C u S 0 4 for 2, 4, 8, 24, or 48 hours, or left untreated for 
the time 0 control. Equal quantities o f the extracted protein were separated by electrophoresis on a 
12% native acylamide gel and detected by excitation o f the GFP and recording the intensity o f the 
emitted light. Samples were then transferred onto a PVDF membrane and blotted for tubulin as a 
loading control. The GFP detection is shown compared to the respective tubulin loading control. Only 
the cell lines and constructs that showed a reaction significantly different to that o f the CM V promoter 
driven control cell lines have been shown.
Time (h)
0 2 4 8 24 48
U p-regu lation  o f  G FP signal is sh ow n  by ex o n s  conta in ing  construct C in the F21 (T  =  
3 .2 3 , p =  0 .0 0 1 ) and G 8 (T  =  2 .5 2 , p =  0 .0 1 2 )  ce ll lines. T h is e ffec t o n ly  b eco m es
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significant at 48 hours post exposure. The promoter region on its own (construct B) only 
showed a significant effect in the G8  cells (T = -3.33, p = 0.001) and this effect peaked at 4 
hours post exposure, dropping rapidly away by 8  hours to a level lower than that of the 
CMV control. In the SH-SY5Y cells the intron 1 and exon 2 only construct (E) was able to 
up-regulate GFP expression from 4 hours post exposure (T = 3.39, p = 0.001). Clearly the 
underlying cell line makes a considerable difference to how the promoter is regulated. 
Since some of the cell lines did not show a response of the full length construct A to the 
copper insult, but sections of the gene did react, this suggests that the response of the gene 
involves both the promoter region and the intron 1 region interacting with each other. The 
finding that increases in GFP expression by construct C were only significant after 48 
hours may suggest that prolonged exposure to copper causes secondary cascades to 
become activated, resulting in different gene expression mechanisms controlling 
expression.
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Figure 3.16 Quantification o f truncated prnp  copper response. Cell extracts were electrophoresed on 
12% native acrylam ide gels, GFP was excited at light wavelength 488 nm and the intensity of emission 
at 530 nm measured. Protein was then transferred onto a PVDF membrane and blotted for tubulin as 
a loading control. The tubulin blots were quantified by densitometry. The GFP signal driven by each 
of the bovine prnp  gene constructs (B, containing the prom oter only; C, containing the non-coding  
sequence from the start of exon 1 to the end of exon 2; D, the promoter plus exon 1; E, intron 1 and 
exon 2) is shown in comparison to that driven by the CM V promoter control in A) F14, B) F21, C) C8- 
D1 A, D) G8, E) SH-SY5Y, and F) Cos-7 cell lines in response to treatment with 100 pM C u S 0 4 for 2, 4, 
8, 24 and 48 hours. Expression is shown relative to the time 0 GFP intensity and quantified with 
respect to tubulin as a loading control. Only those constructs that expressed highly enough to be 
quantified within the limits o f the software have been plotted. Shown are the mean and SEM. n = min 
3, max 12 individual time series.
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3.4.2 Promoter Response to DMSO
DMSO was used to look at the effect of oxidative stress on the PrP promoter in the stably 
transfected cells. DMSO is a versatile molecule. It can act as an oxygen radical scavenger 
and so has been implicated in protection from oxidative stress. However, the incorporation 
of oxygen radicals into the DMSO molecule initiates its breakdown, during which process 
further radicals are released. These are mostly methyl radicals (although at higher 
concentrations methyl sulphoxide radicals are produced by pyrolysis) and in an aqueous 
system can react with oxygen to form peroxyl radicals, thus inducing oxidative stress 
(Misik & Riesz, 1996; Lee et al., 2004). In addition to these qualities, DMSO can also 
initiate apoptosis by collapsing the mitochondrial membrane potential and the subsequent 
activation of caspases 3 and 9. It can induce cellular differentiation of some malignant 
clones, and alter expression of various cell surface antigens (for review see Santos et al., 
2003). Cells were prepared similarly to the method described for CUSO4 treatment. At the 
same time points as described for Cu, cells were treated with 1% DMSO, and extractions 
were as previously described. The response of the whole prnp construct A in each of the 
cell lines is shown in figure 3.17 and the quantification of this shown in figure 3.18.
Significant increases in GFP intensity driven by construct A are seen in the C8-D1A (T = - 
1.52, p = 0.014) and Cos-7 (T = -4.51, p < 0.001) cell lines, with this effect significant as 
early as four hours post exposure, but dropping back to the level of the CMV control in the 
C8-D1A cells by 24 hours post exposure, perhaps reflecting the ability of the cells to deal 
with the insult. The G8  cells show a variable result; an initial drop in activity is seen, 
followed by an increase in activity that then steeply drops away to a significant decrease in 
expression. This reaction is made more significant by the response of the CMV control, 
which is increased after 24 hours exposure indicating non-specific up-regulation of cellular 
proteins but PrP specific down regulation (T = 3.19, p = 0.002). The F14 and SH-SY5Y 
cells do not appear to respond to DMSO at all.
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Figure 3.17 Direct detection o f GFP signal driven by the whole promoter and non-coding region 
construct A in each of the cell lines in response to 1% DMSO treatment. Cell lines stably transfected  
with the destabilised GFP reporter vector driven by whole bovine prnp  gene construct (A; containing  
the prom oter and non coding sequence up to the end of exon 2), were treated with 1% DMSO for 2, 4, 
8, 24, or 48 hours, or left untreated for the time 0 control. Equal quantities o f the extracted protein 
were separated by electrophoresis on a 12% native acylamide gel and detected by excitation o f the 
GFP and recording the intensity of the emitted light. Samples were then transferred onto a PVDF  
membrane and blotted for tubulin as a loading control. The GFP detection is shown compared to the 
respective tubulin loading control.
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Figure 3.18 Quantification of prnp  DMSO response. Cell extracts were electrophoresed on 12% 
native acrylam ide gels, GFP was excited at light wavelength 488 nm and the intensity of emission at 
530 nm measured. Protein was then transferred onto a PVDF membrane and blotted for tubulin as a 
loading control. The tubulin blots were quantified by densitometry. The GFP signal driven by the 
whole gene (promoter and non coding region up to the end o f exon2) construct A is shown in 
comparison to that driven by the CM V promoter control in A) F14, B) F21, C) C8-D1 A, D) G8, E) SH- 
SY5Y, and F) Cos-7 cell lines in response to treatment with 1% DMSO for 2, 4, 8, 24 and 48 hours. 
Expression is shown relative to the time 0 GFP intensity and quantified with respect to tubulin as a 
loading control. Shown are the mean and SEM. Construct A responds significantly differently to the 
CM V control in the C8-D1A, G8 and Cos-7 cell lines (F = 6.01, p < 0.001). n = min 3, max 12 
individual time series.
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As for the copper experiments, the other constructs were tested in all the cell lines to look 
for the regions of the gene that are activated/deactivated by DMSO. The constructs that 
showed a significant response are pictured in figure 3.19 and the quantification is shown in 
figure 3.20.
For all of the constructs that responded to DMSO the reaction only became significant after 
48 hours exposure, much later than for the cell lines in which construct A reacted. Again 
this suggests that control of prnp relies on the interaction of the promoter with the 
sequence that follows it. This is further supported by the reaction of constructs C and E 
showing a significant increase in the F14 cells (T = 3.48, p = 0.001 and T = 3.18, p = 0.014 
respectively) and construct E showing a significant increase in the G8  cells (T = -3.66, p < 
0.001). The reaction of construct E in these cell lines is especially significant since its 
expression was virtually undetectable by phosphorimager detection until the addition of 
DMSO. The promoter region (construct B) was also found to up regulate the GFP signal 
in the C8-D1A (T = -2.28, p = 0.023) and Cos-7 (T = -2.3, p = 0.02) cells. The F21 cells 
that showed an up-regulation of construct A in response to DMSO only showed a small 
increase in the activity of construct C, and the SH-SY5Y cells demonstrated no reaction to 
the DMSO.
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Figure 3.19 Direct detection of GFP signal driven by the constructs that showed a significant response 
to DMSO (F = 4.6, p < 0.001). Cell lines stably transfected with the destabilised GFP reporter vector 
driven by each o f the bovine prttp  gene constructs (B, containing the prom oter only; C, containing the 
non-coding sequence from the start o f exon 1 to the end o f exon 2; D, the prom oter plus exon 1; E, 
intron 1 and exon 2), were treated with 1% DMSO for 2, 4, 8, 24, or 48 hours, or left untreated for the 
time 0 control. Equal quantities o f the extracted protein were separated by electrophoresis on a 12% 
native acylamide gel and detected by excitation of the GFP and recording the intensity o f the emitted 
light. Samples were then transferred onto a PVDF membrane and blotted for tubulin as a loading 
control. The GFP detection is shown compared to the respective tubulin loading control. Only the cell 
lines and constructs that showed a reaction significantly different to that o f the CM V promoter driven 
control cell lines have been shown.
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Figure 3.20 Quantification o f truncated prnp  DMSO response. Cell extracts were electrophoresed on 
12% native acrylamide gels, GFP was excited at light wavelength 488 nm and the intensity of emission 
at 530 nm measured. Protein was then transferred onto a PVDF membrane and blotted for tubulin as 
a loading control. The tubulin blots were quantified by densitometry. The GFP signal driven by each 
of the bovine prnp  gene constructs (B, containing the promoter only; C, containing the non-coding 
sequence from the start of exon 1 to the end of exon 2; D, the promoter plus exon 1; E, intron 1 and 
exon 2) is shown in comparison to that driven by the CM V promoter control in A) F14, B) F21, C) C8- 
D1A, D) G8, E) SH-SY5Y, and F) Cos-7 cell lines in response to treatment with 1% DMSO for 2, 4, 8, 
24 and 48 hours. Expression is shown relative to the time 0 GFP intensity and quantified with respect 
to tubulin as a loading control. Only those constructs that expressed highly enough to be quantified  
w ithin the limits o f the software have been plotted. Shown are the mean and SEM. n = min 3, max 12 
individual time series.
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3.4.3 Promoter Response to A TRA
In addition to factors that increase promoter activity, factors that decrease activity and so 
would down regulate cellular PrPc levels are also of interest. Factors that may down 
regulate PrPc are of especial interest with respect to managing the progression of the 
disease. Since PrPc is up-regulated as part of the disease pathogenesis and is required for 
disease progression, the disease could potentially be managed by maintaining reduced 
levels of PrPc if an agent could be found to produce this effect. Rybner et al. (1997) found 
that ATRA down-regulates PrPc expression in white blood cells, therefore this agent is of 
interest to this study.
Cells were prepared similarly to that described for CuSCU treatment. At the same time 
points as described for copper, cells were treated with 1 pM ATRA, and extractions were 
as previously described. Examples of the levels of GFP detected for the full-length 
construct A are shown in figure 3.21 and the quantification of this data shown in figure 
3.22.
A significant down-regulation of the GFP signal is seen in the F14 (T = 2.93, p = 0.004) 
and F21 (T = 3.61, p = 0.001) cells, this is significant as early as 4 hours post exposure and 
maintained from then the final 48-hour measurement. Down-regulation is also seen in the 
G8  cells but this is not significant until 48 hours post exposure. The remaining cell lines 
show no significant change in expression compared to the CMV promoter control (F = 
0.23, p = 0.636).
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Figure 3.21 Direct detection o f GFP signal driven by the whole promoter and non-coding region 
construct A in each o f the cell lines in response to ATRA treatment. Cell lines stably transfected with 
the destabilised GFP reporter vector driven by whole bovine prnp  gene construct (A; containing the 
promoter and non coding sequence up to the end of exon 2), were treated with 1 pM ATRA for 2, 4, 8, 
24, or 48 hours, or left untreated for the time 0 control. Equal quantities o f the extracted protein were 
separated by electrophoresis on a 12% native acylamide gel and detected by excitation of the GFP and 
recording the intensity of the emitted light. Samples were then transferred onto a PVDF membrane 
and blotted for tubulin as a loading control. The GFP detection is shown compared to the respective 
tubulin loading control.
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Figure 3.22 Quantification of prnp  ATRA response. Cell extracts were electrophoresed on 12% native 
acrylam ide gels, GFP was excited at light wavelength 488 nm and the intensity of emission at 530 nm 
measured. Protein was then transferred onto a PVDF membrane and blotted for tubulin as a loading 
control. The tubulin blots were quantified by densitometry. The GFP signal driven by the whole gene 
(promoter and non coding region up to the end of exon2) construct A is shown in comparison to that 
driven by the CM V promoter control in A) F I4, B) F21, C) C8-D1A, D) G8, E) SH-SY5Y, and F) Cos-7 
cell lines in response to treatment with 100 pM C u S 0 4 for 2, 4, 8, 24 and 48 hours. Expression is 
shown relative to the time 0 GFP intensity and quantified with respect to tubulin as a loading control. 
Shown are the mean and SEM. Construct A expressed in F14 and F21 cells shows a significant down- 
regulatory response compared to the CM V control (F = 5.18, p = 0.001). n = min 3, max 12 individual 
time series.
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The other promoter constructs were tested for their response to ATRA as before. The 
constructs showing a significant change in GFP expression are shown in figure 3.23 and 
the quantification of these reactions is shown in figure 3.24.
The F14 and F21 cells expressing the full-length construct A showed a significant down- 
regulatory response to ATRA, however no response was detected for any of the truncated 
constructs. This suggests that the response of these cell lines requires the interaction of the 
promoter with the intron 1 control sequences. The G8  cells, which show down-regulation 
of construct A after 48 hours exposure, show a significant down-regulation response of 
both construct B (T = 2.73, p = 0.01) and construct C (T = 2.66, p = 0.013) at 48 hours 
indicating that both of these regions are independently able to respond to ATRA. The SH- 
SY5Y cells, which did not show an alteration in the regulation of construct A in response 
to ATRA, show an increase in the GFP signal produced by the activity of construct C (T = 
4.1, p < 0.001), containing the non coding region. This suggests that in these cells ATRA 
is able to activate regulatory pathways, which produce a different effect on the activation 
of the non-coding region of prnp. In addition an initial, significant increase in signal is 
seen for promoter only (construct B) in the Cos-7 cells before activity drops resulting in a 
significant down-regulation (F = -1.96, p = 0.042). This activity is not sustained and 
expression returns to normal levels by 48 hours post exposure.
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Figure 3.23 Direct detection o f GFP signal driven by the constructs that showed a significant response 
to ATRA (F = 1.89, p = 0.017). Cell lines stably transfected with the destabilised GFP reporter vector 
driven by each o f the bovine prnp  gene constructs (B, containing the prom oter only; C, containing the 
non-coding sequence from the start o f exon 1 to the end o f exon 2; D, the prom oter plus exon 1; E, 
intron 1 and exon 2), were treated with 1 pM ATRA for 2, 4, 8, 24, or 48 hours, or left untreated for 
the time 0 control. Equal quantities o f the extracted protein were separated by electrophoresis on a 
12% native acylamide gel and detected by excitation of the GFP and recording the intensity of the 
emitted light. Samples were then transferred onto a PVDF membrane and blotted for tubulin as a 
loading control. The GFP detection is shown compared to the respective tubulin loading control. Only 
the cell lines and constructs that showed a reaction significantly different to that o f the CMV promoter 
driven control cell lines have been shown.
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Figure 3.24 Quantification o f truncated prnp  ATRA response. Cell extracts were electrophoresed on 
12% native acrylam ide gels, GFP was excited at light wavelength 488 nm and the intensity o f emission 
at 530 nm measured. Protein was then transferred onto a PVDF membrane and blotted for tubulin as 
a loading control. The tubulin blots were quantified by densitometry. The GFP signal driven by each 
of the bovine prnp  gene constructs (B, containing the promoter only; C, containing the non-coding 
sequence from the start of exon 1 to the end of exon 2; D, the promoter plus exon 1; E, intron 1 and 
exon 2) is shown in comparison to that driven by the CM V promoter control in A) F14, B) F21, C) C8- 
D1 A, D) G8, E) SH-SY5Y, and F) Cos-7 cell lines in response to treatment with 1 pM ATRA for 2, 4, 8, 
24 and 48 hours. Expression is shown relative to the time 0 GFP intensity and quantified with respect 
to tubulin as a loading control. Only those constructs that expressed highly enough to be quantified 
within the limits o f the software have been plotted. Shown are the mean and SEM. n = min 3, max 12 
individual time series.
94
__________________________________ Chanter 3: Genetic Modulation of PrP Expression
3.4.4 Prnp Promoter Response to Recombinant PrPp
The differences in expression and response to stimuli of the F14 (null) cell line compared 
to the F21 (wild type) cell line, when transfected with the different constructs, indicated the 
presence of PrPc in the cell was having an effect on its own regulation. To investigate if 
recombinant PrPc could alter promoter activity, F14 and F21 cells expressing the whole 
bovine sequence (construct A) and the CMV and vector controls were incubated for 24 
hours with 0.25 or 0.5 ng of water refolded recombinant PrPc. The water refolded PrPc is 
likely to lack the secondary structure that copper gives the N-terminus but there is no risk 
of a confounding effect caused by the release of copper into the cellular environment 
causing a change in promoter activity and GFP production. The results of this treatment 
are shown with the CMV and vector only controls in figure 3.25.
Recombinant PrPc caused a significant up-regulation of the full length construct A in the 
F14 cells in response to both recombinant PrP concentrations tested (T = 2.49, p = 0.017). 
The CMV control showed no response (F14 cells T = -1.23, p = 0.224; F21 cells T = -1.6, 
p = 0.118) and no measurable fluorescence was observed for the vector control cells. An 
up-regulation is also seen in the F21 cells, however this is not significant (T = 3.01, p =
0.057).
95
C hapter 3: G enetic M odu lation  o f  PrP E xpression
A — F I4 cells CMV Whole Vector
PrP Concentration (ng) 0 0.25 0.5 0 0.25 0.5 0 0.25 0.5 
GFP
a-tubulin
B -F 2 1  cells CMV Whole Vector
GFP
PrP Concentration (ng) 0 0.25 0.5 0 0.25 0.5 0 0.25 0.5
■ wamm
a-tubulin
C -  F14 cells D -  F21 cells
a  CMV Control 
□  PrP Whole Promoter
L lJ
0.25 0.5










□  CMV Control
□  PrP Whole Promoter
_E§3
0.25 0.5
Recombinant PrP Concentration 
(ng)
Figure 3.25 Effect o f recombinant PrPc on prnp  activity in F14 and F21 cells. Cell extracts were 
electrophoresed on 12% native acrylam ide gels, GFP was excited at light wavelength 488 nm and the 
intensity o f emission at 530 nm measured. Protein was then transferred onto a PVDF membrane and 
blotted for tubulin as a loading control. The tubulin blots were quantified by densitometry. Response 
of A) F I4 cells and B) F21 cells expressing the CMV control, the whole gene construct (A; promoter 
and non coding region up to the end of exon2), and the vector control when treated with 0.25 or 0.5 ng 
of water refolded recombinant PrP for 48 hours. C and D represent the quantification o f the CMV  
and the prnp  construct A response o f the F I4 and the F21 cells respectively, expression is shown 
relative to the time 0 GFP intensity and quantified with respect to tubulin as a loading control. Shown 
are the mean and SEM. In the F I4 cells construct A shows significant up-regulation in response to 
recombinant PrP compared to the other CM V control and the F21 cells (F = 4.73, p = 0.042). n = 5 
individual time series.
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3.5 Conclusions
The requirement of endogenous PrPc for infection and disease progression (Brown et al., 
1994; Brandner et al., 1996) and the influence of the level of expression of PrP° on the 
incubation period (Scott et al., 1989; Fischer et al., 1996) suggest that the control of PrPc 
expression may be an important consideration in the pathogenesis of the TSEs. Factors 
regulating PrPc expression may be important therapeutic targets. Potentially, factors 
producing a down-regulation of PrPc could be used to slow disease progression as part of 
disease management and therapy.
The finding that the intron 1 region has its own promoter activity and contributes to the full 
activity of the gene sequence is in agreement with previous studies (Baybutt & Manson, 
1997; Inoue et al., 1997; Premzel et al., 2005). However, no previous studies have been 
able to find evidence to suggest that a construct lacking exon 1 may exist. Here it is shown 
that both bovine and murine splice variants lacking exon 1 can be found by the use of 
RLM-RACE. This technique targets only full length, properly capped mRNA, so virtually 
eliminating the possibility that this splice variant has only been detected due to the 
presence of degraded mRNA species.
The finding of control elements inside intron 1 is not unusual. Many genes have conserved 
regulatory regions located within the intron sequences, which may contribute to the control 
of gene expression (Jonsson et al., 1992; Rohrer & Conley, 1998; Hural et al., 2000; 
Chamary & Hurst, 2004). Control elements are preferentially found located in the 5’ 
introns with less control elements found in the introns located further down stream. The 
enhancer effects of these control regions are so essential that some genes will not be 
expressed in their absence. In addition, these control elements may be involved in the 
tissue specific expression of the gene product. Of specific interest here is the identification 
of a putative TATA box within this region of the bovine gene. Prnp* has often been 
classified as a house-keeping gene due to its lack of TATA box, this data may suggest that 
this is not the case and that prnp regulation is much more complicated. Different control 
mechanisms may be employed depending on the requirements of the cell; a basal level of 
expression may be maintained by the promoter region and specific induction driven by the 
intron 1 region.
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This is the first study to show that exon 1 may also be involved in prnp regulation. None 
of the cell lines tested showed any significant activity of the construct containing just the 
promoter and exon 1 despite the full promoter sequence being present, indicating that the 
exon 1 region was interfering with expression. Alternatively, a further part of the sequence 
may be required for promoter activation, however this is unlikely as the promoter alone is 
able to drive expression. Analysis of putative transcription factor binding sites within prnp 
from both bovine and murine genes shows a complete lack of potential binding sites within 
exon 1, indicating that this may be a region of completely inert DNA sequence. As such it 
may be that it does not interact to inhibit PrPc expression but that despite the presence of 
the promoter sequence the transcription apparatus cannot remain correctly assembled on 
the DNA or does not recognise this region as active DNA without the sequence that 
follows it. An alternative theory is that the exon 1 containing mRNA is produced but that 
exon 1 has mRNA regulatory regions, which prevent the mRNA from being translated into 
DNA. Investigation to determine the presence or absence of a GFP mRNA transcript 
containing exon 1 from cells transfected with the promoter and exon 1 construct would 
clarify which theory is correct. Further work could be directed toward determining the 
importance of both exons in the control of mRNA turnover. Database analysis of the 
untranslated regions, followed by mutational studies could be used for this purpose.
Cell line specific variation in expression of both the full length prnp promoter with the 
non-coding region and the truncated constructs was expected since different expression 
levels are seen in different body tissues. This is most likely to be due to the varied 
mechanisms that different cells use to regulate their protein expression depending upon 
their function and their underlying state of health. The F14 and the F21 cell lines exhibit 
differences in their basal stress levels (see chapter 5, part 5.3.3). This may result in 
different activation levels for the factors that control expression of proteins related to stress 
responses including PrPc, which is known to be up-regulated in response to cellular stress 
via heat shock factors in the region preceding the promoter sequence (Shyu et al., 2000; 
Shyu et al., 2002).
The differences in the expression of the murine constructs compared to the equivalent 
bovine constructs in the cell lines studied may be due to different species utilising different 
control mechanisms. However, it is also likely they arise from the differences in the gene 
sequence. Despite the high conservation of the exons the remainder of the gene sequence 
is not highly conserved across species and, as is shown here by the variation in number and
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location of transcription factor binding sites, the differences in sequence means that some 
variation in gene expression is expected due to the ability to bind different transcription 
factors.
Copper and oxidative stress alter prnp activity. Prnp regulation in response to copper and 
oxidative stress insults relies on both the promoter and the control elements within intron
1. When only one of these regions is present the ability to drive mRNA production is 
different to when the gene is complete, and this may reflect the ability of the DNA to coil 
and allow protein-protein interaction of transcription factors. The reaction of each of the 
constructs in all of the cell lines is shown in table 3.2. Varela-Nallar et al. (2005) reported 
that copper up-regulates the prion promoter. This is in agreement with the findings 
presented here, however the authors did not consider the effect of intron 1 on expression. 
The data presented here indicate that this region is highly important in maintaining the 
appropriate response to metal imbalance. In addition Varela-Nallar et al. find that the 
response to copper is cell line specific with responses seen in pheochromocytoma (PC 12) 
cells but not glioma (C6) cells. This supports the data presented here, which shows that the 
changes in prnp activity in response to both copper and oxidative stress are influenced by 
the underlying cell line. Cell line specific modulations in expression induced by copper 
also explain why the study by Toni et al. (2005) showed down-regulation of PrP in 
response to copper. This study also used high exogenous levels of copper, well beyond 
that found physiologically, it is therefore likely that at these high concentrations the cells 
that are surviving are quiescent cells with much lower metabolic activity and so much less 
normal PrPc production. It would be interesting to determine what effect lower 
concentrations of copper have in their culture system.
Previous studies found that ATRA could down regulate PrPc expression (Rybner et al., 
2002; Cabral et al., 2002). The data presented here show that prnp is significantly down- 
regulated in mouse neuroblastoma and myoblast cells, with the neuroblastoma cells 
showing rapid down-regulation within four hours of exposure. It is also found that the 
different gene regions of prnp interact to produce this effect (table 3.2). Down-regulation 
effects are seen by part constructs in some of the cells lines but the effect happens at a 
much slower rate (after 24 hours) than for the full length construct. The finding that the 
full length construct down-regulates so rapidly suggests that ATRA may be able to interact 
directly, perhaps by the activation of RAR and RAREs or by activation of transcription 
factors already present, as opposed to by activation of cascades to induce production of
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specific transcription factors. This would be expected to produce a much slower down- 
regulation and may account for the down-regulation effects observed for the truncated 
constructs. Also noted is that in the cells showing a rapid down-regulation response, the 
effect is sustained up to the 48 hour time point. ATRA is highly labile, and will degrade 
quickly once in culture media at 31°C. For the effect to be sustained, either the down- 
regulation is induced by a more stable breakdown product or ATRA is activating further 
pathways to induce expression of transcription factors that bind to the promoter and 
maintain the effect. This also agrees with the slower down-regulation seen in some of the 
cell lines with the truncated constructs.
Construct
A - Whole B - Promoter C - Exons E-I1+E2 F - CMV
F14 Cu f Cu Cu n/d Cu n/d Cu
DMSO <-> DMSO D M S O t D M SO t DMSO <->
ATRA ATRA ATRA n/d ATRA n/d ATRA
F21 Cu <-> Cu <-> Cu t Cu n/d Cu <-*
DMSO <-» DMSO DMSO <-* DMSO n/d DMSO
ATRA ATRA <-» ATRA <r+ ATRA n/d ATRA <->
C8-D1A Cu <-» Cu <-> Cu Cu Cu
D M SO ■t-1 D M SO t DMSO <-> DMSO DMSO <->
ATRA <-» ATRA <-» ATRA <-> ATRA <-» ATRA <H>
G8 Cu Cu t Cu t Cu n/d Cu <->
DMSO DMSO DMSO <-> D M SO T D M S O f
ATRA <r+ ATRA I ATRA I ATRA n/d ATRA <->
SH-SY5Y Cu Cu Cu Cu t Cu
DMSO DMSO DMSO <-» DMSO n/d DMSO <->
ATRA ATRA <-» A T R A A ATRA ATRA
Cos-7 Cu Cu <-> Cu <-» Cu <-> Cu <->
D M SO t D M S O t DMSO DMSO DMSO
ATRA <-> ATRA n ATRA ATRA ATRA <->
Table 3.2 Response o f prnp  constructs expressed in all cell lines to Cu, DM SO and ATRA stimuli. I p
regulator} responses are shown In T, down-regulatory responses are shown by 4, and no response is 
shown by <->. W here expression levels were too low to be detected by phosphorim aging n/d represents 
not detectable.
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The finding that PrP has the ability to regulate its own expression is likely to be highly 
significant for disease pathogenesis. If the metal imbalances associated with the onset of 
the disease were to cause up-regulation of PrPc, and it then continued to up regulate itself, 
a self exacerbating cycle could be started providing more PrPc and so more substrate for 
conversion into PrPsc. The ability of recombinant PrP to up-regulate prnp is not likely to 
arise from direct interaction of the recombinant PrP with endogenous PrPc, due to the more 
pronounced effect seen in the PrPc null F14 cells. Instead it is likely that PrP interacts with 
another protein on the cell surface causing the activation of a signal transduction cascade, 
which in turn activates transcription factors that bind prnp. These results would further 
suggest that factors that would down regulate PrPc expression could have a place in disease 
management.
Overall the findings presented here highlight the importance of the non-coding post 
promoter sequence in the control of PrP expression. The effect of the underlying cell line 
is shown to be a significant factor in baseline PrP expression as well as in the response to 
external stimuli. Cellular stress, induced by copper and DMSO, alter prnp activity 
producing an overall up-regulation of the gene, and ATRA also affects prnp activity with a 
down regulatory reaction. In addition, prnp appears to be able to influence its own 
expression, providing a potential therapeutic target for the control of disease progression. 
The control of prnp is highly complex, involving interaction of various gene domains with 
each other under the influence of the genetic control mechanisms of the underlying cell 
type.
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4 Copper and PrPc Internalisation
PrPc is a cell surface protein, bound to the outer leaflet of the cell membrane by a GPI 
anchor. PrPc is trafficked to the cell membrane via the exocytic pathway. First it is 
directed into the ER by the N-terminal signal peptide, folded, and modified by the addition 
of the sugar chains in the ER and through the golgi. The mature PrPc is then transported to 
the cell surface (Nuziante et al., 2002; Winklehofer et al., 2003). At the membrane PrPc is 
localised to lipid rafts (Mahfoud et al., 2002; Brugger et al., 2003).
The octameric repeat domain of the PrPc N-terminus is able to bind four copper molecules, 
with a fifth copper binding site located adjacent, and C-terminal, to the repeat domain 
(Homshaw et al., 1995; Brown et al., 1997; Hasnain et al., 2001; Jackson et al., 2001). 
Previous studies have shown that PrPc is readily internalised from the cell membrane in 
response to 500 pM Cu, a reaction that was significant at concentrations as low as 200 pM 
Cu (Pauly & Harris, 1998; Lee et al., 2001). However, although copper concentrations at 
the synapse can reach this high during depolarisation, this level of copper is at the peak of 
conditions found in normal metabolism. For a reaction to be considered relevant 
physiologically it would have to readily occur at much lower concentrations of copper 
(Vassallo & Herms, 2003). Perera and Hooper (2003) found internalisation would readily 
occur at 100 pM copper if applied as a chelate with histidine. Zinc (100 pM) has also been 
shown to internalise PrP, but 500 pM cobalt, manganese or iron had no effect on PrP° 
localisation (Pauly & Harris, 1998).
Copper induced internalisation is abolished in the absence of the octameric repeat domain 
(Lee et al., 2001). In addition, a disease-associated mutation of the octameric repeat 
domain (PG14) abolishes the copper induced internalisation response (Perera & Hooper, 
2001). Since this mutation has nine extra octameric repeats inserted into the octameric 
repeat region, it may be that excessive copper binding is as detrimental to trafficking as the 
abolition of copper binding to this domain. The six most N-terminal amino acids of PrPc 
have also been suggested to be essential for internalisation (Sunyach et al., 2003).
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The present study was concerned with the internalisation of PrPc in response to copper. 
The effect of copper chelation on copper induced internalisation and the range of copper 
concentrations within which an internalisation reaction could be measured were considered 
to determine how likely the internalisation response was to occur under physiological 
conditions. To investigate the regions of PrPc important for internalisation and normal 
cellular processing, domain deletion mutants of PrPc were assessed for the ability to 
internalise. In addition the potential of PrPc to internalise in response to other redox metals 
was evaluated.
4.1 Cellular Location of GFP-PrPc and GFP-PrPc Mutants
GFP-PrP° wild type and domain deletion fusion constructs have been used throughout this 
investigation to assess the response of PrPc to various stimuli. It was, therefore, important 
to confirm that the fusion constructs would be correctly processed and that presence of the 
GFP tag would not affect the metabolism of PrPc. Incorrect processing would be likely to 
detrimentally affect the function of the construct. PrPc is a GPI anchored cell surface 
glycoprotein. So to ensure GFP-PrPc was correctly processed, it was first studied in the 
presence or absence of organelle probes, to ensure it was reaching the cell surface. The 
location of a GPI anchored GFP control was also determined. Following this, the GFP- 
PrPc mutant constructs were observed to identify their localisation.
4.1.1 Location o f GFP-PrPand GFP-GPI
Wild type GFP-PrPc and null GFP-GPI constructs were transfected into F14 (PrP° null 
cells) and stable cell lines established. Cells were observed by confocal microscopy under 
phase and FITC wavelength (excitation 488 nm, emission 530 nm) settings. The pattern of 
GFP localisation is shown in Figure 4.1.
Both the wild type GFP-PrP° and the null GFP-GPI construct were expressed at the cell 
surface as shown by the GFP fluorescence following the cell membrane that is seen under 
the phase. Both constructs also showed a similar intracellular staining pattern. The 
apparent perinuclear clump is thought to be a region of recycling endosomes (Magalhaes et 
al., 2002), which may store GPI anchored proteins until they are needed at the cell surface.
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GFP Plia.se M erge
GFP-PrP
GFP-GPI
Figure 4.1 Localisation of GFP in cells expressing G FP-PrPc or GFP-GPI constructs. The GFP-PrPc 
and GFP-GPI constructs were transfected into F14 (PrPc null mouse neuroblastoma fusion) cells, and 
stable cell lines established. Images were produced using a Zeiss LS 550 confocal laser scanning 
m icroscope and show a section through the cells. Cell surface localisation can be seen by the green 
fluorescence following the contours o f the cell. Scale bar = 10 pm
T o in vestiga te  further the intracellular d istribution o f  PrPc, liv e  ce ll intracellular organelle  
probes w ere u sed  to look  for g o lg i apparatus, ly so so m a l, and m itochondrial loca lisa tion , 
and a p lasm id  w ith  ER d irection  and retention seq u en ces (p D sR ed -E R ) w a s used  to look  
for ER loca lisa tion . The results are sh ow n  in F igure 4 .2 .
B oth  the G FP-PrPc and G FP-G PI constructs sh o w ed  lo w  le v e ls  o f  loca lisa tion  in the ER  
and g o lg i. T his represents constant production and traffick ing through the ex o cy to tic  
pathw ay to the ce ll surface, con sisten t w ith  norm al protein turnover. C on sisten t w ith  the 
ce ll m em brane loca lisa tion  o f  PrPc, no co -lo ca lisa tio n  is seen  w ith  the m itotracker probe. 
A  d ifferen ce  b etw een  the G FP-PrPc and G FP-G PI ce ll lin es is  seen  w ith  the lysotracker  
probe. A  higher lev e l o f  co -lo ca lisa tio n  o f  the G FP-G PI construct is  seen  w ith  the 
lysotracker probe than for the G FP-PrPc construct. T his is due to PrPc b ein g  degraded  
prim arily by the p roteosom e, as op p osed  to the ly so so m e  to w h ich  m ost GPI anchored  
proteins are targeted.
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Figure 4.2 Cellular localisation o f GFP signal in GFP-PrPc and GFP-GPI expressing cells. F14 cells 
stably transfected with the GFP-PrPc and GFP-GPI constructs were incubated with a sphingolipid 
golgi probe, and Lyso-Tracker® Red and M ito-Tracker® Red organelle probes to look for co­
localisation with the GFP signal. ER localisation was probed using co-transfection with the pDsRed- 
ER plasmid (Clontech). Scale bar = 10 pm.
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4.1.2 Cellular Location of Mutant PrP0 Constructs
The cellu lar loca lisa tion  o f  the d eletion  m utants w as determ ined as described  for the G FP- 
PrP0 and G FP-G PI constructs.
Figure 4.3 Cellular location of A) GFP-PrPc, and PrPc mutants B) A23-38, C) A51-89, D) A67-89, E) 
Al 12-119, F) Al 12-136, G) A122-146, H) A135-150. G FP-PrP‘ and GFP-PrPc mutant constructs were 
transfected into F I4 cells and stable cell lines established. Pictures o f GFP localisation were captured  
using a Zeiss LS 550 confocal microscope. M utants B-D show cell surface localisation in the same 
pattern as that o f GFP-PrPc, mutant E also reaches the cell surface but shows some intracellular 
retention, and mutants F-H are fully retained inside the cell. Scale Bar = 10 pm.
T he N -term inal d eletion  m utants (A 23-38 , A 5 1 -8 9 , A 67-89 ) w ere loca lised  to the cell 
surface fo llo w in g  the sam e pattern as the w ild  type G FP-PrP construct (see  Figure 4 .3 ). 
The A l 1 2 -119  d eletion  m utant w as a lso  lo ca lised  to the ce ll surface but sh ow ed  sligh tly  
higher retention  inside the ce ll, as seen  by the presen ce  o f  green v e s ic le s  inside the ce ll. 
T his is a result o f  increased  d irection  to the ly so so m e s  com pared to the w ild  type (F igure  
4 .4 ). In contrast, the C -term inal d eletion  m utants (A l 12-136 , A 1 2 2 -1 4 6 , A l 3 5 -1 5 0 ) did not 
reach the ce ll surface and the green  flu orescen ce  w a s con fin ed  to the inside o f  the ce ll 
(Figure 4 .3 ). W hen the c e lls  w ere incubated w ith  organ elle  probes, the internally lo ca lised  
m utants w ere  sh ow n  to co -lo c a lise  to the E R  (F igure 4 .4 ). T he m erging  o f  the fu sion  
construct G FP signal w ith  the red flu orescen ce  o f  the p D sR ed -E R  probe dem onstrating ER  
loca lisa tion  is  sh ow n  for each  o f  the internals m utants in figure 4 .5 .
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N o  Probe L y so  P robe G o lg i P robe E R  P rob e
A l l  2 -1 1 9
A l l  2 -1 3 6
A 1 2 2 -1 4 6
A 1 3 5 -1 5 0
Figure 4.4 Localisation of PrPc mutant constructs that show retention inside the cell. The stable cell 
lines established with the mutant constructs A l 12-119, Al 12-136, A122-146, and A135-150 show 
internal localisation, which is different from the cell surface localisation of wild type GFP-PrPc. These 
cell lines were incubated with the sphingolipid golgi probe, lyso-Tracker® Red, and M ito-Tracker®  
Red probes to determine where the GFP was expressed. ER localisation was determined by transient 
co-transfection of the plasmid containing the mutant PrPc with pDsRed-ER. Images were captured 
using a Ziess LS 550 confocal microscope. The Al 12-119 mutant shows a slight co-localisation to the 
lysosomes and the rem aining three mutants show co-localisation with the ER probe as seen the orange- 
yellow staining of the cells where the two probes merge. Scale bar = 10 pm.
ER retention o f  the C -term inal d eletion  m utants m ay have occurred for a variety o f
reasons. T he rem oval o f  th is region  m ay h ave rem oved  a b inding site for the chaperones
that m o v e  PrPc through the secretory pathw ay to the ce ll surface, so  preventing its correct
transport. A ltern atively , the rem oval o f  th ese  am ino acids m ay have caused  the protein to
m isfo ld  resu lting in  ER  retention due to redirection  o f  the m utants into the ER A ssoc ia ted
D egradation  (E R A D ) pathw ay. S in ce  th ese m utations are w ith in  the structured C -term inus
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o f  the protein, and sp ec ifica lly  around the hydrophobic region , w h ich  is located  inside o f  
the protein, it is lik ely  that the protein is not m aintained as strongly in its correct 
conform ation  as the w ild  type due to the w eak en in g  o f  the bonds that m aintain this 
conform ation . R eg io n s o f  the hydrophobic dom ain  are lik e ly  to be located  in the interior  
o f  m ature protein resu lting in their am ino acid  seq u en ces b ein g  in a ccessib le  to chaperones, 
su ggestin g  that the seco n d  proposed  internal loca lisa tion  theory is m ost lik ely .
GFP ER probe Merge
G FP-PrP
A l l  2-136
A 122-146
A 135-150
Figure 4.5 ER localisation o f internal PrPc mutant constructs. F I4 cells were transiently co­
transfected with GFP-PrPc, or with the internally retained A l l 2-136, A122-146, or A135-150 
constructs, and with the ER probe pDsRed-ER. The individual GFP and DsRed channels are shown 
along with the merged pictures. Co-localisation of the internal mutants can be seen by the overlap of 
the green and red signals producing a yellow signal. Scale bar = 10 pm.
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4.2 Copper and PrPc Trafficking
Copper is bound by the octameric repeat domain within the N-terminus of PrPc. 
Previously, it has been shown that high exogenous concentrations of copper cause PrP° to 
move away from the cell surface. However the concentrations reported were 200-500 pM, 
which are of limited relevance physiologically. When applied as a chelate with histidine, 
internalisation has been reported at concentrations as low as 100 pM copper (Perera & 
Hooper, 2001), suggesting that this reaction is of physiological relevance. The aims of this 
study were first to confirm that copper internalises the GFP-PrP° construct but not the 
GFP-GPI control, and second to determine the if lower copper concentrations would 
significantly internalise PrP° to confirm the physiological relevance of this reaction.
4.2.1 Copper, Glycine, and PrP° Internalisation
Copper is rarely found in its free, unbound form in physiological systems. Copper in the 
blood or extracellular fluid is transported bound to proteins such as ceruloplasmin, ferritin 
and albumin, thus protecting the cells within the system from its potentially toxic effects. 
To reproduce the effect of bound copper glycine was premixed with CuSC>4 in a 1 CuSC>4 : 
4 Glycine molar ratio (Cu-4xGly). Glycine binds copper but with low enough affinity to 
readily release it to amino acids with stronger affinity such as the histidines found in the 
copper binding octarepeat domain of PrPc. The assays were carried out on stably 
transfected F I4 GFP-PrPc and GFP-GPI cells, using the mixed population to allow 
expression levels to be considered. Live cells were cultured in chambered cover slips and 
incubated in OptiMEM serum free and phenol red free media. Reagent was added at time 
0 , cellular response to the reagent were observed by confocal microscopy, and images were 
captured at time 0, 10 minutes and 2 hours. Internalisation of PrPc was measured by the 
change in cell surface intensity of the GFP signal.
A concentration of 500 pM CUSO4  significantly increased the internalisation of PrPc after 
10 minutes exposure (see Figure 4.5). This reaction was also significant at 100 pM CUSO4  
after 2 hours exposure. However, as previously stated, free copper is not usually found in 
physiological systems so copper complexed to glycine was used to replicate the effect of 
chelated copper. Using the pre-mixed Cu-4xGly, 100 pM Cu produced a more rapid 
reaction than the 500 pM CUSO4 . This indicates that copper may be more effectively 
delivered into PrPc when it is chelated, thus causing a greater reaction. 400 pM glycine on
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its own had no significant effect on PrPc. No effects of any of the tested reagents were 
seen on the GFP-GPI construct, with cell surface fluorescence remaining constant 
throughout all the treatments and time points. The lack of response of the GFP-GPI 
construct eliminated the possibility of a non-specific internalisation effect or metal 
quenching of the GFP at the cell surface.
To eliminate the possibility that the internalisation is an effect of over expression, the 
percentage change in fluorescence was plotted against the time 0 intensity to look for 
trends. No trends caused by the over expression of PrPc were found (figure 4.7). The 
implication is that the effect of copper on GFP-PrPc cells is not a result of over expression 
of PrP°.
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G F P -P i P G F P -G P I
Tim e 0 10 m inutes 2 hours Tim e 0 10 m inutes 2 hours
No 
B.e agent
500 pM  
C u S 0 4
100 pM  C u S 0 4 
w ith 4 0 0  pM  
G lycine
4 0 0  pM  
G lycine
B □  No treatment
□  500 pM Cu
□  100 pM Cu
□  100 pM Cu-4xGly
□  400 pM Gly
fti J_ I I
L 1 1 1 T f f
-10
-20
10 mins 2 hours 10 mins 2 hours
GFP-PrP GFP-GPI
Figure 4.6 Copper and copper glycine trafficking o f  GFP-PrPc and GFP-GPI cells. A) shows 
individual cell responses at time 0, 10 minutes and 2 hours after addition o f reagent. Scale bar =10 pm. 
B) shows the percentage internalisation compared to the fluorescence measured by recording GFP  
intensity at the cell surface at time 0. Significant internalisation is seen for the GFP-PrPc construct in 
response to 100 pM C u S 0 4 (after 2 hours), 500 pM C u S 0 4 and 100 pM Cu-4xGly (F = 6.04, p < 0.001). 
Shown are the mean and SEM. n = min 12, max 22 cells.
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Figure 4.7 Effect o f expression levels on internalisation response. Difference at 10 minutes (open
circles) and 2 hours (black circles) between cells treated with 100 pM C u S 0 4 with 4x glycine compared 
to raw intensity at time 0. The spread o f data points in this plot shows that the rate of internalisation 
in response to copper is not influenced by the expression level o f the cell.
4.2.2 Copper Dose Response
The difference in the rate o f  internalisation when using 100 pM  Cu-4xGly as opposed to 
100 pM  Cu alone is pronounced, but this concentration o f  copper is at the higher end o f 
concentrations that may be relevant physiologically. A n internalisation reaction at 100 pM  
Cu could only occur at a significant rate during depolarisation o f  the neurone. A t the 
synapse copper concentrations can reach 300 pM  on depolarisation. How ever, resting 
concentrations are more like 15 pM  and there is a blood exchangeable level o f 8 pM  
(Kram er et al., 2001; Vassallo & Herms, 2003). For a reaction to be physiologically 
significant it w ould have to be readily proceeding w ithin these limits. Therefore, further 
assays were carried out as above with lower copper concentrations (5, 20, and 50 pM  Cu- 
4xGly).
The dose-response curves (figure 4.8) show that in 10 m inutes there is a significant 
internalisation response to 20 pM  Cu-4xGly (F = 7.21, p < 0.001) and after 2 hours this
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resp on se  is  sign ifican t at le v e ls  as lo w  as 5 pM  C u -4xG ly  (F =  14 .09 , p <  0 .0 0 1 ). T his 
in d icates that, as copper le v e ls  at the syn ap se  sp ike during depolarisation , the rate o f  
in ternalisation  o f  PrPc w o u ld  rise sign ifican tly . U nder the norm al range o f  copper in the 
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Figure 4.8 Dose response curves for Cu treatment o f cells expressing GFP-PrPc and GFP-GPI. Cells 
were treated with 5 pM, 20 pM, 50 pM or 100 pM Cu-4xGIy. Percentage Internalisation, measured as 
decrease in GFP signal compared to that at time 0, is shown for the G FP-PrPc and GFP-GPI cell lines 
at (A) 10 minutes and (B) 2 hours. Shown are the mean and S.E.M. n = 18 cells.
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4.3 The Destination of Copper Internalised PrPc
Internalisation of PrPc has been measured in this study by the decrease in GFP signal at the 
cell surface. However, as the signal is internalised, it decreases, making the determination 
of its destination difficult. The destination of the internalised PrPc was investigated by 
indirect immunofluorescence. This method allowed for the assessment of PrPc levels in 
acidic organelles where GFP fluorescence may be quenched.
F14 cells were stably transfected with pcDNA-PrP(m), a mammalian expression vector 
containing a DNA insert encoding murine PrPc without the GFP reporter. The transfected 
cells were cultured on coverslips. Cells were treated for 10 minutes or 2 hours with 100 
pM Cu, Cu-4xGly, Gly only, or were left untreated, before fixing and staining PrPc with a 
FITC antibody probe. Cu-4xGly treated cells showed a vesicular pattern emerging inside 
the cell, while the signal of PrP at the cell membrane was decreased and not as smooth and 
continuous as the untreated cells (Figure 4.9). The glycine only treated cells showed the 
same pattern throughout. This indicates that the internalised PrPc was being directed into 
acidic vesicles, most probably early endosomes, where the reduced pH may have resulted 
in quenching of the GFP signal in the GFP-PrPc cells.
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Figure 4.9 Indirect im munofluorescence staining o f PrPc in F14 cells. F14 cells were transfected with 
pcDNA 3.1 PrPc. PrPc was detected using the rabbit DR1 primary antibody directed against amino 
acids 89-103 o f the PrPc sequence, and visualised with a secondary FITC conjugated anti rabbit 
antibody. Images were captured using a Zeiss LS 550 confocal microscope using excitation and 
emission wavelengths o f 488 nm and 530 nm respectively. Shown are untreated cells representing 
localisation at time 0, and cells treated for 10 mins and 2 hours with 100 pM Cu-4xGly or 400 pM 
glycine. Internalisation is seen in the PrPc expressing cells by the developm ent o f a punctuate pattern 
as the PrPc moves from the cell surface into endocytic vesicles. Scale bar = 10 pm.
It w a s a lso  p o ss ib le  that the reduction  in PrPc at the ce ll surface w as due to PrPc b ein g  shed  
or c lea v ed  from  the ce ll surface. M atrix m eta lloproteinases (M M P s) m ay be activated  by  
Cu and th ese  have prev iou sly  been  sh ow n  to c lea v e  PrP° w h en  activated  (Parkin et al., 
2 0 0 4 ). A s  a result part o f  the lo ss  o f  the signal m ay have been  due to the lo ss  o f  the N -  
term inal dom ain  (con ta in in g  the G FP sign al) into the surrounding m ed ia  due to c leavage. 
S in ce  som e G FP cou ld  be seen  in sid e the c e ll th is w ou ld  be occurring a lo n g sid e  the 
in ternalisation reaction. T o in vestigate  the d estination  o f  PrPc, extracts from  ce lls  that 
w ere cultured in O ptiM E M  and incubated for 2 hours untreated, treated for the w h o le  2 
hours or for o n ly  the final 10 m inutes w ith  100 p M  C u 4xG ly  w ere co llec ted . N ative  
P A G E  g e ls  w ere  run, G FP intensity  m easured u sin g  a phosphorim ager at G FP w a v elen g th s  
(excita tion  4 8 8  nm  and em iss io n  5 30  nm ), and proteins w ere transferred onto a 
n itrocellu lose  m em brane. M em branes w ere b lotted  for PrPc le v e ls  u sin g  an antibody that 
detected  a C -term inal ep itop e o f  PrPc. F o llo w in g  blotting, m em branes w ere stripped and
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tubulin  im m unodetected . Q uantification  w a s m ade w ith  respect to tubulin as a load ing  
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Figure 4.10 Total PrPc levels in F I4 cells following 100 pM Cu-4xGly treatment. (A) Western blots of 
F14 G FP-PrPc cells treated with 100 pM Cu-4xGly. Protein was extracted from the cells at 10 minutes 
and 2 hours, and untreated cells were used as time 0 controls. Samples were electrophoresed on a 12% 
native acrylam ide gel. GFP signal was detected using a phosphorim ager and PrPc or tubulin detected 
by western blot, n = 3. (B) Blots were scanned and band intensities quantified by densitometry.
Direct linear ANOVA was used to look for differences in the trend o f detection of GFP and PrPc C- 
terminus in the cell extract. No significant difference was seen (F=0.53, p=0.469, n=3). Shown are the 
mean and S.E.IM.
The m easured G FP and PrPc sign a ls sh ow ed  a d ecrease in total sign a l, h ow ever  this  
resp on se w a s variable and is not statistica lly  sign ifican t. W hilst the decrease in signal 
su g g ests  there m ay increased turnover o f  PrP° or lo ss  into the m ed ia  (F igure 4 .1 0 ), the lack  
o f  sig n ifica n ce  requires further in vestiga tion  be m ade. T herefore the GFP and PrPc lev e ls  
in the m ed iu m  surrounding the ce lls  w a s analysed .
To in vestiga te  the potential lo ss  o f  PrPc into the surrounding m edia , the m edium  from  the 
ab ove exp erim en ts w as co llec ted  at the tim e o f  harvesting the c e lls , spun to co llec t  the 
protein and the protein p e lle t separated by n ative P A G E  as for the ce lls  extracts. 
Q uantification  o f  G FP and PrPc in the m edia  extracts w as m ade w ith  respect to the total 
ce ll num ber plated. The in ten sities m easured sh o w ed  a d ecrease o f  both PrPc and G FP in
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the m ed ia , w h ich  w as returned a lm ost to norm al le v e ls  by the addition  o f  protease  
inh ib itors (F igure 4 .1 1 ). T his w ou ld  su ggest that extracellu lar p roteases are activated by  
the increased  ex o g en o u s copper resu lting in h igher degradation o f  PrPc ex p elled  in to the  
m ed ia , but that there is no sign ifican t change to the quantity o f  PrPc secreted  or released  by  
























Figure 4.11 Protease inhibition of PrPc degradation in culture medium. (A) F14 GFP-PrPc expressing 
cells treated with 100 fiM Cu-4xGly, in the presence and absence of protease inhibitors, 2 mM PMSF 
and 1 mM benzamidine. Extracts were prepared at time 0, 10 minutes and 2 hours after treatment 
with Cu. Following native PAGE, GFP was detected using a phosphorim ager and PrPc detected by 
western blotting. (B) Quantification of the blots. Two-sam ple t tests were used to look for significant 
differences between the Cu experim ents carried out with/without the protease inhibitors present. The 
media harvested from the Cu only treated cells shows a significant decrease in the detected o f either 
GFP or PrP (F = 3.88, p = 0.039). Following protease inhibition treatment significant differences were 
seen in com parison to untreated samples for both the GFP (t = 3.24, p = 0.048) and the PrPc detection 
(t = 10.78, p = 0.002). Neither the GFP or the PrP detected was significantly decreased in the media 
after protease inhibition. Shown are the mean and S.E.M . n = 3.
117
Chapter 4: Copper and PrPc Internalisation
4.4 PrPc Functional Regions and Copper Internalisation
Copper binds to the octameric repeat domain and the absence of this domain abolishes 
copper induced internalisation (Lee et al., 2001). In addition the N-terminal domain 
following the signal peptide, specifically amino acids 23-28, is thought to be essential for 
PrPc trafficking (Nunziante et al., 2003). To investigate more fully the domains of PrPc 
important for internalisation several mutant constructs were employed. Deletions, shown 
in figure 2.1, included the far N-terminus of the mature protein (A23-38), the octameric 
repeat region (A51-89), most of the octameric repeat region but leaving one complete 
repeat intact (A67-89), the palindromic region (Al 12-119), and three mutations of the 
hydrophobic domain (A 112-136, A122-146, A135-150). The stably transfected mutant cell 
lines were exposed to 100 pM Cu-4xGly. This concentration was chosen since it provides 
the maximal response to copper (see figure 4.7), and so it is likely that a decreased 
response should not be overlooked due to too low a concentration being used. 
Internalisation could only be measured in those mutants that were expressed at the cell 
surface. However the internal mutants were observed under the same conditions to look 
for any response.
4.4.1 Cell Surface Mutants and Copper
As previously reported, removing the octameric repeat region completely abolished 
internalisation (Figure 4.12 and 4.13b). After 2 hours the A51-89 mutant showed increased 
GFP signal at the cell surface. Such an increase may be due to the cell mobilising the PrPc 
to the surface in an attempt to deal with the copper insult. This indicates that for copper 
induced internalisation of PrPc, copper binding to the octameric repeat domain is more 
significant than that binding to the fifth site. The A67-89 mutant demonstrated reduced 
ability to internalise compared to the wild type but it did significantly internalise. This 
shows that just one octameric repeat is required for this reaction to proceed, although not 
fully, and further emphasizes the importance of the octameric repeat domain for copper 
induced internalisation. The A23-38 N-terminal deletion mutant was expected not to react 
to copper. However it did internalise significantly, with a rate equalling that shown by the 
A67-89 mutant. Therefore copper binding to the octameric repeat region overrides the role 
of this region in internalisation. The final cell surface mutant, Al 12-119, lacking the 
palindromic region thought to be a cleavage site, showed no internalisation in response to 
copper. This was unexpected, and shows for the first time that this region is involved in
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copper induced  internalisation. PrPc m ay need  to be c leaved  before it can internalise, or 
alternatively , th is region m ay d irectly  react w ith  C u or the octam eric repeat reg ion  to 
induce internalisation.






Figure 4.12 Change in wild type and mutant GFP-PrPc cell surface expression following Cu treatment. 
Cells were treated with 100 pM Cu-4xGly, and images captured using a Zeiss LS 550 confocal 
microscope at time 0, 10 minutes, and 2hours. Shown are individual F I4 cells expressing either GFP- 
PrPc, or GFP-PrPc mutants A23-38, A51-89, A67-89, or Al 12-119. Significant internalisation was seen 
as a decrease in membrane intensity of the GFP signal for the A23-38 and A67-89 mutants but not for 
the A51-89 and Al 12-119 mutants. Scale bar = 5 pm.
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Figure 4.13 Effect o f mutations on basal GFP expression levels and response to Cu. (A) Boxplot of 
basal expression levels o f each of the membrane localised constructs. The box represents the mean and 
inter-quartile range. One-way ANOVA was used to test for significant differences in basal expression  
of the constructs; no significant difference is seen (F = 1.14, p = 0.346). (B) The percentage
internalisation, compared to the time 0 membrane intensity, o f each of the membrane localised mutant 
constructs compared to the GFP-PrPc and GFP-GPI cell lines. Significant internalisation is seen for 
the A23-38 and A67-89 cell lines compared to the G FP-PrPc and GFP-GPI cell lines (F = 21.26, p 
<0.001, n = min 12, max 18), but not for the A51-89 and A l 12-119 cell lines. The A51-89 mutant is seen 
to increase at the cell surface. Untreated and glycine treated controls showed no significant difference 
to basal expression (shown in appendix C).
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B ased  on  the ev id en ce  o f  previous stud ies (N unziante et al., 2 0 0 3 ) , the d eletion  o f  the far 
N -term in u s w as exp ected  to ab o lish  internalisation, but this w as not seen . T o confirm  this, 
im m u n oflu orescen t sta in ing  w a s carried out on c e lls  exp ressin g  a PrPc construct con ta in in g  
the sam e m utation but w ithout the G FP tag (F igure 4 .1 4 ). T his sh o w ed  that this m utation  
d o es have a pronounced  e ffec t on traffick ing but that it is traffick ing to the ce ll surface  
rather than aw ay from  it that is m ost a ffected . PrPc m inus the N -term in u s still loca tes to 
cellu lar m em branes but predom inantly  th ose in sid e the ce ll, in clu d in g  the nuclear  
m em brane, w h ich  can be seen  clearly  by the perinuclear stain ing. S in ce  th is m utant 
appears not to be trapped in the E R  in the sam e w ay  as the C -term inal d eletion  m utants, it 
is  lik e ly  that it is not retained in the ce ll to be d irected into E R A D . Instead it m ay lack a 
region  w here chaperones that are in v o lv ed  in the m ovem en t o f  PrP through the ce ll to the 
ce ll surface w ou ld  norm ally  bind. In the G FP tagged  m od el, there m ay be sites w ith in  GFP  
that are in som e w ay  able to com p en sate for th is, or the ce ll surface exp ression  m ay be 
clearer due to the m ore acid ic  pH o f  internal organ elles quench ing  the G FP signal.
TimeO 10 minutes 2 hours
100 J.IM 
Cu-4xGly
400 jliM  
Glycine
Figure 4.14 Im munofluorescent staining of F14 cells expressing pcDNA-3.1 PrP(m)A23-38. F14 cells 
were transfected with pcDNA 3.1 PrPc. PrPc was detected using the rabbit DR1 primary antibody 
directed against amino acids 89-103 o f the PrPc sequence, and visualised with a secondary FITC 
conjugated anti rabbit antibody. Images were captured using a Zeiss LS 550 confocal microscope 
using excitation and emission wavelengths of 488 nm and 530 nm respectively. Shown are untreated 
cells representing localisation at time 0, and cells treated for 10 mins and 2 hours with 100 pM Cu- 
4xGly or 400 pM glycine. An internal staining pattern is seen by the localisation of the FITC signal 
inside the cell. Scale bar = 10 pm.
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4.4.2 Internal Mutants and Copper
T he A l 12 -1 3 6 , A 1 2 2 -1 4 6 , and A l 3 5 -1 5 0  m utants are predom inantly located  in the ER. 
B asal in tensity  is not sign ifican tly  d ifferent b etw een  the ce ll lin es (F =  0 .5 1 , p =  0 .4 8 2 ). 
H ow ever, the signal is m uch low er at the ce ll surface than in sid e the ce ll (figure 4 .1 6 b ). 
T he ce ll surface signal m easured m ay be due to PrP° in organ elles n ext to the ce ll surface  
rather than PrPc ex p ression  at the m em brane. T o see  i f  these m utants w ou ld  sh o w  any  
resp on se  to Cu treatm ent, c e lls  w ere treated as for the ce ll surface m utants and readings  
w ere taken from  both the ce ll surface and the interior. N o  change in the location  or the 
in ten sity  o f  the G FP signal w as ob served  for any internal m utant fo llo w in g  copper  
treatm ent (F igure 4 .1 5  and 4 .1 6 b ), although a sligh t d ecrease in m em brane in tensity  w as  
seen  for the A l 12 -136  m utant, w h ich  is m ost lik ely  to be an artefact o f  the very lo w  
in tensity  o f  G FP at the surface. It is  lik e ly  that even  i f  the externally  applied  copper  
reaches the m utant protein  and b eco m es incorporated, it is still targeted for destruction and  
so  d o es not m ove  from  its p o sitio n  in resp on se to copper.




Figure 4.15 Response of internally localised mutants to 100 pM Cu-4xGIy. F14 cells stably transfected 
with the GFP-PrPc mutants Al 12-136, A122-146, and A135-150 were treated with 100 pM Cu-4xGly, 
and images captured using a Zeiss LS 550 confocal microscope at time 0, 10 minutes, and 2hours. The 
location and intensity o f the GFP signal show no significant change. Scale bar = 10 pm.
122




3000 -  
2000  -  
1000  -  
0 -
A 112-136 A122-146 A135-150




















10 mins 2 hours 10 mins 2 hours
Membrane Internal
Figure 4.16 Effect o f internal mutations on GFP-PrPc expression levels and response to Cu. (A) 
Boxplot o f basal expression levels o f each of the ER localised constructs in F I4 cells. The box 
represents the mean and inter-quartile range. (B) The percentage intensity decrease, compared to the 
time 0 membrane intensity, o f each o f the ER located mutant construct cell lines. Shown is the change 
both at the membrane and inside the cell where the protein is found. No significant change in location 
or intensity o f GFP signal is seen. F = 2.3, p = 0.097, n = 12. Untreated and glycine treated controls 
showed no significant difference to baseline expression (F = 1.67, p = 0.333, appendix C).
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4.5 PrPc Internalisation and Other Metal Ions
Perera and Hooper (2001) and Brown and Harris (2003) also reported PrPc internalisation 
with zinc (Zn). Zn and manganese (Mn) have been reported to bind to the octameric repeat 
domain of PrPc. For this reason the ability of these metals to internalise PrPc was 
investigated. The assays were carried out as described above. Mn is much more toxic to 
cells than Cu or Zn, therefore a lower concentration of Mn was used (20 pM) to produce 
an elevated exogenous concentration that was not high enough to kill the cells. At the start 
of the assay the cells were incubated with 20 pM MnSC>4 or 100 pM ZnSC>4 , and 
observations made at time 0, 10 minutes and 2 hours. In addition, given that the Cu 
induced internalisation reaction proceeds much faster when Cu is delivered to the cells, a 
four molar excess of glycine premixed with each metal was also assayed.
Neither Mn nor Zn alone or complexed to glycine caused PrP° to internalise. No 
significant reaction of either the GFP-PrPc or GFP-GPI cells was seen to either metal (F = 
0.10, p = 0.748; Figure 4.17), indicating that PrPc may not be binding these metals or that 
binding does not cause internalisation. This could possibly be due to metal binding to a 
different site on the protein or a different fit in the sites of the octameric repeat region.
124
C hanter 4: C opper and PrPc Internalisation
A G F P -P i  P G F P -G P I
1
Tim e 0 2 hours Tim e 0 10 m inutes 2 hours
20 pM  
M n S 0 4
20 pM  M n S 0 4 
w ith 400 pM  
Glycine
100 pM  
Z n S 0 4
100 p M Z n S 0 4 
w ith  400 pM  
Glycine
B
Figure 4.17 The response o f GFP-PrPc and GFP-GPI to treatm ent with Mn and Zn. A) shows 
individual cell responses at time 0, 10 minutes and 2 hours after addition of reagent. Scale bar =10 pm. 
B) shows the percentage internalisation compared to the GFP intensity measured at the cell surface at 
time 0. Percentage internalisation in response to Mn and Zn and respective chelates is shown 
compared to the 100 pM Cu-4xGly results. No significant internalisation is seen in response to any of 
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4.6 Conclusions
The aims of this study were to address if copper could stimulate PrPc internalisation under 
conditions that would arise physiologically, to determine the domains of the protein 
important for this function, and to consider whether other metals could produce the same 
reaction.
Previous studies have show that high exogenous concentrations of copper induce 
internalisation of PrPc (Pauly & Harris, 1998; Brown & Harris, 2003). However, the 
concentrations reported are extremely high (200-500 pM) and, whilst these concentrations 
may be seen during neuronal depolarisation, to conclude that the reaction would occur 
physiologically requires that it would proceed at much lower concentrations. The data 
presented here shows that copper induced internalisation occurs much more readily when 
copper is delivered to the cell as a chelate. Copper is transported in the body chelated by 
transport proteins including ceruloplasmin, ferritin and albumin, and would also 
preferentially bind amino acids than remain unbound, and so copper induced 
internalisation of PrP° is much more likely to occur under conditions resembling those 
found physiologically. The function of the glycine may be to provide more efficient 
delivery into PrPc or it may maintain the Cu ion in the redox state preferable for PrPc 
binding. The finding that glycine facilitates internalisation is in agreement with previous 
studies that suggest histidine facilitates uptake of radioactive Cu into neurones and 
astrocytes (Brown, 1999; Brown, 2004).
Using copper as a chelate, this investigation has found that concentrations as low as 5 pM 
can induce significant internalisation of PrP within two hours, and at 20 pM this reaction is 
significant as early as ten minutes after exposure. The blood plasma exchangeable 
concentration of Cu is 8 pM (Kramer et al.,2001; Bums et al., 2002), and at the synapse 
Cu concentrations are reported to be around 15 pM, rising to 100-300 pM during neuronal 
depolarisation (Vassallo & Herms, 2003). This suggests the exogenous levels of Cu at the 
synapse would be causing a constant low level of PrPc internalisation reaction, and that on 
depolarisation of the neurone, and subsequent increase in exogenous Cu, PrPc at the cell 
surface would be rapidly internalised. There may be several reasons for this. The 
internalisation reaction may be a part of maintaining the environmental balance at the 
synapse so that the released metal ions can do no damage to the cells. Alternatively, PrPc
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may be an intermediate in Cu trafficking and incorporation into cellular proteins (Brown, 
1999). Another explanation is that the binding of Cu may be involved in the activation of 
PrP° either by directly binding to PrPc or by activation of proteases at the cell membrane 
that then cleave and activate PrPc (Parkin et al., 2004).
The fate of PrPc in response to copper is still unclear. The concentration of PrPc in cells 
treated with copper is decreased compared to untreated cells, indicating that either PrP° is 
cleaved from the cell surface or routed for degradation once inside the cell. No increase in 
the concentration of PrP° was seen in the media taken from the copper treated cells 
compared to untreated cells after treatment with protease inhibitors. Certain proteases at 
the cell surface are involved in PrPc cleavage and may become activated in response to 
copper (Parkin et al., 2004). Therefore, protease inhibitors were applied to cells during 
copper treatment to prevent PrPc expelled in the media being degraded. Since no change in 
the concentration of PrP expelled into the media was seen, it is likely that the reason for the 
decrease in cell extracts in response to copper is due to increased turnover of PrPc. Cell 
permeable inhibitors of the proteosome or lysozomal enzymes could be employed to 
determine if PrPc destruction is increased.
The trafficking of PrPc to the cell surface appears to be highly dependant on the integrity of 
the hydrophobic region of the protein. The PrPc mutants lacking part of the hydrophobic 
domain (Al 12-136, A122-146, and A135-150) are not correctly trafficked to the cell 
surface and localise to the ER. Hydrophobic regions usually stabilise protein folding by 
forming the core of the protein, therefore this region of PrPc is likely to be important for 
maintenance of PrPc tertiary structure. As a result, it is likely mutations of the hydrophobic 
domain do not reach the cell surface due to protein misfolding and redirection into ERAD. 
Cui et al. (2003) have previously shown that mutations in this region exert little if any 
effect on the secondary structure of PrPc, with the alpha helical content showing little 
variation. However two of the hydrophobic domain mutants (A 112-136 and A122-146) are 
lacking amino acids that form part of the beta sheet, 128-131 (Riek et al., 1996), and so in 
their absence the beta sheet will not form correctly. This suggests that the beta sheet may 
stabilise PrPc structure. The A135-150 mutation lacks most of helix 1 (located at amino 
acid positions 144-154), and although this does not affect the overall alpha helical content 
as shown by Cui et al., its position at the C-terminal end of the hydrophobic region may 
result in a pronounced effect on tertiary structure. An alternatively theory is that sites 
within the hydrophobic domain provide epitopes for chaperone binding, which would
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direct PrPc to the cell membrane. This may explain the slight internal retention observed 
for the Al 12-119 mutation. However, the hydrophobic domain is expected to be hidden 
inside the protein and so inaccessible to chaperones. Accordingly the deletions would be 
most likely to affect tertiary structure and, by do so, remove or reposition motifs 
recognised by chaperones.
In addition the far N-terminus has a pronounced effect on the transport of PrPc to the cell 
surface. When amino acids 23-38 are missing, the protein is trafficked into the 
intracellular membranes of the cell, and less reaches the cell surface. Since this region is 
unstructured, and perinuclear localisation is seen as well as to ER localisation, it is likely 
that, rather then misfolding causing ERAD, the protein is missing a binding site for a 
chaperone that is involved in movement through the exocytotic pathway to the cell surface.
Whereas trafficking to the cell surface is dependent on the hydrophobic region, trafficking 
away from the cell surface is reliant on the N-terminal regions. In agreement with previous 
studies (Lee et al., 2001; Perera & Hooper, 2001), the octameric repeat domain is essential 
for copper induced internalisation. The absence of this region not only completely 
abolishes internalisation, but also produces a significant accumulation of PrPc at the cell 
surface after 2 hours. It is possible that this mutation affects not only the ability of the 
protein to internalise, but also the regulation of its movement through the secretory 
pathway, resulting in increased mobilisation of the protein in response to Cu. In addition 
to the octameric repeat region, a fifth copper binding site has been identified (Jackson et 
al., 2001). However the results of this investigation would indicate that this site is not 
involved in the internalisation of PrPc in response to Cu. The importance of the octameric 
repeats is further emphasised by the finding that just one repeat is sufficient to restore a 
significant, although reduced, reaction.
A unique discovery of this investigation is that the palindromic region (amino acids 112- 
119) is essential for Cu induced PrPc internalisation. Previous studies have found that that 
this region is necessary for the proposed antioxidant function of the protein (Cui et al., 
2003), and it has been shown that PrP° is cleaved at this site (Chen et al., 1995). This 
region may be necessary for the movement of PrPc into membrane microdomains or 
clathrin coated pits, or PrPc may have to be cleaved before it can move away from the 
membrane. In addition, PrP° mutants lacking this domain have been shown to be resistant 
to conversion into PrPSc, signifying this domain may be involved in PrPsc formation by
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in itiating the associa tion  w ith  PrPc that a llo w s con version  (H olsch er  et al., 1998; N orstrom  
& M astrianni, 2 0 0 5 ).
P reviou s stud ies o f  PrP internalisation have su ggested  that the far N -term in u s is essentia l 
for in ternalisation  (L ee et al., 2001; N u n zian te et al., 2003; W alm sley  et al., 2 0 0 3 ). In 
contrast, th is study found that a lthough d eletion  o f  th is reg ion  (am ino acids 2 3 -3 8 ) d oes  
s lo w  copper induced internalisation , it d oes not ab o lish  it. M utation o f  am ino acids 2 3 -3 8  
had a m uch  m ore pronounced  a ffect on  traffick ing to the ce ll surface. A  further study  
sh o w ed  that the very  N -term inal am ino acid residues, K K R PK P, are an essen tia l 
recogn ition  seq u en ce for m ovem en t tow ard sp ec ific  m em brane m icrod om ain s and coated  
pits (S u n yach  et al., 2 0 0 3 ). A lth ou gh  the fin d in g  that in ternalisation  can be induced by  
copper w h en  am ino acids 2 3 -3 8  are m issin g  is  in  contrast to the fin d in gs published  by  
Sunyach  et al., the studies do both agree that m ovem en t to the ce ll surface is im paired in  
the ab sen ce o f  this region. T aylor et al. (2 0 0 5 ) found that th is far N -term inal region  w as  
required for PrPc m ovem en t at the ce ll m em brane, facilitating  p assage out o f  lip id  rafts and 
subsequent internalisation  by clathrin coated  pits. PrPc has a lso  been  sh ow n  to be 
in ternalised  by a caveo lae-m ed ia ted  pathw ay (Peters et al., 2 0 0 3 ). T his m ay exp la in  the  
discrepancy b etw een  the results presented here and th ose p rev iou sly  reported. In the 
ab sen ce o f  the N -term inal region  copper induced  PrPc internalisation  is s lo w ed , sin ce  the 
clathrin pathw ay is e ffe c tiv e ly  b lock ed , h ow ever  internalisation  d oes occur due to the 
ca lveo lae-m ed ia ted  pathw ay rem ain ing active. The region s o f  PrP im portant for copper  
induced internalisation are sum m arised in F igure 4 .1 8 .
GPI anchor signal 
sequence
Figure 4.18 Domains of PrPc important for copper induced internalisation. Essential domains are 
shown in red and the N-terminal region found to alter but not stop internalisation is shown in amber.
Stud ies by  Perera and H ooper (2 0 0 1 ) and B row n and Harris (2 0 0 3 ) a lso  found that zinc  
cou ld  induce internalisation  o f  PrP. T h ese  fin d in gs w ere not repeatable in th is study either  
w h en  Zn w a s adm inistered as a chelate  or a lone. T he concentration  used here w as
N -term inal signal 
peptide
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considerably lower than that used by Brown and Harris, 100 pM and 250 pM ZnSC>4 
respectively, however some effect would have been expected. This suggests that, although 
Zn induced internalisation may occur, Cu is the more dominant metal in initiating the 
internalisation process. No internalisation effect of PrPc was seen in response to Mn, 
suggesting that if Mn is binding it is not producing the same response as copper.
From the evidence presented here it is apparent that the copper induced PrPc internalisation 
reaction would happen readily under physiological conditions. This suggests that copper 
induced internalisation is relevant for PrPc function. PrP° may be delivering copper into 
storage vesicles to remove it from the exogenous environment, where it may be able exert 
potentially toxic effects. Copper delivery could be into cellular enzymes such as SODs or 
into storage molecules for later incorporation into enzymes. Copper could potentially 
activate a PrPc signal transduction cascade, where internalisation is the first response and 
PrPc goes on to activate other, possibly protective, proteins. Much further investigation is 
needed to clarify what role copper induced internalisation of PrPc does play within the cell, 
clarifying where PrPc is directed within the cell and if it interacts with other proteins may 
help to determine the function of PrPc.
In conclusion, the prion protein internalises in response to copper, this reaction is 
preferential and swift under conditions that arise physiologically. PrPc is located to the 
synapse, and as such would internalise rapidly in response to synaptic fluctuations in Cu. 
Cu induced PrPc internalisation is dependant on the presence of the octameric repeat and 
palindromic domain but also influenced by the far N-terminus. Furthermore, the far N- 
terminus and the hydrophobic region have a pronounced effect on PrP transport to the cell 
surface.
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5 Cellular Protection and FrPc
Early changes in prion disease include altered metal ion concentrations in the brain and an 
associated inability to deal with oxidative stress insults (Wong et al., 2001b; Thackray et 
al., 2002). Therefore, a role as a protective molecule has been suggested for PrPc. PrP° 
protects neurones against copper toxicity (Brown et al., 1998). This protective effect can 
be extended to PrPc null neurones by incubation with a peptide corresponding to the copper 
binding octameric repeat domain of PrPc. This suggests that by incorporation of copper 
into itself PrP° protects cells against the deleterious effects of this metal ion.
Incorporation of copper into PrP° may protect cells against death by preventing copper 
from generating free radicals by switching redox states, as occurs during the Fenton 
reaction (Brown et al., 1998; Nishimura et al., 2004). However, the incorporation of 
copper into PrPc may have a more functional role. The internalisation of PrPc in response 
to copper (Pauly & Harris, 1998) has lead to the theory that PrPc acts as a copper 
chaperone, delivering the metal ion to enzymes within the cell such as SODs, which 
mediate the cellular protective response against oxidative stress (Brown & Besinger, 
1998). In addition, PrPc has been shown to have SOD-like activity both in vitro and in vivo 
(Brown et al., 1999; Wong et al., 2000; Brown et al., 2001), so may itself impart a cellular 
protective response at the cell membrane.
The SOD-like response of PrPc is dependant on copper binding to the octameric repeat 
region and requires at least two copper molecules to be bound (Brown et al., 2001). In 
addition to the octameric repeat domain the hydrophobic domain has been reported to be 
essential for PrPc antioxidant activity (Cui et al., 2003; Sakudo et al., 2005). PrPc also 
shares several features with mouse SOD genes (Premzel et al., 2005), and is up-regulated 
in response to ischaemic brain damage, accumulating at the site of damage where high 
concentrations of ROS are found (McLennan et al., 2004). However conflicting results, 
suggesting that PrPc has no SOD-like activity, have been reported (Hartter et al., 2000; 
Jones et al., 2005), leaving the putative SOD-like function of PrPc still highly debated.
Alternative to PrPc acting an antioxidant enzyme itself, it has been suggested that PrPc is a
cell surface receptor for oxidative stress, which on activation can start a signal transduction
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cascade (Mouillet-Richard, 2000; Spielhaupter & Schatzl, 2001, Watt et al., 2005). The 
pathways that would be activated by such a cascade may include PKA and ERK pathways 
of neuroprotection (Chiarini et al., 2002; Schneider et al., 2003), explaining the protective 
effect of PrPc.
The role of PrP° in protection against cellular stress remains to be defined, and the 
suggestion that PrPc functions as an anti-oxidant is still a matter of controversy. To 
investigate the role of PrPc in protection against cellular stress, its ability to protect cells 
against metal imbalance was investigated. In addition, given the suggestion that PrPc is a 
superoxide dismutase, the potential to protect against direct oxidative stress insults was 
investigated and the mechanisms of protection against metal ion insult were then 
examined. The domains of PrPc important for each protective reaction were considered.
5.1 Metal Toxicity and PrPc Protection
The high binding affinity of PrPc for Cu implies that the role of PrPc involves Cu. As 
suggested above, such roles may include Cu transport, signal transduction, or protection 
against sources of cellular stress including metal ion fluctuations or ROS. The ability of 
PrPc to protect against the toxicity of Cu was investigated and the important functional 
regions of the protein considered. Other metals, including Mn and Zn, have been 
suggested to bind to PrPc (Brown et al., 2000; Jackson et al., 2001), therefore the ability of 
PrP° to protect against toxicity of these metals was also investigated.
5.1.1 Copper Toxicity and P rl* Protection
Cu is rarely found in its free, unbound form in biological systems, so in these experiments 
Cu chelated by a four times molar excess of glycine (Cu-4xGly) was used to replicate the 
effect of endogenous bound Cu. Stable cell lines were established by transfecting F14 
cells with GFP-PrPc (wild type) and GFP-GPI (null) constructs, and these were treated 
with 0-200 pM of CuSC>4 , Cu-4xGly, and 0-800 pM glycine only concentrations for four 
days then assayed for viability using an MTT assay. The results are shown in Figure 5.1.
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Figure 5.1 Viability GFP-PrPc and GFP-GPI cells treated with copper alone, Cu-4xGly or glycine 
alone. Survival o f GFP-PrPc and GFP-GPI transfected F14 cells was determined by MTT assay after 
treatment with A) C u S 0 4, B) Cu-4xGly, or C) glycine alone for four days, as shown by the percentage 
viability of the cells compared to that o f untreated cells monitored in parallel. Shown are the mean 
and SEM. GFP-PrPc significantly protects against copper induced cell death compared to the GFP- 
GPI null cells in the range o f 25-100 pM, but only when copper is delivered as a chelate with glycine (F 
= 13.61, p < 0.001, * indicates significant results), n = 4 repeats, each o f 3 replicates.
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W hen treated with the free copper (C 11SO 4), a small but non-significant protective effect is 
exhibited by the PrPc expressing cells com pared to the null cells (F = 0.52, p = 0.815; see 
Figure 5.1a). In contrast when the Cu is applied com plexed to glycine, the protective 
effect is m uch m ore pronounced and can then be seen to be statistically significant (F = 
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Figure 5.2 Viability o f GFP-PrPc and GFP-GPI cells at various time points up to 4 days when treated 
with 50 pM Cu-4xGly. F14 cells stably transfected with GFP-PrPc and GFP-GPI constructs were 
treated for 8, 24, 48, 72, or 96 hours with 50 pM Cu-4xGly then assayed for viability using the IMTT 
assay. Results are shown compared to untreated cells representing a time 0 value. Shown are the 
mean and SEM. n = 4 repeats, each o f 3 replicates.
To be sure that the reaction seen was significant after four days incubation, the G FP-PrPc 
and GFP-G PI cells were treated at 8, 24, 48, 72, and 96 hour tim e points w ith 50 pM  Cu- 
4xGly. The results show a significant difference betw een the cell lines from 48 hours 
onwards (T = 3.58, p = 0.037). A t the 96 hour tim e point used for these assays the cells are 
beginning to recover but the difference betw een the cell lines is still significant (T = 3.69, p 
= 0.019). A slight difference in viability is seen betw een the data shown in Figure 5 .IB  
and 5.2, this is due to the passage num ber o f  the cells used. The cells have a finite life and 
later passages lose the phenotype. Therefore, care was taken that all subsequence assays 
used cells at passage 10 or less in age.
W hen the Cu and Cu-4xGly treatm ents are com pared within the same cell line it can be 
seen that the increased difference in viability o f  the cell lines (figure 5.1) is due to more 
death o f  the GFP-GPI cells in response to Cu chelated with glycine as opposed to an
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increased protective effect o f  PrPc when copper is adm inistered this way (figure 5.3). The 
viability o f  the G FP-PrPc cells is only slightly altered when both treatm ents are com pared 
indicating that the glycine neither significantly enhances nor dim inishes the protective 
effect o f  PrPc (F = 1.32, p = 0.256), but causes Cu to be more toxic to null cells than when 















Figure 5.3 Copper-glycine is more toxic to PrPc null cells than to wild type cells. Comparison of  
survival o f F I4 cells stably transfected with A) GFP-PrPc and B) GFP-GPI cells treated with Cu and 
Cu-4xGly as measured by the MTT viability assay. GFP-GPI cells show a significantly reduced 
survival when treated with the Cu-4xGly compared to the Cu only, whereas the GFP-PrPc cells show  
little change. Shown are the mean and SEM. n = 4 repeats, each of 3 replicates.
5.1.2 Domains o f PrPp Functional in Protection Against Copper Toxicity 
Since Cu binds to the octam eric repeat dom ain it was expected that this region would be 
essential for the protective effect o f  PrP°. Deletion m utants (previously described and 
shown in figure 2.1) were used to investigate the regions o f  PrPc important for this 
protective function. F14 cells, stably transfected with the m utant PrPc constructs, were
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treated w ith  C 11S O 4 , C u -4xG ly , and G ly  on ly  as for the G FP-PrPc and G FP-G PI c e ll lin es, 
and v iab ility  m easured by M T T  assay. T he resu lts are grouped by s ig n ifica n ce , figure 5 .4a  
sh o w s ce ll lin es that responded s ign ifican tly  d ifferently  (F =  7 .8 5 , p <  0 .0 0 1 ) and figure  

















Figure 5.4 The response o f PrPc mutant cell lines treated with Cu-4xGly. F I4 cells stably transfected 
with G FP-PrPc and GFP-PrPc mutant constructs were treated for four days with a range of Cu4xGly 
concentrations and assayed by MTT assay. Results are expressed relative to the 100 % value o f the 
untreated controls. The octam eric repeat deletion (A51-89) and the hydrophobic domain section 
deletion (A122-146) show significantly decreased survival compared to the wild type F = 7.85, p < 0.001
(A), whereas the remaining cell lines showed no significant decrease in survival in response to copper
(B). Shown are the mean and SEM. n = 4 repeats, each of 3 replicates.
T he d eletion  o f  the octam eric repeat dom ain  (5 1 -8 9 ) ab o lish ed  the p rotective e ffect o f  the  
protein in resp on se  to the copper insu lts (F igure 5 .4a). T he presen ce  o f  ju st one octam eric  
repeat appears to re-estab lish  the protection  that PrPc affords, ind icating that ev en  one  
repeat is su ffic ien t for the PrPc protective response.
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In addition, the deletion mutant lacking amino acids 122-146 of the hydrophobic domain 
showed significantly decreased survival compared to the wild type protein (Figure 5.4a), 
indicating that this domain is also important for protection of cells against copper toxicity. 
The requirement for this region suggests that the protection against copper toxicity may not 
be simply due to PrPc chelating Cu within its octameric repeat region, but that further 
mechanisms may be involved. PrPc could potentially be also protecting against copper 
toxicity by reducing the oxidative stress that a redox metal such as copper may induce. 
This will be considered in Section 5.3. The remaining mutant cell lines did not show any 
significant difference from the wild type (Figure 5.4b).
5.1.3 Manganese Toxicity and PrPc Protection
Mn is a much more toxic metal than copper. Since PrPc may bind Mn and the above 
results show it protects against copper toxicity, the toxicity of Mn on the GFP-PrPc and 
GFP-GPI cell lines was investigated. Mn is weakly bound by glycine, therefore Mn was 
prepared complexed to glycine in a lMn:4Glycine molar ratio as used for Cu. MnS0 4  and 
Mn-4xGly were added to GFP-PrPc and GFP-GPI cells, and cells were incubated for four 
days then viability measured by MTT assay.
A significant protective effect is seen by increased viability of the GFP-PrPc cells 
compared to the GFP-GPI cells (F = 14.72, p < 0.001; figure 5.5), showing that PrPc 
protects against Mn toxicity. This effect only becomes apparent at high manganese 
concentrations. This may be due to the octameric repeat domain of PrPc having a higher 
affinity for Cu, so Mn concentrations would have to appreciably exceed copper 
concentrations before Mn can complete for the octameric repeat binding sites. If this were 
the case PrPc would be protecting against the Mn insult by the chelation of the Mn ions. 
PrPc could also be protecting against the oxidative stress caused by the Mn ions 
undergoing redox reactions, which would become considerably more toxic to cells at 
higher concentrations of Mn. In contrast to the Cu results, the Mn complexed to glycine 
produced the same pattern of survival of each cell line as the unbound, free Mn (F = 8.35, 
p < 0.001). The most likely reason for this effect is that glycine binds to Cu with much 
greater affinity than it does to Mn. The stability constants for the two metals at pH 7.4 are 
Cu Ki = 5.87, and Mn Ki = 0.67 (Dawson et al., 1994). With Mn having a low affinity, it 
is likely that the protective effect observed is primarily due to protection against free 
manganese, which is released from the glycine once it is added to the medium. Also Mn 
incorporation into PrPc may not be more efficient if Mn is chelated than if it is not.
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Figure 5.5 Mn treatment o f PrPc null and wild type cell lines. F14 cells stably transfected with GFP- 
PrP" and GFP-GPI constructs were treated for four days with A) M n S 0 4 and B) M n S 0 4 with a four 
times molar excess of glycine and viability determined by MTT assay. GFP-PrPc protects significantly 
against cell death induced by either treatment compared to the GFP-GPI cells, however there is no 
significant difference between the effects seen for Mn or Mn-4xGly. Shown are the mean and SEM. n 
= 4 repeats, each of 3 replicates.
5.1.4 PrPc Protection Against Other Metals
There is ev id en ce  that PrP binds other m etals such  as Zn, Fe and N i (Jackson  et al., 2 0 0 1 ). 
T o in vestiga te  the p rotective ability  o f  PrPc against these m etals 0 -2 0 0 p M  ZnSC>4 , NiSC>4 , 
and F e 2 S 0 4  w ere used  to  treat G FP-PrP 0 and G FP-G PI ce lls . N o  sign ifican t protective  
effec t w a s seen  to any o f  these m etals, for Zn F =  0 .3 0 , p =  0 .5 8 7 , for N i F =  1.85, p =  
0 .1 1 2 , and for Fe F =  0 .5 8 , p = 0 .451  (figure 5 .6 ).
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Figure 5.6 Response o f PrPc null and wild type cells to treatment with Zn, Ni, and Fe. F14 cells stably 
transfected with GFP-PrPc and GFP-GPI constructs were treated with A) Z n S 0 4, B) N iS 0 4, and C) 
Fe2S 0 4 for four day and then viability measured using the MTT assay. No significant differences in 
survival are seen between the GFP-PrPc and GFP-GPI cell lines in response to any of the treatments. 
Shown are mean and SEM. n = 4 repeats, each of 3 replicates.
T he lack o f  PrPc p rotective e ffec t against these m etals m ay be due to low er b inding affin ity  
o f  PrPc for th ese m etals, or that the protective function  o f  PrPc d oes not in v o lv e  these m etal 
ions. It is a lso  p o ssib le  the m ethod o f  protection is the reason for the lack o f  response. I f
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the protective effect shown by PrPc is a response to the oxidative stress caused by active 
redox metals such as Cu and Mn, it may not be able to respond to less redox active metals, 
which cause toxicity primarily via the metal ion itself.
5.2 PrPc and Protection Against Oxidative Stress
5.2.1 PrP° Protection Against DMSO and Xanthine Oxidase Insults 
PrPc has been suggested to have SOD-like activity itself. To consider if this capability is 
sufficient to protect the cells from death induced by oxidative stress dimethyl sulphoxide 
(DMSO) and xanthine oxidase were used to induce oxidative stress insults. At the start of 
the assay 0-3% DMSO (Figure 5.7a) or 0-50 mU xanthine oxidase (Figure 5.7b) with 50 
pM xanthine (included in control wells also), was added to the cells and after 24 hours 
treatment cell viability was measured using the MTT assay.
PrPc protected against insults induced by DMSO (F = 4.8, p < 0.001) and xanthine oxidase 
(F = 4.32, p < 0.001) indicating that the oxidative protection observed is not restricted to 
just that caused by metal ions. This indicates that the protective effect of PrPc against 
metals may not just be due to the chelation of the metal ion preventing oxidative stress but 
potentially also due to the removal of any oxidative insult directly.
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Figure 5.7 Response o f PrPc null and wild type cells to oxidative stress insults. F14 cells stably 
transfected with GFP-PrPc and GFP-GPI constructs were treated for 24 hours with A) DMSO and B) 
xanthine oxidase to induce oxidative stress. Viability was determined by the MTT assay. An increased 
survival o f the GFP-PrP cell line is seen by an increased viability compared to the GFP-GPI cell line. 
Shown are the mean and SEM. n = 4 repeats, each of 3 replicates.
5.2.2 PrP° Functional Domains for Protection Against Oxidative Stress 
The dom ain s im portant for PrPc function  w ere considered  u sin g  the d eletion  m utants. For 
this the c e lls  w ere ex p o sed  to D M S O  (figure 5 .8 ) or xanthine o x id a se  (figure 5 .9 ) as for the 
G FP-PrPc and G FP-G PI ce ll lin es, and assayed  as before.
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Figure 5.8 PrPc mutant cell lines treated with DMSO. F I4 cells stably transfected with GFP-PrPc and 
GFP-PrPc deletion mutants were treated for 24 hours and viability determined by MTT assay. 
Deletion o f amino acids 23-38, 51-98, and 112-136 produced the most significant decrease in cellular 
survival compared to the wild type GFP-PrPc cells (A), however all the remaining mutants show some 
degree of reduced survival (B). Shown are the mean and SEM. n = 4 repeats, each of 3 replicates.
A ll o f  the m utant ce ll lin es sh ow ed  som e degree o f  reduced survival com pared to the w ild  
type w h en  treated w ith  D M S O  (F igure 5 .8 ). For m ost o f  the ce ll lin es  reduced survival is  
seen  at 2%  D M S O  but overall v iab ility  is not s ign ifican tly  d ifferent to w ild  type, h ow ever  
for ce ll lin es  exp ressin g  the m utants A 2 3-38 , A 5 1 -8 9 , and A 1 1 2-136  survival w as  
sign ifican tly  reduced from  that o f  w ild  type (F =  4 .9 2 , p <  0 .0 0 1 ).
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Figure 5.9 PrPc mutant cell lines treated with xanthine oxidase. F14 cells stably transfected with GFP- 
PrP1^ and GFP-PrPc deletion mutants were treated for 24 hours to induced oxidative stress and viability 
determined using the MTT assay. Mutants lacking amino acids 51-89, 122-136, and 135-150 showed 
the most reduced survival compared to the GFP-PrPc cells F = 5.14, p < 0.001 (A). The remaining 
mutants did not show significantly reduced survival (B). Shown are the mean and SEM. n = 4 repeats, 
each o f 3 replicates.
C on sisten t w ith  the fin d in gs o f  the D M S O  assays, d eletion  o f  the octam eric repeat dom ain  
rem oves the ab ility  o f  the protein to respond to ox id ative  stress induced  by xanthine  
o x id a se  (F igure 5 .9a). The p rotective e ffec t is a lso  lo st w ith  the rem oval o f  the 
hydrophobic dom ain  and the area im m ed iately  fo llo w in g  it. T he rem aining d eletion  
m utants sh o w ed  no sign ifican t reduction in survival w hen  treated w ith  xanthine o x id ase  
(F igure 5 .9b ).
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5.3 Method of PrPc Protection Against Copper
As suggested previously PrPc may protect against cellular injury from Cu by several 
methods. The octameric repeat region binding and chelating the Cu ions may prevent them 
from binding to other cellular proteins causing damage, and also may prevent oxidative 
stress by keeping Cu static in one oxidation state. Alternatively the protection may be due 
to the ability of PrPc to act as an anti-oxidant and so remove the stress that the Cu ion is 
causing to the surrounding environment. There is also the possibility that both methods 
could act together for the overall protection of the cell. The evidence presented so far 
suggests that PrPc protects against the Cu ion itself but also against the oxidative stress that 
the ion may induce, therefore further investigation is needed to more fully characterise the 
role of PrPc in protection against Cu induced cellular death. To this end several methods 
have been employed, both indirectly looking for markers of oxidative stress and directly 
measuring reactive oxygen species.
5.3.1 PrP°, Copper, and Anti-Oxidants
The first approach considered to elucidate the mechanism of action of PrP° was the use of 
anti-oxidants for the purpose of restoring the viability of the GFP-GPI cells to that of the 
GFP-PrPc cells. Restoration to a similar viability level would be likely if the protective 
effect of PrPc was a result of removing the oxidative stress caused by the Cu ion as 
opposed to just chelation of the ion itself. F I4 (null) and F21 (wild type) cells were used 
for this comparison. Cells were treated for four days with Cu plus bovine SOD, catalase, 
N-acetyl cysteine, or a combination of these, and then tested for viability using the MTT 
assay.
Using the anti-oxidants on the cells in conjunction with the Cu treatment did not produce 
any effect on either cell line (F = 0.72, p = 0.619; figure 5.10). Thus indicating that the 
protective effect is not likely to be due solely to PrPc anti-oxidant activity.
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Figure 5.10 Rescue effect of anti-oxidants on copper treated F14 and F21 cells. Cells were treated 
with 50 pM Cu-4xGly w ith or w ithout SOD, catalase, N-acetyl cysteine, or all o f these antioxidants to 
assess if null cell survival could be rescued to that o f wild type. Cells were treated for four days then 
viability determined by MTT assay. No antioxidant, or combination o f  anti-oxidants, had any 
significant effect on the survival o f the cell lines. Shown are the mean and SEM , n = 4 repeats, each of 
3 replicates.
5.3.2 PrPc, Copper, and Markers o f Oxidative Stress
Lipid p eroxidation  is a m echanism  o f  cellu lar injury in response to ox id ative  stress, and 
lip id p erox id es can th em se lv es  in flict further dam age on ce lls . L ipid p eroxide sp ec ies  
m alon d ia ld eh yd e (M D A ) and 4 -h yd roxya lk en y ls (H A E ) can be detected  by tw o  variations 
on the sam e assay , the first o f  w h ich  is sp ec ific  for M D A  and the secon d  that is  less  
sp ec ific  for M D A  but a lso  detects H A E . C ells  w ere treated for 48  hours w ith  5 pM  Cu- 
4 x G ly , 50  pM  C u -4xG ly , 2 0 0  p M  G ly, 50  pM  CUSO 4 , or left untreated. T hese  
concentrations w ere d ecid ed  by con sid erin g  v iab ility  d ifferen ces b etw een  the G FP-PrPc 
and G FP-G PI c e lls  (figure 5 .1 1 ), and concentrations at w h ich  copper m ay occur  
p h y sio lo g ica lly . C ells  w ere co llected  by centrifugation  and w ash ed , before  
h o m ogen isa tion  in 2 0  m M  phosphate buffer (pH  7 .4 ). The assays w ere carried out u sing  
the B io x y tech  ®  L P O -5 8 6 ™  kit from  O xis R esearch.
S ign ifican t concentrations o f  lip id  peroxidation  m arkers w ere o n ly  seen  in the G FP-G PI 
c e lls  in resp on se  to 50 p M  CuSCL (F = 3 .9 , p = 0 .0 4 ). S ign ifican t increases in  peroxidation  
m arkers w ere not seen  w ith  the equivalent concentration  o f  C u -4xG ly . The ch ela tion  o f  the
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Cu ion by the glycine may prevent it changing redox states, which would cause oxidative 
stress and lipid peroxidation of cells, whereas the free copper is not restrained in this way. 
Alternatively the incorporation of Cu into PrP° may occur much more readily when Cu is 
complexed to glycine so PrPc may be able to chelate much more of the glycine bound 
copper than the free copper. Thus allowing free Cu to remain free and induce oxidative 
stress. A further possibility is that the glycine itself is protecting against oxidative stress. 
Glycine has been reported to have the ability the remove reactive oxygen species 
(Senthilkumar et ah, 2003), and so may be removing the reactive oxygen species that Cu 
creates. The glycine on its own showed no significant increase or decrease in oxidative 
stress markers. An anomalous result is seen for 5 pM Cu-4xGly when MDA and HAE are 
measured. Since this is not seen for MDA detection it is likely that HAE markers are 
responsible for this increase and may signify that at low concentrations Cu is able to cause 
oxidative damage even when chelated. This may be due to the cell not activating 
protection mechanisms because the Cu levels are not high enough to be detected as toxic.
The evidence so far suggests that PrPc is able to protect against the oxidative stress that 
free Cu can cause. Direct detection of radical levels is required to confirm that it is acting 
to removing the ROS insult.
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Figure 5.11 Detection of lipid peroxidation markers malondialdehyde (M DA) and 4-hydroxyalkenyls 
(HAE) in G FP-PrPc and GFP-GPI cells following copper treatments. F14 cells stably transfected with 
GFP-PrPc and GFP-GPI constructs were grown to produce approximately 5 x 107 cells per condition at 
the time of extraction. Cells were treated for 48 hours with 5 or 50 pM Cu-4xGly, 50 pM C u S 0 4, 200 
pM Glycine, or left untreated for basal marker levels. Two variations o f the LPO -5861'1 assay 
(OxisResearch®, Portland, USA) were then used to quantify MDA alone or MDA with HAE. 
Significantly increased markers (*) are only seen in the GFP-GPI cell line when treated with 50 pM 
C u S 0 4. Shown are the mean and SEM compared to the untreated values, n = 4 repeats, each of 3 
replicates.
5.3.3 PrPc, Copper, and Direct Detection o f Free Radicals 
T he direct d etection  o f  free radicals a llo w s for the m easurem ent o f  both the ox id ative  stress 
that Cu is ab le to induce and the ab ility  o f  PrP to control cellu lar le v e ls  o f  R O S. T w o  
m ethods w ere em p loyed  to look  for free radicals in sid e ce lls . Individual ce lls  exp ressin g  
G FP-PrPc or G FP-G PI constructs w ere m onitored  u sin g  R ed oxS en sor®  Red stain, 
a llo w in g  the G FP signal and the red signal o f  the probe to be d etected  together, and a 
p opulation  response w as determ ined u sing  C M -H 2 D C F D A  probe.
5 .3 .3 .1  G FP-PrPc, C opper, and Free R adical D etection  by R ed ox  Sensor R ed  
G FP-PrPc and G FP-G PI transfected ce lls  w ere incubated w ith  R ed oxS en sor®  R ed probe 
for 10 m inutes prior to the start o f  the assay. A ssa y s  w ere carried out in O ptiM E M , w ith
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100 pM  C u S 0 4, 100 pM  C u -4xG ly , or 4 0 0  p M  g ly c in e  added at tim e 0 and im ages  
captured at 0, 5, 10, and 15 m inutes. Untreated c e lls  w ere fo llo w ed  in parallel to account 
for basal ch an ges in o x id a tiv e  stress. F I 4 ce lls  w ere a lso  a ssayed  to m onitor the 
d ifferen ces in response that m ight arise due to transfection and se lec tio n  pressure.
0 m in s  5 m in s  lO m in s  15 m in s
F 1 4
G F P -P rP
G F P -G P I
Figure 5.12 Images o f F14 cells and F14 cells stably transfected with GFP-PrPc and GFP-GPI 
constructs stained with redox sensor red probe and incubated for 15 minutes with 100 pM C u S 0 4. 
Images were captured using a Zeiss LS 550 confocal microscope. Increased ROS is seen by an increase 
in signal o f the probe, with the GFP-GPI (null) cells showing a greater increase in signal than the GFP- 
PrP0 (wild type) cells. Scale bar = 20 pm.
A  sign ifican t increase in the in tensity  o f  the redox red sensor is seen  in the F 14 and G FP- 
GPI c e lls  com pared to the G FP-PrPc ce lls  in response to free C u indicating that the 
o x id a tiv e  stress lev e ls  in the PrPc exp ressin g  c e lls  are le ss  a ffected  by  the stress insult 
induced  by C u than G FP-G PI c e lls  (F =  4 .2 3 , p =  0 .043 ; F igure 5 .1 2  and 5 .1 3 ). T herefore  
the PrPc that is present is h elp in g  regulate the o x id ative  con d ition s w ith in  the cell.
A s  seen  for the LPO assay , the C u -4xG ly  and g ly c in e  o n ly  treatm ents had no sign ifican t  
e ffec t on  the intracellular lev e l o f  ox id a tive  stress o f  any o f  the ce ll lin es after 15 m inutes
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Figure 5.13 Quantification of Redox Red probe signal intensity in untransfected F I4 cells and cells 
stably transfected with GFP-PrPc and GFP-GPI constructs treated with A) no reagent, B) 100 pM 
C u S 04 , C) 100 pM Cu-4xGly, and D) 400 pM Glycine. The change in signal intensity (measured at the 
time of image collection by the Zeiss LSM software) is expressed as a ratio o f time point value: time 0 
value, to show the magnitude of signal change comparable to the time 0 reading, n = min 12, max 25 
cells.
5 .3 .3 .2  G FP-PrPc m utants, C opper, and Free R adical D etec tio n  by R ed o x S en so r®  R ed
T o look  at h o w  the different m utants w ere able to deal w ith  the stress insult, the N -
term inally  exp ressed  m utants (A 2 3 -3 8 , A 5 1-89 , A 67-89 , A 1 1 2 -1 1 9 ) w ere stained w ith  the
redox sensor probe and the assays carried out as described  above. O nly the N -term inal
m utants w ere exam ined  due to the internal loca lisa tion  o f  the C -term inal m utants
interfering w ith  the redox red signal (see  Section  4 .1 .2 ).
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0 m in s 5 m in s 10 m in s 15 m in s
G FP-PrP
A 2 3 -3 8
A 5 1 -8 9
A 6 7 -8 9
A l l  2 -1 1 9
Figure 5.14 F14 GFP-PrPc and cell surface F14 GFP-PrPc mutants stained with redox sensor red and 
incubated for 15 minutes with 100 pM C u S 0 4. Images were captured at 0, 5, 10, and 15 minutes using 
a Zeiss LS 550 confocal microscope. Deletion o f the octameric repeat domain (A51-89) showed the 
greatest increase in probe signal with the other mutants unaffected. Scale bar = 10 pm.
A n  increase in o x id ative  stress is  seen  in the ce lls  exp ressin g  the d eletion  o f  the octam eric  
repeat reg ion  (A 5 1 -8 9 ), sh ow n  by sign ifican tly  increased  probe in tensity  in response to Cu  
treatm ent (F =  6 .5 8 , p =  0 .0 0 8 ). The rem aining m utants, d e le tion s o f  the far N -term inus  
(A 2 3 -3 8 ), all but one octam eric repeat (A 6 7 -8 9 ) and the palindrom ic reg ion  (A 1 1 2 -119), 
sh ow ed  no sign ifican t increase in ox id ative  stress com pared  to the G FP-PrP construct (see  
figure 5 .1 4  and 5 .1 5 ). C u -4xG ly  and g ly c in e  o n ly  treatm ents sh ow ed  no sign ifican t change
; Pgfeli- wc V
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in  the leve l o f  intracellular free radicals in any o f  the ce ll lin es  (figure 5 .15  c and d 
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Figure 5.15 Quantification of Redox Red probe signal intensity in F14 GFP-PrPc and cell surface 
mutant cell lines, in response to A) no treatment, B) 100 pM C u S 04 , C) 100 pM Cu-4xGly, and D) 400 
pM Glycine. The change in intensity (as recorded by the Zeiss LSM software at the time of image 
collection) is expressed as a ratio o f time point value: time 0 value, to show the magnitude o f the signal 
change com parable to the time 0 reading. A significant increase in intracellular oxidative stress is seen 
only with the deletion o f the octameric repeat domain (A51-89) in response to the free Cu insult, n = 
min 12, max 25 cells.
5 .3 .3 .3  F 14  and F21 ce lls , C opper, and Free R adical D etection  by D C F D A  A ssa y
F 14 and F 2 1 c e lls  w ere used  to look  at the e ffec t o f  PrPc on the R O S caused  by Cu. C ells
w ere prepared in m icrotitre p lates, stained w ith  C M -H 2 D C F D A  probe, and reagent (1 0 0
p M  C u S 0 4 , 100 pM  C u -4xG ly , 4 0 0  pM  G ly) w as added at tim e 0, w ith  readings taken by
a flu o rescen ce  m icroplate reader at tim e 0, 30  m inutes and 2 hours.
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The background rate of conversion of the probe to a fluorescent signal by ROS is 
significantly higher in the F14 (PrP null) cells than in the F21 cells (F = 6.17, p = 0.006; 
figure 5.16a), demonstrating that the F14 cells are unable to deal as well as the F21 cells 
with the ROS produced during metabolism and so suffer a greater basal level of oxidative 
stress than the F21 cells. The presence of ROS rises in the F14 cells F21 cells treated with 
free Cu (figure 5.16b), this is significantly greater in the F14 cells (F = 26.62, p < 0.001). 
No increase in the levels of ROS above basal metabolism is seen for either treatment with 
Cu-4xGly (F = 0.13, p = 0.72) or glycine alone (F = 0.02, p = 0.884), and these treatments 
appear to reduce the difference in stress levels between the cell lines, an effect that may be 
due to protection against the free radicals by glycine (figure 5.16c and d respectively).
As for the individual cell data from the redoxsensor® red probe, this data is in agreement 
with the LPO results for oxidative stress markers, which showed that significant markers 
were seen for the null cells in response to free Cu but not for the Cu-4xGly. This data 
shows that endogenous PrP° directly protects against oxidative stress induced by increased 
Cu levels, and also that PrPc helps control free radical levels within the cell during normal 
respiration.
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Figure 5.16 F14 and F21 cell oxidative stress measured by DCFDA assay when cells are A) untreated, 
or treated from time 0 with B) 100 pM C u S 04 , C) 100 pM Cu-4xGly, or D) 400 pM glycine alone. 
The increase plotted has been calculated as a ratio of time point value:tim e 0 value, to show the 
m agnitude o f the increase comparable to the time 0 reading. Shown are the mean and SEM. n = 5 
repeats, each o f 6 replicates.
To ensure that the C u -4xG ly  w as unable to induce ox id a tiv e  stress and that there w as not a 
tim e d elay  in radical production  F 14 and F21 c e lls  w ere treated w ith  100 p M  C u -4xG ly  for 
24 , 4 8 , 7 2 , or 96  hours, or left untreated, then assayed  u sin g  the C M -F ^ D C F D A  assay  to 
look  for ch an ges in the ox id ative  stress lev e ls  o f  the ce lls . R esu lts  are sh ow n  in Figure  
5 .1 7 , and are corrected for v iab ility  o f  the ce lls .
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Figure 5.17 F14 and F21 cells were treated for 0, 24, 48, 72, or 96 hours with 100 pM Cu-4xGly, then 
intracellular oxidative stress levels were measured by DCFDA assay. The level o f ROS plotted has 
been calculated as a ratio o f time point value:time 0 value, to show the magnitude o f the change 
com parable to the time 0 reading. Shown are the mean and SEM. No significant change in oxidative 
stress is seen (F = 0.6, p = 0.44). n = 4 repeats, each of 6 replicates.
S in ce  C u -4 x G ly  is not inducing o x id ative  stress at any tim e point but the concentrations  
used  caused  sign ifican t death by four days (se e  section  5 .1 ), it is un lik ely  that the 
m ech an ism  by w h ich  PrPc protects against bound copper is rem oval o f  an o x id a tiv e  stress  
insult. Instead it is lik ely  that the protection  that PrPc exh ib its  against copper induced  cell 
death, w h en  copper is adm inistered as a chelate, is due to the ab ility  o f  PrP to bind the 
m etal ion  thereby preventing copper ion s b inding to and denaturing cellu lar proteins 
resu lting in c e ll cy c le  arrest and ce ll death.
T he potential for PrPc to regulate lev e ls  o f  R O S in response to 50p M  M n S 0 4 , w h ich , like  
copper, is a h ig h ly  reactive redox m etal, w as in vestigated . A lso , to determ ine i f  PrPc cou ld  
act against a direct R O S insult, and not ju st prevent o x id a tiv e  stress by m etal binding, 
ox id a tiv e  stress w as induced using  1 % D M S O , 2 0  m U  xanth ine ox id ase , and a lso  100 pM  
hydrogen  perox id e, w h ich  is an extrem ely  potent R O S releasin g  agent (figure 5 .1 8 ).
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Figure 5.18 ROS detected in F14 and F21 cells in response to Mn, and agents inducing oxidative stress. 
Cells were treated for 2 hours with (A) Mn, (B) DMSO, (C) xanthine oxidase and (D) hydrogen 
peroxide. M easurement of ROS was made at time 0, 30 minutes and 2 hours using the DCFDA assay. 
Shown are mean and SEM. n = 5 repeats, each o f 4 replicates for Mn, n = 6 repeats, each of 4 replicates 
for oxidative stress agents.
In addition  to the e ffec t o f  Cu on intracellular ox id ative  stress lev e ls , M n, D M S O , xanthine  
o x id a se  and hydrogen  peroxide all cause an increase in o x id a tive  stress in both ce ll lines. 
T he F21 c e lls  sh ow ed  a m uch lesser  increase in R O S com pared to the F I 4 ce lls  in response  
to the M n and hydrogen  p eroxid e insu lts, h ow ever  th is p rotective e ffec t w as not as ev ident  
against the D M S O  and xanthine ox id ase  insu lts, m ost lik e ly  due to these reagents 
producing a le ss  potent insult.
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5.4 Conclusions
The high conservation of the copper-binding octameric repeat region across all 
characterised mammalian species (Wopfner et al., 1999), suggests that copper binding is 
fundamental to PrPc function. Previous studies have found PrPc protects neurones against 
copper toxicity (Brown et al., 1998; Brown, 2004; Nishimura et al., 2004), leading to the 
hypothesis that PrPc is involved in cellular protection against metal ion fluctuations. 
Furthermore, PrPc has been shown to have superoxide dismutase-like activity when copper 
is bound (Brown et al., 1999; Wong et al., 2000; Brown et al., 2001), resulting in the 
development of the highly controversial theory that the function of PrPc is as an anti­
oxidant.
The data presented here clearly show that PrPc protects against toxicity induced by copper 
and oxidative stress. The protective effect against copper is much more pronounced when 
copper is delivered to PrPc via a carrier such as glycine. In biological systems copper is 
chelated by chaperones or amino acids to protect against its high toxicity, and so is rarely 
found in a free or unbound form, therefore these findings are consistent with a protection 
effect that would be physiologically relevant. However, the studies on PrP° protection 
against free radicals on exposure to copper and copper-glycine showed that changes in free 
radical levels were only seen when free, unbound copper was applied to the cells. The 
copper-glycine did not induce oxidative stress in the null cells despite being significantly 
more toxic to the cells than the free copper. Therefore, protection against copper is not just 
against the oxidative stress that copper can produce by switching redox states, it is against 
the metal ion itself.
The cause of this non-oxidative toxicity of copper when presented as a chelate may be due 
to increased incorporation into incorrect cellular proteins. Copper is more efficiently 
delivered into PrPc when presented as a chelate (Brown, 1999). It is likely that chelated 
copper ions are also more efficiently delivered into other copper-binding proteins than free 
ions, saturating cellular copper storage mechanisms and resulting in copper incorporation 
into proteins that would, under standard physiological conditions, bind other metal ions. 
Predki and Sarkar (1992) showed that copper could be substituted for zinc in zinc finger 
proteins and by doing so ablates their function. Chelation of copper is known to increase 
uptake by neurones (Hartter & Bamea, 1988), therefore it is likely that more copper is 
being transported inside the cells and so can bind to intracellular proteins. Other
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m ech an ism s by w h ich  copper is su ggested  to cause to x ic ity  included  altering energy  
m etab o lism  and g ly c o ly s is  (Lai & B lass, 1984), and by form ation o f  cupric salt crystals, 
w h ich  cou ld  dam age cellu lar organ elles (Johnson  & C am pbell, 1982).
T he reg ion s o f  PrPc im portant for protection  against the copper, D M S O  and xanthine  
o x id a se  insu lts are illustrated figure 5 .19 . W hen the d ifferent insu lts are considered  
together, d eletion  o f  the sam e reg ion s repeatedly reduces PrPc activ ity . In agreem ent w ith  
p rev iou s stud ies (B row n et al., 2001; Z eng et al., 2003; Sakudo et al., 2 0 0 3 ), the octam eric  
repeat dom ain  is essen tia l for the protective function  o f  PrP°. S in ce  the protection against 
copper to x ic ity  is im paired in the ab sen ce o f  the octam eric repeat dom ain  this reg ion  is 
ev id en tly  im portant for PrP° function . The fifth  copper-b ind ing  site, although still intact, is 
unable to com p en sate  for this e ffect. T his su ggests that the PrP° protective response  
against copper requires m ore than one copper m o lecu le  to be chelated  in the N -term inal 
region . In addition , the anti-oxidant activ ity  o f  PrPc is d im in ish ed  in the absence o f  Cu  
b ind ing  to the octam eric repeat reg ion  (B row n  et al., 1999), therefore in the absence o f  the 
octam eric repeats a lack  o f  function  w ou ld  be exp ected . T his w as observed  in these  
exp erim en ts. T he observation  that w h en  ju st on e repeat is  present p rotective ability  is 
restored is a lso  in d icative o f  the im portance o f  th is region  for the function  o f  the protein.
N-terminal signal Octameric repeat Hydrophobic GPI anchor signal




Figure 5.19 Domains of PrPc important for protection against copper, DM SO, and xanthine oxidase 
insults.
D ele tin g  the hydrophobic region  or part o f  it im pairs PrPc function  in response to C u or 
o x id a tiv e  stress. T his reg ion  has p rev iou sly  been  sh ow n  to be essen tia l for PrPc activ ity  
(C ui et al., 2 0 0 3 ). I f  the cellu lar protection  sh ow n  by PrPc is an en zym atic  response the 
rem oval o f  the hydrophobic region, w h ich  is lik e ly  to be at the core o f  the protein, w ou ld
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be likely to result in destabilisation of the tertiary structure (see chapter 4), so affecting the 
active site and preventing the protein from functioning properly. Alternatively this region 
may be a radical binding site for a chelation function, or may mediate binding to other 
cellular proteins to commence signal transduction cascades that might result in activation 
of cellular protection factors.
Deletion of amino acids 23-38 reduced PrPc protection against DMSO, but not xanthine 
oxidase or copper. This region has been suggested to be involved in PrPc internalisation 
(Sunyach et al., 2003). DMSO is highly cell permeable, therefore it may penetrate the cell 
and cause damage. The A23-38 mutant may be unable to internalise quickly enough to 
protect the cell. This would not be the case for xanthine oxidase or copper where the 
insults could be mostly removed at the cell surface.
In conclusion, the data presented shows PrPc is able to protect against cellular injury from 
copper, manganese and oxidative stress. Defence against copper is due to both protection 
against non-oxidative toxicity of the metal ion itself, and prevention of oxidative stress 
induced by redox changes that the metal ion can undergo. The protective ability of PrPc 
against copper and oxidative stress requires the octameric repeat domain and the 
hydrophobic region. In addition, the N-terminus may play a role in defence against 




There is a lack of knowledge on the regulatory control of PrP° expression at the genetic 
level and, despite much investigation, no consensus concerning the function of PrP°. This 
study aimed to reveal the mechanisms of gene control at the DNA level, and to further the 
knowledge of the metabolism and properties of PrPc. Ultimately, this study endeavoured 
to provide clues as to the true function of PrP° and offer potential pathways for therapeutic 
intervention in TSE pathogenesis.
6.1 Prnp and Tissue Specific PrPc Expression and Regulation
The control of prnp is complex. It involves control elements in the pre-exon 1 promoter 
region, requires intron 1 for full activity, and responds to certain cellular stresses via heat 
shock elements found in the region of DNA preceding the promoter region (Baybutt & 
Manson, 1997; Inoue et al., 1997; Shyu et al., 2000; Shyu et al., 2002; Premzel et al., 
2005). In addition, this study has shown that intron 1 may have its own promoter activity, 
sufficient to drive the production of PrP mRNA lacking exon 1. In bovine prnp this 
alternative transcription is possibly initiated by the presence of a TATA box, a motif that 
had not been found previously in the PrP gene of any characterised species (Basler et al., 
1986; Westaway et al., 1994; Inoue et al., 1996; Saeki et al., 1996; O’Neill et al., 2003). 
To determine the importance of the TATA motif in the production of an mRNA transcript, 
mutational studies to remove the important bases could be used to look for reduction or 
elimination of the transcript lacking exon 1. An additional finding of this study is that 
exon 1 may be involved in prnp regulation either at the gene or mRNA level. The precise 
nature of exon 1 in the control of PrP° expression is an area of further study.
The construct containing the full-length prnp promoter plus non-coding region differed in 
expression levels in the different cell types studied. Intron control elements have been 
implicated in tissue specificity, implying that the importance of the intron 1 control region 
may lie in tissue specific expression of PrPc. PrP° is expressed at different levels in 
different tissues, with the highest expression found in tissues of the central nervous system.
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This variation is involved in disease propagation and pathology (Brown et al., 1994; 
Brandner et al., 1996; Scott et al., 1989; Fischer et al., 1996). Differences in genetic 
regulation may account for tissue specific expression, however PrPc half-life also differs 
across different tissues (Caughey et al., 1989; Borchelt et al., 1990; Parizek et al., 2001; Li 
et al., 2003), which may contribute to the different PrPc levels. Consequently, not only the 
genetic regulation of prnp, but also protein metabolism of PrPc is influenced by the 
underlying cell type. Expression level and turnover may be related to PrPc function. In 
tissues where PrPc is less required, it may persist for longer than in tissues where it is 
highly functionally active and requires rapid replacement.
The intron 1 control region may be involved in gene activation in response to various 
stresses. This study shows that wild type mouse neuroblastoma fusion cells, mouse 
myoblasts, and monkey kidney cells expressing the bovine complete non-coding region, 
and human neuroblastoma cells expressing just intron 1 and exon 2  of the non-coding 
region are up-regulated in response to copper, despite the full length construct showing no 
change in activity in any of these cells lines. Mouse PrPc knock-out neuroblastoma fusion 
cells expressing either of the above constructs showed up-regulation to a DMSO insult, as 
did the mouse myoblast cells expressing intron 1 and exon 2 only. This suggests that this 
region could be important in stress associated prnp regulation in certain cell types. 
Activation of these control mechanisms may only happen on PrPc depletion, when the cell 
becomes vulnerable to the insult and so activates transcription via up-regulation of stress 
associated transcription factors. Additionally, hamster prnp usually transcribes a two-exon 
splice variant, however the emergence of a three-exon splice variant has been found during 
infection (Li & Bolton, 1997). Therefore, the intron 1 region may have a role in splicing, 
with stress altering the splice variant produced. Further studies should aim to determine 
the specific regions of prnp, and the control elements contained within these regions, that 
are important for alteration in gene activity in response to stimuli.
From the data presented in these studies it is not possible to conclude if the different 
responses to stimuli seen across the cell lines are due to the transfection of bovine as 
opposed to murine prnp. Experiments are currently underway to establish if murine prnp 
constructs behave in the same way as the bovine constructs. This is especially important 
since four of the host cell lines are murine and the variation in genetic responses seen 
cannot be attributed to changes in prnp activity, but may instead be a confounding factor 
introduced by the underlying species difference.
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6.2 Prnp, PrPc and Copper
PrPc is a copper binding protein, with up to five copper molecules coordinated within the 
unstructured N-terminal region. Four copper molecules may be bound by the octameric 
repeat domain and a further copper molecule is potentially bound by a fifth site located 
immediately C-terminal to the octameric repeat domain (Homshaw et al., 1995; Brown et 
al., 1997; Jackson et al., 2001). Previous studies have shown that copper regulates prnp 
(Toni et al., 2005; Varela-Nallar et al., 2005), however the two studies report opposing 
effects, with down-regulation seen by Toni et al. and up-regulation by Varela-Nallar et al. 
This study finds that cells deficient in PrPc up-regulate prnp in response copper, but unlike 
the above previous studies, no effect of copper was found on any of the cell lines that 
endogenously expressed PrPc. In this study, however, copper was applied as copper 
sulphate, unchelated, so it may not have been delivered into the cell as efficiently as when 
applied bound to a chelator. Evidence suggests that copper is more efficiently incorporated 
into PrPc when it is delivered via a chelator (Brown, 1999; Ji & Zhang, 2004). In the study 
by Varela-Nallar et al. (2005), where an increase in promoter activity was observed in 
response to copper, the copper was applied as a glycine chelate and produced a reaction at 
lower concentrations than those that were used here, 50 pM as opposed to 100 pM. 
Therefore, to further these studies, copper applied with glycine should be studied. Up- 
regulation of prnp in response to copper-glycine in the Varela-Nallar et al. study may not 
directly involve copper incorporation into PrPc, but rather may be due to the greater 
toxicity of the chelated copper as opposed to free copper to the cells. This is supported by 
the findings of the current study where only the null cells were seen to respond by up- 
regulation of prnp in response to copper. This may cause the cell to initiate a greater 
protective response than that required to deal with a free copper insult, including an 
increase in prnp promoter activity.
The importance of chelation for copper incorporation into PrP° is seen in the copper 
induced internalisation reaction. Cell surface PrPc is internalised much more rapidly when 
copper is applied as a glycine chelate. In addition, data from cellular viability assays 
comparing PrPc null and wild type cells shows that PrPc can efficiently protect against 
chelated copper, which is significantly more toxic to null cells than free copper.
When chelated with glycine, copper induced PrPc internalisation is significant at 
concentrations as low as 5 pM CUSO4 . This is within normal extracellular copper
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concentrations. At 20 p,M this reaction is significant after just ten minutes exposure. 
Copper concentrations at the synapse are reportedly around 15 pM when the neurone is in 
its polarised resting state and can rise to over 100 pM on depolarisation (Vassallo & 
Herms, 2003). This suggests that PrP° is quickly turned over or recycled at the synapse 
under resting conditions of the neurone, and on depolarisation would be internalised even 
more rapidly. The fate of internalised PrPc is less clear. It is directed inside the cell, but 
may be trafficked to recycling, early or late endosomes, or to the golgi (Borchelt et al., 
1993; Shyng et al., 1994; Magalhaes et al., 2002). The destination of PrP° may be 
influenced by the concentration of exogenous copper. Under low copper conditions, 
internalisation may result in targeting of PrPc to recycling endosomes where it can be 
stored for future use. Under high copper conditions, it may be internalised too rapidly to 
be directed to one specific site within the cell. This could result in cell surface PrPc being 
sent back into the recycling pathway but also a significant quantity being diverted for 
destruction by lysosomes or the proteasome. If this were the case, it is likely that the 
promoter would be up-regulated in the event of sustained copper insult, as the cellular 
levels of PrPc become depleted and cells are less able to cope with the insult.
Exogenous concentrations of metal ions are altered during the disease pathogenesis (Wong 
et al., 2001b). Perturbations include decreased copper, iron, magnesium and calcium, and 
increased manganese. It is unclear if these variations are the result of or caused by disease 
pathogenesis. The metal ion perturbations seen during disease pathogenesis could alter 
prnp activity and might be considered for further investigation. Also, the effects of 
prolonged metal ion exposure on gene activity could be investigated in the future.
In contrast to previous studies that find the far N-terminal amino acids 23-38 of PrPc are 
essential for internalisation (Shyng et al., 1995; Nunziante et al., 2003; Sunyach et al., 
2003), the data presented here show that the octarepeats and the palindromic region 
override requirement for the far N-terminus for PrPc trafficking. The difference between 
the results presented here and those seen previously for the N-terminal trafficking may be 
due to inherent limitations of a GFP-fusion protein system. The inclusion of a large tag 
such as GFP within a protein may affect its structure, metabolism or processing. The GFP 
tag was inserted into the N-terminal, unstructured region of PrP° to avoid the structural 
changes that might arise had it been inserted into the structured C-terminus. The C- 
terminal antibody (5C3, Li et al., 2000) used to detect internalised GFP-PrPc in the PrPc 
trafficking studies is unable to detect synthetic peptides, and so is likely to be directed
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against an epitope formed by correct folding of PrP°. This indicates that the GFP tag is not 
interfering with the folding of the C-terminus. The GFP-PrPc construct is correctly 
expressed at the cell surface so under normal conditions the processing of the protein is not 
affected, and GFP-PrPc is internalised in response to copper as is seen for the untagged 
PrPc, in agreement with the processing of PrPc reported previously (Pauly & Harris, 1998; 
Brown & Harris, 2003). However it was still possible that the tag might alter processing 
related to the N-terminus. For this reason the immunofluorescent staining was carried out 
on the A23-38 mutant without the GFP tag. This showed that the GFP might be interfering 
with the processing of the mutant. The GFP tagged mutant was observed predominantly at 
the cell surface, whereas the untagged mutant was retained within the cell in a pattern that 
indicated it was in the membranes of organelles throughout the cell. This difference may 
be due to GFP in intracellular organelles fluorescing less intensely than cell surface GFP 
due to organelle acidity quenching the signal. The intracellular immunofluorescent 
staining pattern of the A23-38 mutant seen in this study also contradicts the previous 
studies on the role of the N-terminus in PrPc trafficking. These previous studies reported 
that deletion of this region stopped PrPc internalisation, but in the current study A23-38 
PrPc was retained within the cell. Therefore little could be concluded from its response to 
copper. The contrast seen may be due to experimental methods. The studies previously 
reporting the effect of N-terminal deletion on PrP° trafficking may have used un- 
permeablised cells, preventing the anti-PrPc antibody from staining mutant PrPc retained 
within the cell, and instead only the fraction of mutant PrP° that reaches the cell surface 
would be observed.
The mechanism of PrPc internalisation may be altered by increased copper concentration. 
The importance of the palindromic cleavage site suggests that PrPc may be internalised not 
in its complete form but, instead, after cleavage by proteases at the cell surface. The 
requirement for the palindromic region for PrPc trafficking from the cell surface in 
response to copper seen in the present study has not been shown previously. This cleavage 
site is associated with normal, non-disease related cleavage of PrPc. At the cell membrane 
PrPc is localised to lipid rafts (Mahfoud et al., 2002; Brugger et al., 2003). The N-terminal 
amino acids may have a function directing PrPc out of lipid rafts for internalisation via 
clathrin-coated vesicles (Taylor et al., 2005). The C-terminus and GPI anchor may hold 
PrPc in lipid rafts, while cleavage at the palindromic region could release the N-terminus. 
This would allow the N-terminus to move out of the lipid raft domain and be internalised 
by the clathrin-mediated pathway. The data presented in this study followed the path of N-
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terminally-GFP tagged PrPc, or untagged PrPc with an N-terminally directed antibody. 
Therefore, from the current data, it is not possible to determine if the N-terminus alone is 
directed into the cell. The C-terminus may control the cellular position of the structured 
region of PrPc (Kaneko et al., 1997), causing it to be retained at the cell surface for a yet 
undetermined function. Alternatively, since the C-terminus is required for calveolae- 
mediated internalisation (Peters et al., 2003), the two fragments of PrPc may be 
internalised by different pathways, and potentially sent to different destinations. 
Disruption of lipid rafts and therefore caveolae-mediated internalisation could be used to 
determine the importance of this mode of internalisation. Caveolae-mediated 
internalisation may account for the differences observed for the N-terminal A23-38 mutant, 
as clathrin-mediated internalisation may have been blocked, and therefore the protein 
would be directed into other pathways for internalisation.
Although the above hypotheses explain some differences between the results presented 
here and those of other groups, they do not clarify the role of copper. Copper may increase 
cleavage of PrPc, perhaps by inducing structural changes within the N-terminus allowing 
exposure of the palindromic cleavage site to proteases. This might increase the rate of 
internalisation of the N-terminus, thus directing more copper inside the cell. Clathrin 
mediated endocytosis usually occurs via the classical endocytic pathway, where PrPc 
would be directed to acidic vesicles and so might release copper. From the acidic vesicles, 
copper could be directed back out of the cell by incorporation into cellular exocytotic 
vesicles, such as synaptic vesicles, and then released back into the surrounding 
environment. This is supported by a previous study by Brown (1999), who found that 
copper up-take and release at the synapse directly correlated with the expression of PrPc. 
Following internalisation, the cleaved PrPc would have served its function as a copper 
transporter and so would then be targeted for destruction. Degradation of PrPc following 
cleavage is likely to require concomitant up-regulation of prnp to maintain cellular PrPc 
levels. This is could explain copper mediated up-regulation of the promoter seen in this 
study and by Varela-Nallar et al. (2005). Alternatively, if the function of PrPc were to be 
delivery of copper into cellular enzyme systems, it might respond to decreased copper 
concentrations by up-regulating gene activity and protein to allow the maximal collection 
of copper from the surrounding environment.
Copper may also mobilise PrP° under conditions where cell surface PrPc is depleted or 
unable to bind copper. The A51-89 mutant was seen to accumulate at the cell surface in
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response to copper. To determine if copper alters trafficking to the cell surface as well as 
away from it, wild type cells could be pre-treated with phospholipase C or D to remove 
GPI anchored proteins from the cell membrane, and the appearance of PrPc at the surface 
could then be monitored with and without increased exogenous copper.
The presence of PrPc significantly protects the cells from copper. Cell viability assays 
showed that PrPc significantly protected wild type cells against cell death induced by 
glycine chelated copper compared to PrPc null cells. Glycine chelated copper treatment of 
PrPc null cells did not produce the significant increase in ROS that free copper was able to 
induce. Therefore, protection against copper toxicity is not just against the oxidative stress 
that results from copper redox activity, but also against the metal ion itself. The protective 
effect may be due to the chelation of the copper ions within the octameric repeat region of 
PrPc, or due to initiation of wider cellular protection mechanisms. For both copper induced 
internalisation and protection against the copper ion insult, the intact octameric repeat 
domain is required. This suggests that the binding of copper to this region is central to 
PrPc function. Support for this is provided by previous studies, which have shown that 
disease associated mutation of the octameric repeat region has adverse effects on PrPc 
copper induced internalisation (Perera & Hooper, 2001). Furthermore, PrPc protective 
ability is diminished in the absence of the octameric repeat domain (Brown et al., 2001; 
Sakudo et al., 2003). Only one repeat is required to restore PrP° trafficking and protection, 
albeit at a depleted level, emphasising the importance of this region.
The lack of activity when the octameric repeat region is missing suggests that the fifth 
copper-binding site is either not involved in this function or unable to coordinate copper 
correctly without some of the amino acids of an octarepeat. Brown et al. (2001) showed 
that at least two coppers ions need to be co-ordinated to the octameric repeat region for 
significant antioxidant activity, therefore one full repeat and the fifth site together may 
bind two copper molecules and restore PrPc protective function and trafficking. A recent 
study suggests that in the absence of the octameric repeat domain, the fifth site has 
enhanced copper binding activity (Thompsett et al., 2005). With just one repeat present, 
incorporation into the fifth site may be stronger than in the presence of the entire domain, 
allowing it to partially compensate for the lack of the remaining repeats. Mutational 
studies of the fifth site in the presence of a single octameric repeat would clarify this point.
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The finding that the hydrophobic region of PrP° is necessary for both its correct cellular 
processing and for function is not unexpected. Hydrophobic domains stabilise the 
structure of proteins by forming the core. In the absence of this region, the protein would 
not be expected to fold correctly and so would be redirected into cellular degradation 
pathways, such as ERAD, for destruction. Incorrectly folded protein is unlikely to retain 
structural features essential for function such as enzymatic active sites, and so would be 
expected to lack normal function. However, a study by Cui et al. (2003) has shown that 
these deletions do not significantly affect the secondary structure of PrPc, with the mutant 
proteins expressing similar alpha helical content to the wild type. Therefore any effect that 
these mutations have on PrPc structure would have to be at the tertiary level, which could 
still produce the same lack of function.
As previously stated, PrP° protection against copper is directed against both oxidative 
stress caused by processes such as the Fenton reaction and also against the copper ion 
itself. These experiments are the first to show that PrPc protects against non-oxidative 
toxicity. The protection provided by PrPc against oxidative stress caused by free copper is 
rapid, in agreement with the internalisation studies that saw copper significantly internalise 
PrPc within 10 minutes at concentrations of 20 pM or greater. Direct incorporation of 
copper into PrPc may be part of PrPc protective ability, but direct protection against free 
radicals may also be involved. This protection may be enzymatic, with PrP° protecting by 
SOD like activity, or it may be a result of PrPc having a high affinity for certain ROS and 
effectively mopping up the free radical insult before it can damage the cell. Further work 
would need to establish non-oxidative mechanisms by which chelated copper damages the 
cell, and thus determine how PrPc is able to protect against these mechanisms. The 
requirement of the octameric repeat domain for the protection response strengthens the role 
of copper binding as the protective mechanism. However the hydrophobic domain, which 
causes relocation of PrPc within the cell, also impairs the survival of copper treated cells. 
This may be a result of PrPc not reaching the cell surface and so not being able to sequester 
copper before it can cause damage to the cell. Alternatively, it may be that the PrPc 
hydrophobic core contains or stabilises an active site that is essential for its protective 
function.
The regions of PrPc identified as important for metabolism and function are shown in 
figure 6.1.
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Figure 6.1 Cellular processing and function o f PrPc. The domains identified as important by the 
current study have been circled in red at the site where they are found to be relevant.
6.3 Prnp, PrPc and Oxidative Stress
PrPc has p rev iou sly  been  su ggested  to have a role in the protection  against cellu lar  
o x id a tiv e  stress and PrPc it s e lf  has been  found to have superoxide d ism utase like activ ity  in 
the p resen ce o f  bound copper (B row n  et al., 1999; B row n et al., 2 0 0 1 ). D ata presented  
here sh ow  that PrPc null ce lls  have higher basal lev e ls  o f  R O S su ggestin g  that PrPc has a
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role in modulating cellular antioxidant activity in unstressed cells. Oxidative stress 
induced by DMSO was found by this study to up-regulate the prnp promoter. Wild type 
PrPc expressing cells showed increased survival in response to oxidative insults induced by 
DMSO and xanthine oxidase than PrPc null cells. The increased survival is most likely to 
be due to the ability of PrPc wild type cells to maintain lower intracellular levels of free 
radicals after insults from DMSO, xanthine oxidase and hydrogen peroxide compared to 
null cells. This data supports a role for PrPc in dealing with cellular oxidative insults.
Deletion studies showed that the octameric repeat domain was essential for this protection. 
It is likely that the need for copper binding is the reason for the requirement of this domain. 
Similarly to the internalisation studies, function is restored in the presence of just one 
repeat. The hydrophobic domain is also required for this protection. However, in contrast 
to the internalisation studies, the deletion of the palindromic region alone does not abolish 
the protection against oxidative stress. This suggests that cleavage of this site may be less 
important for protection against oxidative stress insults.
A recent study by Watt et al. (2005) proposed that cleavage of cell surface PrPc at the 
second cleavage site found at the end of the octameric repeat domain (amino acids 88-89 in 
mice) was the first step in the activation of a PrPc mediated signal transduction cascade, 
which could result in the up-regulation of cellular stress proteins. This form of cleavage 
has previously been associated with disease due to increased cleavage products being 
found in infected brains (Chen et al., 1995). In disease, the C-terminal fragment produced 
by this cleavage is protease resistant, however the fragment produced in response to 
oxidative stress is not (Watt et al., 2005). Watt et al. find that mutation of the alanine 
residue at amino acid position 116 to valine (A 116V) inhibits cleavage at the end of the 
octarepeat region in response to oxidative stress. This indicates that residues of the 
palindromic region may be required for the second cleavage and the authors suggest that 
the interaction of the alanine (116) with the copper bound octameric repeats is likely to 
initiate cleavage. This is in contrast to the results presented here, which do not find that 
the palindromic region is necessary for protection against oxidative stress. However, the 
octameric repeat domain is required. In its absence the loss of copper binding and 
removal of the cleavage site at the C-terminus of the repeats may prevent correct 
processing in response to oxidative stress, and thus prevent activation of any protective 
cascade. The N-terminus enhances the formation of proteinase K resistant PrP (PrPres), as 
shown by Lawson et al. (2001), who find that N-terminally truncated PrPc, whilst still able
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to form PrPSc, does so at a much slower rate. The inability to undergo oxidative stress 
mediated cleavage during the pathogenesis of prion disease could result in impaired ability 
to respond to the insult directly. Alternatively activation of a signal transduction pathway 
could increase gene activity to produce more PrPc to compensate for the insult, providing 
more full length PrPc that might be converted into PrPres. Specific mutation of this 
cleavage site could clarify the importance of processing in the PrPc mediated oxidative 
stress response.
The requirement for the hydrophobic domain suggests that the structure of the C-terminus 
must be intact for its correct function. The high conservation of this structure across 
several species suggests that it is of considerable importance to the function of PrPc. 
Therefore, if following cleavage the C-terminus was to remain on the cell surface, it would 
be likely to perform some function. Watt et al. (2005) suggest that the N-terminus may be 
a signalling molecule, translocated inside the cell in response to the cleavage stimuli, and 
that the C-terminus remains on the cell surface as a receptor. Pathological PrPc mutations 
associated with some TSEs impair PrPc trafficking through the cell, and are retained within 
the ER (Singh et al., 1997; Ivanova et al., 2001; Negro et al., 2001). Likewise the mutants 
with deletions of the hydrophobic region used here were trapped within the ER. If PrPc 
could not be correctly trafficked to the cell surface it would not be able to perform a signal 
transduction function that requires cell surface activation by cleavage. If it has an 
alternative cellular protection function at the cell surface, any mutation that alters 
trafficking to the cell surface or affects that rate of movement away from the membrane 
may impair the ability of PrPc to exert a protective response.
Cleavage of PrP° in response to stimuli may not result in separation of the N-terminal and 
C-terminal fragments. Instead, the two termini may be separate subunits of the complete 
protein, able to bind together and be activated by the cleavage event. In this situation, the 
complete uncleaved PrPc protein could act as a proenzyme. If this were the case PrPc 
would not be the only example of such a protein. Various caspases are synthesized as a 
single-chain zymogen, and activated by cleavage of the protein in a linker region between 
two subunits, in some cases releasing the short linker segment (for review see Stennicke & 
Salvesen, 2000; Shi, 2004). PrPc has two cleavage sites in its putative linker region and so 
could undergo single or double cleavage events. The double cleavage of PrPc in this 
region could potentially release a linker sequence. However this has been considered 
previously and no linker sequence has been found (Watt et al., 2005). In support of an
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interaction between two subunits, a study by Yao et al. (2003) found that the six most N- 
terminal amino acid residues in the mature protein (positions 23-28) interact with amino 
acids 143-146 just prior to the start of helix 1, indicating that the two parts of PrPc could be 
bonded together. This reaction is dependant on the formation of the beta sheet. Epitope 
mapping has also suggested that the N-terminus is able to interact with the C-terminus, 
possibly through the threonine located on the exterior of helix 2 at position 189 of the 
murine protein (Li et al., 2000). This interaction was suggested to be caused by ligand 
binding. These potential interactions and the destinations of the separate termini of 
cleaved PrPc are both worthy of further investigation. Dual antibody labelling of PrPc 
using antibodies directed against the N-terminus and the C-terminus could be used to 
follow the termini on internalisation. Disruption of specific internalisation pathways could 
be used to determine if one terminus will internalise without the other.
6.4 Prnp, Prion Disease, and Disease Management
The aim of determining the normal metabolism and function of PrPc in health is to better 
understand cellular pathways or processes where therapeutic intervention can be used to 
manage disease pathogenesis. The differences in the expression of the murine constructs 
compared to the equivalent bovine constructs in the cell lines studied, and the variation in 
number and location of transcription factor binding sites, shows that, although the gene 
structure is conserved across the two species, the gene sequence shows considerable 
variation. Single nucleotide polymorphisms of the human pre-exon 1 promoter region 
have been associated with sporadic CJD (Mead et al., 2001). Theoretically even point 
mutations of transcription factor binding sites that might allow more potent factors to bind 
the sites could result in higher PrPc expression levels and increased susceptibility to prion 
disease. The lack of conservation of these regions across species may mean that some 
species are at greater risk of prion disease than others. In addition, the Mead et al. study 
found several polymorphic sites within intron 1. Since this region appears to be important 
in prnp regulation, polymorphisms may result in altered gene control and as a consequence 
lead to phenotypes that are more or less susceptible to disease. Studies to identify specific 




During the end stages of the disease, PrP° (or PrPSc) may be regulating itself. Data 
presented here show that PrPc can up-regulate prnp activity significantly in PrPc null cells, 
indicating that regulation is indirect, possibly via interaction with other cell surface 
proteins. The lymphocyte signalling with which PrPc has been associated is activated by 
the lattice of PrPc formed in caps at the cell membrane (Li et al., 2001; Bainbridge & 
Walker, 2005). Exogenous PrPc might interact with the cell membrane to produce a 
similar effect. During the early stages of disease progression endogenous PrP° levels may 
become depleted due to conversion to PrPSc. The loss of function associated with this 
change, as well as altered metal ion concentrations, may result in the cell up-regulating 
prnp. This may cause increased levels of PrPc, increased substrate for the conversion 
reaction, and, by the overall increase in PrP, a further increase in promoter activity causing 
the disease to progress in an exponential fashion. Down-regulating the promoter and 
breaking the cycle could be a very important method of therapeutic intervention. Further 
investigation to determine the method by which PrPc is able to regulate prnp would be 
valuable. It would also be of interest to repeat the current studies with PrPSc to determine 
if its presence in disease can up or down-regulate prnp.
Agents that might alter prnp regulatory pathways resulting in PrPc protein down-regulation 
may have a role in disease management by providing less substrate for conversion into 
PrPSc. Copper modulates prnp activity, but this reaction is variable across different cell 
lines, so it is still unclear if copper modulation of prnp could be useful. Copper chelators 
would have limited application in disease management due to the importance of copper in 
various enzyme systems including SODs. In agreement with previous studies (Rybner et 
al., 1992; Cabral et al., 2002), this work shows that ATRA down-regulates prnp and PrPc 
expression. It is likely to exert its effect by alteration of several transcription mechanisms, 
including modulation of transcription factors involved in cellular differentiation and 
alteration of chromatin structure. Unfortunately the potential side effects to the regulation 
of other genes may make this drug unsuitable for use in TSE patients. Serious side effects 
can be seen in those treated with ATRA for promyelocytic leukaemia, including retinoic 
acid syndrome which may lead to organ failure and death (for review see Larson & 
Tallman, 2003). Therefore it is beneficial to continue the search for a more benign 
treatment for TSE patients.
DMSO has previously been suggested as a potential therapeutic agent for TSE treatment 
due to findings that the accumulation of PrPSc and disease progression was delayed in
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DMSO treated hamsters (Shaked et al., 2003). This is in contrast to the data presented 
here, which show that prnp is up regulated in response to DMSO. An agent that up- 
regulates PrPc expression would be expected to provide more substrate for conversion and 
therefore would be unsuitable for use in disease therapy. This highlights the difficulty in 
using a multifaceted agent such as DMSO. Agents with a more unambiguous mode of 
activity may be more suitable for trial.
Factors that could maintain low cellular levels of oxidative stress may down-regulate the 
activity of prnp and result in a decrease in the quantity of PrPc protein produced by the 
cell. Antioxidant replacement could also counteract decreased activity of cellular SODs 
seen during disease pathogenesis due to aberrant metal metabolism. Mitochondrial 
SOD/SOD2 synthetic mimetics that can cross the blood brain barrier have been shown to 
protect SOD2 null mice against spongiform encephalopathy that results due to the null 
phenotype and may have a potential use in treatment of prion diseases (Melov et al., 2001). 
Agents such as this should be further investigated for potential therapeutic uses.
6.5 Concluding Remarks
This study aimed to further understanding of the genetic regulation, metabolism, and 
function of PrPc. Prnp was studied to consider regions of the gene important for activity, 
regulation of expression across different cell lines, and gene activity in response to stimuli. 
The internalisation and protection responses of PrPc to copper, and the regions important 
for these responses were considered. Also, PrPc protective response to oxidative stress was 
studied to provide insight into the putative function of PrPc.
The importance of copper has been clearly demonstrated at the gene and at the protein 
level. Copper exerts significant effects on the regulation of PrPc metabolism, and is 
essential for PrPc protective function. PrPc is internalised in response to physiological 
levels of copper complexed to glycine, and protects cells against copper induced death, 
both by protection against the metal ion itself and copper induced oxidative stress. PrPc 
also protects against a direct oxidative stress insult. The octameric repeat domain is 
required for both the protective effect of PrPc against copper and oxidative stress, and for 
the internalisation of PrPc in response to copper. In both cases copper binding to at least 
one octameric repeat is essential for PrPc response. The palindromic region and its
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associated processing have been shown for the first time to have a role in copper induced 
internalisation of PrP°. Also essential for both the correct cellular processing of PrPc and 
its protective function is the hydrophobic core of the protein. The regulation of the gene is 
complex, involving interaction of the promoter with intron 1, with the gene showing 
additional activity initiated by intron 1 alone. Gene activity is tissue specific with basal 
expression varying across different cell lines, and separate regions of the gene important 
for regulating response to stimuli in various tissues.
Overall these results have provided significant insight into the genetic control of PrPc 
expression, demonstrated the importance of PrPc in copper and oxidative stress response, 
and confirmed that the octameric repeat domain and hydrophobic region are indispensable 
for PrP° function. In addition, control elements within prnp may provide potential sites for 
therapeutic intervention by control of protein expression. This study presents a valuable 
contribution to the understanding of the physiological role of PrPc and highlights new areas 
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Appendix A -  Plasmid Maps
S h o w n  b e lo w  are the p lasm id  m aps for vectors used  to c lo n e  the test constructs.
pcDNA3.1 Vectors
Map Of The figure below summarizes the features of the pcDNA3.1(+) and pcDNA3.1(-) vectors.
pcDNA3.1(+) and ^he complete sequences for pcDNA3.1(+) and pcD>'A3.1(-) are available for down-
pcDNA3 1(-) loading from onr W orld Wide Web site (www.rmitrogen.com) or from Technical
Service (see page 13). Details of the multiple cloning sites are shown on page 3 for 
pcDNA3.1(+) and page 4 for pcDNA3.1(-)
<+>,*
=  ° °  ~  _  
^CL<t:x<t:^:oQQQUjujcag><><Q-q:CL|
> ~ _ m ~ c o  =
© 2 ( 5  CD to o  o i S  E  Cl C " 2 — £
^  CL Q  I h f  §  t t
C om m ents for pcDNA3.1 (♦)
5428 nudeotides
CMV promoter: bases 232-819 
T7 promoter/priming site: b ases 863-882 
Multiple doning site: bases 895-1010 
pcDNA3.1/BGH reverse priming site: bases 1022-1039 
BGH polyadenylation sequence: b ases 1028-1252 
f1 origin: b ases 1298-1726 
SV40 early promoter and origin: bases 1731-2074 
Neomydn resistance gene (ORF): bases 2136-2930 
SV40 early polyadenylation signal: bases 3104-3234 
pUC origin: bases  3617-4287 (complementary strand)
Ampidllin resistance gene (bla): bases 4432-5428 (complementary strand) 
ORF: bases 4432-5292 (complementary strand)
Ribosome binding site: bases 5300-5304 (complementary strand) 
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E c o O m \
(3403)
N ot I (949) 
Xba  T (959)
d2EGFP





I I 21 31 41 61 91
T A  GCG  CTA  C C G  GA C T C A  GAT CTC G A G  CTC A A G  CTT C G A  ATT C T G  CAG TCG ACG  G T A  CC G  C G G  GCC C G G  GAT C C A  CCG GTC G CC A CC ATG GTG 
Eco* 7111 BglU Xhoi V  MW III fcoRI Pstl Sal I Kpn I \  Apa I V e a m H I  Age\
Sac I flee  I AsplM  I \  BspU *\ Xma III ~  r A  it r  i
Restriction Map and Multiple Cloning Site (MCS) of pd2EGFP-1. Unique restriction sites are in bold The N o t \ site follows 
the d2EGFP stop codon. The X b a  I site is methylated in the DNA provided by BD Biosciences Clontech If you wish to digest 
the vector with this enzyme, you will need to transform the vector into a d a m '  host and make fresh DNA
Location of features:
• MCS: 12-89
• Destabilized enhanced green fluorescent protein (d2EGFP) gene
Start codon (ATG): 97-99; stop codon: 940-942 
Insertion of Val at position 2: 100-102
GFPmutl chromophore mutations (Phe-64 to Leu; Ser-65 to Thr): 286-291
His-231 to Leu mutation (A-»T): 789
Mouse ornithine decarboxylase PEST sequence: 820-942
• SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1099-1104 & 1128-1133 
mRNA 3’ ends: 1137 & 1149
• ft single-strand DNA origin: 1196-1651 (packages noncoding strand of d2EGFP)
• Bacterial promoter for expression of Kanr gene
-35 region: 1713-1718; -10 region: 1736-1740 
Transcription start point: 1748
• SV40 origin of replication: 1992-2127
• SV40 early promoter
Enhancer (72-bp tandem repeats): 1823-1986 & 1897-1968 
21-bp repeats: 1972-1992, 1993-2013 & 2015-2035 
Early promoter element: 2048-2054 
Major transcription start points: 2044, 2082, 2088 & 2093
• Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2176-2178; stop codon: 2968-2970
G-*A mutation to remove Pst I site: 2358
C ^A  (Arg->Ser) mutation to remove BssH II site: 2704
• Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3206-3211 & 3219-3224
• pUC plasmid replication origin: 3555-4201
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pd2EGFP-N1T Vector Information
E co O m  I
(3985)
G C T A Q O G C T A  CCG GAC TCA  GAT CTC 








pd2EGFP BsrG I (i 389)
Pstl (1495)
Not I (1531)








AAG CTT CGA  A T T  CTG  CAG TGG ACG  GTA C O G  OQ G  GCC C O G  GAT C CA  CGG GTC  G C C  A CC ATG GTG 
Wnd III f i t j f i l  ft.fi S a f i  ttpn  I \  Apal ^fanrfil Age I 
A c t  I A s c 7 » l  \  B s o m l  Xma I 
S a c  II S o u l
Restriction Map and Multiple Cloning Site (MCS) of pd2EGFP-N1 Vector. Unique restnction sites are in bold. The 
Mof I site follows d ie  d2EG FP stop codon The Xba i site is methylated in the DNA provided by BD Biosciences Clontech 
If you wish to digest the vector with this enzym e, you will need to transform the vector into a  darrr strain and m ake fresh  DNA
Location of features:
• Human cytom egalovirus (CMV) im mediate early promoter: 1-589
E nhancer region:59-465; TATA box: 554 -560
Transcription start point 583
C —»G mutation to rem ove Sac I site: 569
• MCS: 591-671
• Destabilized enhanced  green  fluorescent protein (d2EG FP) gene
Start codon (ATG): 679-681 : stop codon 1522-1524 
Insertion of Val at position 2: 682-684
G FPm utl chrom ophore m utations (Phe-64 to Leu: Ser-65 to Thr): 871-876
His-231 to Leu mutation (A-+T) 1373
M ouse ornithine decarboxylase PEST seq u en ce  1402-1524
• SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1681-1685  & 1710-1714; mRNA 3' ends: 1719 & 1742
• f1 single-strand DNA origin: 1778-2233 (packages the noncoding strand of d2EG FP.)
• Bacterial prom oter for expression of Kan' gene
-3 5  region 2295-2300; -1 0  region 2318-2322  
Transcription start point 2330
• SV40 origin of replication 2574-2709
• SV40 early prom oter
E nhancer (72-bp tandem  repeats): 2407-2479  & 2480-2550  
21-bp repeats: 2554-2574 , 2575-2595; & 2598-2618  
Early prom oter elem ent 2630-2636  
Major transcription start points: 2626, 2664, 2670, & 2675
• Kanamycin/neomycin resistance  gene
Neomycin phospho transferase coding se q u e n c e s  start codon (ATG): 2758-2760; stop  codon;3550-3552
G-»A mutation to rem ove Pstl site: 2940
C —»A (Arg to Ser) mutation to rem ove SssH  II site: 3286
• H erpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3788-3793  & 3801-3806
• pUC plasmid replication origin: 4137-4780
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▲ = C alracticulin  targ e tin g  sec 
♦  = KDEL reten tion  se q u en c e
q u e n c e  
Plasmid Map of pDsRed2-ER. Unique restriction sites are shown in bold.
Location of features
• Human cytomegalovirus (CMV) immediate early promoter: 1-589
Enhancer region: 59-465; TATA box: 554-560 
Transcription start point: 583
• Calreticulin signal sequence: 597-647
• Discosoma sp. red fluorescent protein (DsRed2) gene: 663-1337
KDEL coding sequence (in frame with DsRed2): 1350-1361 
Stop codon 1362-1364
• SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1576-1581 & 1605-1610; mRNA 3‘ ends: 1614 & 1626
• f1 single-strand DNA origin: 1673-2128 (packages the noncoding strand of DsRed2-ER)
• Bacterial promoter for expression of Kanr gene
-35 region: 2190-2195; -10 region: 2213-2218 
Transcription start point: 2225
• SV40 origin of replication: 2469-2604
• SV40 early promoter
Enhancer (72-bp tandem repeats) 2302-2373 & 2374-2445 
21-bp repeats: 2449-2469, 2470-2490 & 2492-2512 
Early promoter element: 2525-2531 
Major transcription start points: 2521, 2559, 2565 & 2570
• Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2653-2655; stop codon: 3445-3447
• Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3683-3688 & 3696-3701
• pUC plasmid replication origin: 4032-4675
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pE G FP -C 1 V ec to r In fo rm ation
G enBank Accession #  U 55763









N he  I (592) 
E c o tl  III (5971
4001(6011
BsrG I (1323) 
MCS
(1330- 1417)
M ill I ( 1642) 
Dra 111 ( 1872)
Stu  I
( 2577)
iso 1380 1370 1400
TAC M G  TCC G G A C T C  A 6 A T C T  C G A G C T  C M 6 C T T C G  A A T TCT G C A G T C  GAC G G T  ACC GCG 6 GC CCG G G A T C C  A CC GGA TCT A G A  T A A C T G  A TC  A
BspE\ Bgl II Xbo I >  Hini HI fc o f i I Pst\ Sal I Kpn I 7 4*5*1 N  fem H  I Xba I* B d  I*
S a c  I i a  sn T if i  i ( BsaMO  I * n » l
Eel136 tl S m a  I
Restriction Map and Multiple Cloning Site (MCS) of pEGFP-C1. All restriction sites shown are unique. The Xba I and 
Bel I sites O  are methylated in the DNA provided by BD Biosciences Clontech If you wish to digest the vector with these 
enzymes you will need to transform the vector into a d a n r  host and make fresh DNA.
L o c atio n  o f  fea tu res
• Hum an cytom egalovirus (C M V ) im m ediate early promoter: 1 -5 8 9
Enhancer region. 5 9 -4 6 5 , TA TA  box: 5 5 4 -5 6 0
Transcnption start point: 583
C —»G mutation to rem ove S ac  I site: 569
• Enhanced green fluorescent protein gene
Kozak consensus translation initiation site: 6 0 6 -6 1 6  
Start codon (ATG ): 6 1 3 -6 1 5  Stop codon: 1 4 0 8 -1 4 1 0  
Insertion of Val at position 2: 6 1 6 -6 1 8
G F P m u tl chromophore mutations (P he-64 to Leu; S er-65 to Thr): 8 0 5 -8 1 0
H is-231 to Leu mutation (A —*T): 1307
Last amino acid in wild-type G FP: 1 3 2 7 -1 3 2 9
• M CS: 1 3 3 0 -1 4 1 7
• S V 40  early m RNA polyadenylation signal
Polyadenylation signals: 1 5 5 0 -1 5 5 5  & 15 7 9 -1 5 8 4 ; m RNA 3' ends: 1588 & 1600
• f1 single-strand DNA origin: 1 6 4 7 -2 1 0 2  (Packages the noncoding strand of E G FP  )
• Bacterial promoter for expression of Kanr gene
- 3 5  region: 2 1 6 4 -2 1 6 9 ; - 1 0  region: 2 1 8 7 -2 1 9 2  
Transcription start point: 2199
• S V 40 origin of replication: 2 4 4 3 -2 5 7 8
• S V 40 early promoter
Enhancer (72-bp tandem  repeats): 2 2 7 6 -2 3 4 7  & 2 3 4 8 -2 4 1 9  
2 1 -bp repeats: 2 4 2 3 -2 4 4 3 , 2 4 4 4 -2 4 6 4 , & 2 4 6 6 -2 4 8 6  
Early promoter element: 2 4 9 9 -2 5 0 5  
M ajor transcription start points: 2495 , 2533 , 2539  & 2544
• Kanam ycin/neom ycin resistance gene
Neom ycin phosphotransferase coding sequences:
Start codon (ATG ): 2 6 2 7 -2 6 2 9 ; stop codon. 3 4 1 9 -3 4 2 1
G —>A mutation to rem ove Pstl site 2809
C -* A  (Arg to S er) mutation to rem ove BssH II site: 3155
• Herpes simplex virus (H S V ) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3 6 5 7 -3 6 6 2  & 3 6 7 0 -3 6 7 5
• pUC plasmid replication origin: 4 0 0 6 -4 6 4 9
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Appendix B -  CMV Blots
S h ow n  b e lo w  are exam p les o f  phosphorim ager readings for the C M V  control in response  
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Appendix C -  Trafficking 
Controls
E xam p les o f  the A ) untreated and B ) g ly c in e  on ly  treated traffick ing contro ls for the ce ll  
lin es  not sh ow n  in the m ain  text.
No Reagent








A ) U ntreated
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TimeO 10 minutes 2 hours
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